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TEMPORAL NEUROMUSCULAR ALTERATIONS OF THE QUADRICEPS 
AFTER UNILATERAL ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION 
 
Objective: The primary aim of this research was to examine the temporal pattern 
of neuromuscular quadriceps deficits in both the involved and uninvolved limbs of 
patients assigned to the control group after anterior cruciate ligament 
reconstruction (ACLr), by assessing quadriceps strength, voluntary activation, 
and corticomotor excitability prior to surgery (baseline), three months after ACLr, 
and six months after ACLr. A secondary aim of this research was to determine 
whether quadriceps strength, voluntary activation, and/or corticomotor excitability 
assessed in patients prior to ACLr and/or at three months after surgery, is 
predictive of lower extremity postural control and/or self-reported function at six 
months after ACLr. Lastly, a tertiary aim of this research was to determine if a 12-
week home-based neuromuscular electrical stimulation (Home-NMES) program 
elicits greater bilateral improvements in quadriceps strength, voluntary activation, 
and corticomotor excitability of patients at three and six months after ACLr 
compared to a 12-week standard home-exercise program (control group). 
Participants: Fifty patients scheduled to undergo unilateral ACLr were randomly 
allocated to the home-NMES group (19 Female, 6 Male; age: 18.9 ± 5.4 years; 
height: 170.8 ± 9.7 cm; weight: 74.6 ± 18.5 kg; 28.0±20.0 days-post-injury) or 
control group (14 Female, 11 Male; age: 19.4 ± 4.5 years; height: 171.1 ± 11.5 
cm; weight: 70.7 ± 11.9 kg). Methods: A randomized clinical trial design was 
used in this study. Prior to ACLr, isometric quadriceps strength and voluntary 
quadriceps activation were assessed in both limbs of patients, and corticomotor 
excitability was assessed in the involved limb. Three days after ACLr, both 
groups were instructed to begin their allocated interventions. The Home-NMES 
group administered NMES to their involved limb’s quadriceps three sessions a 
day for 15 minutes, and five days a week for 12 weeks using a portable NMES 
device. The control group was treated according to the current standard-of-care, 
but they were also instructed to perform volitional isometric quadriceps 
contractions for the same duration and frequency as the Home-Based NMES 
protocol. The outcomes measures were reassessed in both groups at three and 
six months post-ACLr. Main Outcome Measures: Quadriceps strength and 
voluntary activation were assessed using maximal voluntary isometric 
contractions and the superimposed burst technique, respectively. Normalized 
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peak knee extension torque and central activation ratio were used to quantify 
isometric quadriceps strength and activation, respectively. Corticomotor 
excitability was evaluated with transcranial magnetic stimulation, and quantified 
with active motor threshold). The Y-balance test anterior reach (YBT-A) and 
Knee Injury and Osteoarthritis Outcome Score (KOOS) were used to assess the 
patients lower extremity knee function at six months post-ACLr. Statistical 
Analyses: Specific Aim 1: A 2x3 (limb x time) mixed model, ANOVA with 
repeated measures was performed in the control group to assess differences 
between the involved limb and the uninvolved limb for isometric quadriceps 
strength, and voluntary quadriceps activation over time. A one-way mixed model, 
ANOVA with repeated measures was performed in the control group to assess 
differences in corticomotor excitability over time. Post-hoc comparisons were 
performed when appropriate. Specific Aim 2: Separate, mixed model, linear 
regression analyses were performed in the control group (involved limb) to 
determine the effect that the neuromuscular quadriceps outcome measures 
assessed at baseline and 3 months post-ACLr, had on lower extremity knee 
functional outcome measures assessed at 6 months post-ACLr. Specific Aim 3: A 
2x2x3 (group x limb x time) mixed model, ANOVA with repeated measures was 
performed to assess group differences between the involved limb and the 
uninvolved limb in isometric quadriceps strength, and voluntary quadriceps 
activation over time. A 2x3 (group x time) mixed model, ANOVA with repeated 
measures was performed to assess group differences in corticomotor excitability 
over time. Post-hoc comparisons were performed when appropriate. Results: 
Aim 1: Patients demonstrated lower quadriceps strength on their involved limb 
compared to their uninvolved limb at baseline, three months post-ACLr, and six 
months post-ACLr. Quadriceps strength progressively decreased in the involved 
limb of patients from baseline to 3 months post-ACLr, baseline to 6 months post-
ACLr, and increased from 3 months to 6 months post-ACLr. Quadriceps strength 
was also decreased in the uninvolved limb of patients from baseline to 6 months 
post-ACLr. ). Irrespective of when it was assessed, voluntary quadriceps 
activation was higher in the involved limb of patients compared to their 
uninvolved limb. There were no changes in corticomotor excitability of the 
involved limb over time. Specific Aim 2: The quadriceps strength of patients at 
three months post-ACLr had a significant positive effect on their 6-month YBT-A 
performance KOOS score. ). Neither voluntary quadriceps activation or 
corticomotor excitability or AMT (at baseline or 3-month post-ACLr) had a 
significant effect on any of the 6-month lower extremity functional outcome 
measures. Specific Aim 3: Irrespective of limb or when it was assessed, 
quadriceps strength was higher in the control group compared to the Home-
NMES group. Both groups demonstrated lower quadriceps strength on their 
involved limbs compared to their uninvolved limbs at baseline, three months 
post-ACLr, and six months post-ACLr. Quadriceps progressively decreased in 
the involved limbs of both groups from baseline to three months post-ACLr and 
baseline to six months post-ACLr, and increased from three months to six 
months post- ACLr. At baseline, voluntary quadriceps activation was higher in the 
involved limbs of both groups compared to their uninvolved limbs. There were no 
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group differences or changes over time observed in the involved limb of both 
groups with corticomotor excitability. Conclusion: Although quadriceps weakness 
is more apparent in the involved limb of patients after ACLr, the quadriceps 
strength of their uninvolved limb was also affected. Clinicians are encouraged to 
not rely on a quadriceps strength limb symmetry index when making return-sport-
decisions for their patients after recovering from ACLr. The quadriceps in the 
uninvolved limb of patients demonstrated more inhibition, which may explain the 
quadriceps strength deficits observed in the uninvolved limb of patients following 
ACLr. To reduce the risk of subsequent injury upon return-to-sport and protect 
against the development of knee OA, we recommend that clinicians incorporate 
bilateral interventions aimed at restoring quadriceps strength and disinhibiting the 
quadriceps. Intensive quadriceps strengthening should be performed in the early 
stages of ACLr rehabilitation, so that lower extremity function can be improved in 
patients later on. Lastly, the effectiveness of home-based NMES as a modality 
for restoring quadriceps strength and activation in patients after ACLr is 
inconclusive. Home-based NMES provides patients with the ability to receive 
higher doses of NMES to the quadriceps; but its effectiveness may be limited by 
low contraction intensities and poor treatment compliance in patients. 
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 Anterior cruciate ligament (ACL) injuries are one of the most common 
knee-joint injuries seen in orthopaedics, with up to one quarter of a million of 
these injuries occurring in the United States each year.1 The majority of ACL 
injuries occur in young athletes who participate in high-risk sports, such as 
football, soccer, basketball, and skiing. ACL reconstruction (ACLr) is the 
recommended treatment for patients diagnosed with ACL injuries in effort to 
restore knee-joint stability, preserve the menisci, and allow patients to return to 
their desired levels of physical activity. The Centers for Disease Control and 
Prevention estimated that over 100,000 ACL surgeries are performed annually.2 
However, there are several postoperative side effects observed in patients 
following ACLr that must be considered. 
 Compared to healthy individuals, patients who have had previous ACLr 
have demonstrated decreased functional performance,3-10 and reported reduced 
levels of function and quality of life.8,9,11,12 Schmitt and colleagues8 reported that 
in patients who were cleared to return to sport after unilateral ACLr demonstrated 
greater limb asymmetry on functional hop test, and lower self-reported function 
compared to healthy athletes of similar age, height, and weight. In addition, 
unilateral ACLr has been repeatedly shown to alter lower extremity biomechanics 
in patients during walking,13 running,14,15 and jumping/landing tasks.16-20 Lastly, 
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ACLr does not protect patients from the development of knee osteoarthritis (OA), 
an unforgiving and incurable disease that is associated with both disability and 
mortality.21,22 Within the first decade after ACLr, it has been reported that over 
one third of patients develop knee OA, and this prevalence approaches 50% by 
the second decade.23 Furthermore, patients who undergo ACLr are found to have 
a 29% higher odds of developing knee OA compared to those who are ACL-
deficient.23 
Perhaps the most apparent side effect that is observed in patients after 
ACLr is a persistent quadriceps strength deficit in the involved limb. Although 
quadriceps weakness is also present in patients after ACL injury, it is further 
exacerbated after they undergo ACLr.3,24-31 Studies have reported quadriceps 
strength deficits in patients beyond 12 months and up to 20 years after 
ACLr.5,11,25,32-50 Kuenze et al.48 recently compared the quadriceps strength limb 
symmetry indices (LSI) of 22 patients who were an average of 2.5 years removed 
from primary ACLr, and 24 matched, healthy controls. They reported significant 
group differences in quadriceps strength, with the healthy controls demonstrating 
nearly symmetrical quadriceps strength (LSI = 97 ± 14%), and the ACLr patients 
still exhibiting persistent asymmetry beyond 2 years after surgery (LSI = 85 ± 
21%). Furthermore, growing evidence demonstrates that the quadriceps strength 
deficits observed in patients after unilateral ACLr are not specific to the involved 
limb, but are observed in the uninvolved limb as well.32,42,45,51,52 Chung et al.45 
recently assessed the temporal changes in bilateral quadriceps strength of 75 
patients up to 24 months after unilateral ACLr, and compared their values to 75 
‐ 3 ‐ 
 
matched, healthy controls. As expected, the quadriceps strength on the involved 
limb was significantly lower than that of the uninvolved limb at each postoperative 
time point leading up to 24 months (p < 0.05), but when these values were 
compared to that of the healthy control group, both the involved and uninvolved 
limbs of the ACLr group demonstrated significantly lower quadriceps strength at 
each time point. Although a LSI is typically used to quantify quadriceps strength 
deficits in the involved limbs of patients after ACLr, reports such as these 
suggest that using the uninvolved limb as the reference may deceive clinicians 
by underestimating the true magnitude of quadriceps weakness that is present. 
Therefore, it may be more beneficial for clinicians to individually compare the 
postoperative quadriceps strength of both limbs to the quadriceps strength of the 
uninvolved limb measured prior to ACLr. 
Restoring quadriceps strength in patients after ACLr is a primary focus for 
clinicians during rehabilitation, due to the association quadriceps weakness has 
with the aforementioned side effects of ACLr. A number of studies have 
demonstrated the negative effect quadriceps weakness has on functional 
performance and self-reported function in patients after ACLr.3,7-9,11,28,39,48,53-65 
Quadriceps strength has been shown to predict 25% (r2 = 0.25) of the variance in 
single-leg hop distance,54 and over 60% (r2 = 0.61) of the variance in self-
reported function of patients with a prior history of ACLr.61 Several studies have 
also demonstrated that quadriceps weakness contributes to the biomechanical 
alterations observed during dynamic tasks.54,63,66-72 Ithburn and colleagues63 
recently conducted a study comparing the quadriceps strength and single-leg 
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drop-landing biomechanics of 93 patients who were eight months post-ACLr, and 
47 age-matched healthy controls. They subdivided patients into high-strength 
and low-strength groups, and then compared the biomechanical data between 
the three groups. They not only found that both the ACL groups demonstrated 
greater knee-joint biomechanical asymmetries during landing compared to the 
healthy controls, but that these asymmetries were even more pronounced in the 
low-strength ACLr group compared to the high-strength ACLr group. 
 Perhaps the most detrimental effect quadriceps weakness has is on the 
knee-joint health of patients after ACLr. During normal gait, three to four times of 
an individual’s bodyweight is transmitted through their knee-joint.73 To limit 
excessive joint loading, the quadriceps serve as the primary shock absorber for 
the knee-joint. During ground contact (weight acceptance), the quadriceps 
eccentrically contract to absorb the majority of external forces at the knee.73-75 As 
a result, the forces transmitted through the knee-joint become dissipated, and 
minimal stress is placed on articular cartilage.76,77 Conversely, weakness of the 
quadriceps would cause higher loads to be transmitted at the knee-joint, and 
expose the articular cartilage to more contact. Therefore, it has long been 
hypothesized that quadriceps weakness contributes to the onset and progression 
of knee OA in patients following ACLr. 
Within the past decade, several studies have been able to support this 
hypothesis through longitudinal investigations.78-83 Tourville and colleagues79 
prospectively assessed tibiofemoral joint space narrowing and isokinetic knee 
extension torque (KET) in 38 patients prior to ACLr and 4 years postoperatively. 
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After follow-up testing, the authors separated patients into narrow and normal 
joint space groups based upon their 4-year radiographs, and compared the ACLr 
patients’ quadriceps strength to that of 32 healthy controls. At baseline, the 
quadriceps strength in both ACLr groups was lower than that of healthy controls. 
However, the peak KET of the narrow ACLr group’s was also significantly lower 
than that of the normal ACLr group. Four years after ACLr, the quadriceps 
strength of the normal ACLr group improved and was not significantly different 
compared to healthy controls, while the narrow ACLr group’s quadriceps strength 
remained lower than both the normal ACLr group and healthy controls. 
Furthermore, a recent systematic review and meta-analysis reported that patients 
who exhibit early quadriceps weakness have a 65% higher odds of developing 
knee OA years later (OR = 1.65).78 
In addition to the quadriceps strength deficits that are observed in patients 
after ACLr, there are concurrent neural alterations occurring throughout various 
levels of the central nervous system that result in neural quadriceps dysfunction 
(NQD). The most evident type of NQD that patients exhibit following ACLr is the 
inability to voluntary activate the quadriceps on the involved limb.32,34,51,84-86 This 
decreased voluntary activation can be explained by a diminished ability to fully 
recruit the motor units innervating the quadriceps and a reduced motor neuron 
firing frequency.87 Healthy individuals without a history of knee injury or surgery 
have the ability to volitionally activate at least 95% of the available motor units 
innervating the quadriceps.88 Therefore, a volitional activation of 95% has been 
generally accepted as the cutoff value for determining whether or not a patient 
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has neural inhibition of their quadriceps after ACLr.89,90 Like quadriceps 
weakness, quadriceps inhibition has been reported to exist bilaterally in patients 
after unilateral ACLr, with the nonsurgical limb being equivalent to that of the 
surgical limb. 32,51,91 
One of the more recent types of NQD that has been observed in patients 
after ACLr is a modified corticomotor excitability associated with the 
quadriceps.34,51,84 Corticomotor excitability is typically assessed by applying 
transcranial magnetic stimulation (TMS) to the area of the motor cortex where the 
quadriceps are most represented, and measuring the resulting neuromuscular 
responses at the quadriceps through surface electromyography (EMG).92-95 As 
opposed to quadriceps weakness and inhibition, modifications in corticomotor 
excitability are not observed immediately after unilateral ACLr.51 Lepley and 
colleagues51 longitudinally assessed the changes in corticomotor excitability of 
20 patients before and after undergoing unilateral ACLr. When compared to 
healthy controls, no differences in corticomotor excitability were found 
preoperatively or at two weeks postoperatively, but it was lower in patients at six 
months post-ACLr. However, it remains unknown whether changes in 
corticomotor excitability occur in patients during the first several months following 




After knee-joint injury and/or surgery, the knee becomes immobilized due 
to pain and swelling, causing the quadriceps to atrophy and weaken. As 
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mentioned above, quadriceps weakness can lead to altered lower extremity 
mechanics and reduced function, which may predispose patients to future injury 
such as knee OA. However, the problem is that a majority of studies assessed 
the correlation between quadriceps strength and observed sequelae (i.e., altered 
biomechanics, reduced function, knee OA, etc.) in patients cross-sectionally after 
they returned to sport activity, and were unable to determine whether earlier 
quadriceps strength deficits explained the sequelae observed in patients later on 
after ACLr. Answering this question would provide further evidence for clinicians 
to focus on quadriceps strengthening in patients during the early stages of ACLr 
rehabilitation.  
NQD has been thought to be a driving factor behind the cyclical sequelae 
(see Figure 1.1).96 NQD has been shown to explain nearly half of the variance in 
quadriceps strength of patients after ACLr.97 Therefore, NQD is thought to 
contribute to altered lower extremity biomechanics, reduced function, and early 
knee OA that are observed in patients with quadriceps weakness. However, little 
to no research has been able to confirm the effect of NQD on these 
postoperative sequelae. Furthermore, since NQD is believed to limit the ability of 
patients to regain quadriceps strength after ACLr, postoperative rehabilitation 
protocols should involve methods to properly target NQD. Traditional 
rehabilitation protocols that consist of isometric or concentric modes of exercise 
to enhance quadriceps strength in patients after ACLr have been largely 
ineffective.98,99 This led to the introduction and development of disinhibitory 




Figure 1.1. Cyclical sequelae of knee-joint injury/surgery. An adapted paradigm 
from Stokes and Young, 1985, Clinical Science, 67, 7-14.96 
 
have been shown to successfully mediate NQD in patients with a history of knee-
joint injury/surgery by targeting its underlying mechanisms.100-102 
Neuromuscular electrical stimulation (NMES) is a motor-based modality 
which elicits muscle contractions by directly activating the intramuscular nerve 
branches through surface electrodes at the skin.103 NMES has been well 
established in the literature as an effective modality for restoring quadriceps 
strength in patients after ACLr.70,104-110 Although these strength improvements 
can be easily attributed to the muscle hypertrophy,111-115 it is believed that neural 
adaptations elicited by NMES are partly responsible for the increases in muscle 
strength.111-113,116,117 However, there is conflicting evidence concerning the 















injury/surgery. Several studies have reported improvements in the voluntary 
quadriceps activation of patients with NMES interventions.116,118-122 Stevens et 
al.118 assessed the effect of a quadriceps exercise program supplemented with 
NMES for patients after total knee arthroplasty. Compared to those patients who 
did not receive supplemental NMES, the group who received NMES with 
exercise demonstrated significant improvements in voluntary quadriceps 
activation at three weeks, six weeks, and six months postoperatively.101 Other 
studies have negated the disinhibitory effects of NMES,123-128 but no study has 
investigated the disinhibitory effect of NMES in patients after ACLr. Furthermore, 
portable NMES units have demonstrated promising results in regard to improving 
outcomes.129-131 The higher volume of NMES combined with the convenience of 
home-based NMES, make these units an attractive modality for postsurgical 
patients. Therefore, research is needed to assess the effect of home-based 
NMES on improving neuromuscular quadriceps function in patients after ACLr. 
 
1.3 SPECIFIC AIMS 
  
1. To examine the temporal pattern of neuromuscular quadriceps 
deficits in both the involved and uninvolved limbs of the patients 
assigned to the control group after ACLr, by assessing 
quadriceps strength, voluntary activation, and corticomotor 
excitability prior to ACLr (baseline), three months after ACLr, and 
six months after ACLr. We hypothesized that quadriceps strength 
and voluntary activation would be lower in the involved limb compared 
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to the uninvolved limb at each time point. We believed this because 
previous reviews have demonstrated side-to-side quadriceps strength 
differences in patients after ACLr at similar time points.98,132 Secondly, 
we expected that quadriceps strength and voluntary activation would 
decrease in the involved limb at three months post-ACLr compared to 
baseline, and return to baseline values at six months post-ACLr. We 
believed this because neuromuscular quadriceps function has been 
found to be more affected within the first few months after ACLr 
compared to ACL injury,3,24,27,31,133 and it begins to return to 
preoperative levels around six months post-ACLr.24,51  We expected 
that the corticomotor excitability of the involved limb’s quadriceps 
would progressively decrease over time, and be most pronounced at 
six months in accordance with the recent findings from Lepley et al.51 
Lastly, we expected that the quadriceps strength and voluntary 
activation of the uninvolved limb to progressively decrease over time, 
because recent studies have shown that these two measures are 
decreased in both limbs of patients after unilateral ACLr.34,42,45,51,84,91 
 
2. To determine whether quadriceps strength, voluntary activation, 
and/or corticomotor excitability assessed in patients prior to 
surgery and/or at three months after ACLr, can predict lower 
extremity postural control and/or self-reported function at six 
months post-ACLr. We hypothesized that the patients’ quadriceps 
strength and activation assessed at baseline and three months after 
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ACLr would significantly influence the lower extremity postural control 
and self-reported function at six months post-ACLr. We believed this 
because these measures are sensitive to change within the first few 
months after ACL injury and reconstruction,3,24,27,31,133 and they have 
previously been reported to affect knee function in patients.53-55,60-
62,72,134 Secondly, we expected that corticomotor excitability would have 
an insignificant influence on these same outcomes, mainly because 
this measure has been found to be less affected within the first few 
months after ACL injury and reconstruction.51 
 
3. To determine if a 12-week home-NMES program elicits greater 
bilateral improvements in quadriceps strength, voluntary 
activation, and corticomotor excitability of patients at three and 
six months after ACLr compared to a 12-week standard home-
exercise program (control group). We hypothesized that patients 
who performed the home-NMES program would demonstrate greater 
bilateral improvements in quadriceps strength, voluntary activation, 
and corticomotor excitability at both three and six months post-ACLr 
compared to patients in the control group. We believed this because of 
the previous literature that has demonstrated neuromuscular 
improvements in the quadriceps of patients after NMES 
interventions,105,106,118,122 the evidence of NMES targeting cortical 
areas of the brain,116,135-137 and the phenomenon of cross-education 
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CHAPTER 2: REVIEW OF LITERATURE 
 
2.1 INTRODUCTION 
2.1.1 Evidence of Quadriceps Weakness 
 Quadriceps weakness is the most prevalent neuromuscular deficit 
observed in the involved limbs of patients following ACL injury and ACLr. The 
incidence and progression of quadriceps weakness has been well documented in 
the literature.3,5,8,11,24-49,51,52,56,57,59,64,65,86,91,98,132,133,140-179 As a result, quadriceps 
weakness has become an expected side effect of knee-joint trauma amongst 
clinicians. Although ACLr is the recommended treatment to restore knee-joint 
stability and improve function in patients with ACL injuries, it is not an effective 
treatment for restoring quadriceps strength. In fact, quadriceps weakness is 
further exacerbated in patients after ACLr compared to when they were without 
an intact ACL (ACL-deficient).3,24-31 Moreover, the amount of quadriceps 
weakness a patient exhibits prior to ACLr has been reported to be directly related 
to the magnitude of quadriceps strength that will be further lost after 
ACLr.27,56,64,147 Therefore, it is important for clinicians to focus their rehabilitation 
on restoring quadriceps strength in patients both before and after ACLr. 
Quadriceps strength is typically assessed by having the patient perform a 
maximal voluntary contraction of the quadriceps during an open kinetic chain, 
knee extension task. This can be performed either isometrically (fixed knee-joint 
angle) or isokinetically (fixed angular velocity), with peak KET being the primary 
measure of interest (measured in Nm or ft·lbs). An LSI is commonly used to 
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quantify quadriceps weakness in patients after ACLr, which involves dividing the 
peak KET produced in the involved limb by the peak KET produce in the 
uninvolved limb (often reported as a percentage). Previous literature reviews 
have reported that the average quadriceps strength LSI observed in patients 
after ACLr was less than 80% at six months post-ACLr,98,132 and less than 90% 
at 12 months post-ACLr.132 A criterion that is regularly used by clinicians when 
determining whether a patient is ready to return to activity/sport after ACLr, is if 
their quadriceps strength LSI is equal to or greater than 90%.8,28,68,180,181 
However, most patients are discharged from rehabilitation and receive medical 
clearance to return to their pre-injury physical activities or sports between six and 
12 months after their ACLr.  
This incongruity is most likely the result of the clinical methods used to 
assess quadriceps strength in these patients. An isokinetic dynamometer is 
referred to as the “gold standard” tool for measuring KET attributed to quadriceps 
strength. However, these devices are rarely available in physical therapy clinics 
due to their high financial cost. Therefore, most clinicians resort to manual 
muscle tests or leg extension machines, which can compromise the validity and 
reliability of the quadriceps strength assessment. In addition, quadriceps strength 
LSI is known to be affected by angular velocity used during isokinetic 
assessments. Several studies have reported insufficient quadriceps strength 
symmetry (LSI ≤90%) in patients after ACLr when testing (concentrically) at an 
angular velocity of 60°/s, but when testing at angular velocities of 120°/s or 
faster, these same patients were able to meet the criterion (LSI 
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≥90%).30,31,57,132,133,142,168,178,179 Most recently, Hsiao et al.31 assessed quadriceps 
strength LSI in patients after ACLr using a variety of angular velocities (isokinetic) 
as well as knee-joint angles (isometric). When compared to the pre-ACLr values, 
significant decreases in quadriceps strength LSI were only observed at the 
slower angular velocities (concentric at 50°/s and 100°/s) and the larger knee 
flexion angles (70° and 90°). Although this phenomenon has yet to be fully 
understood from a physiological standpoint, it must be considered by clinicians 
when performing quadriceps strength assessments on these patients. Current 
evidence suggests that quadriceps strength should be tested isometrically at 70-
90° of knee flexion,31 and/or isokinetically at an angular velocity of 60°/s 
(concentric) in order to detect asymmetries in patients following ACLr.98,132  
The length of time quadriceps weakness has been found to persist in 
patients following ACLr is of equal concern. Studies have reported quadriceps 
strength deficits in patients beyond 12 months and up to 20 years after 
ACLr.5,11,25,32-50 Kuenze et al.48 recently compared the quadriceps strength LSI of 
22 patients (average of 2.5 years removed from primary ACLr), and 24 matched, 
healthy controls of comparable age, height, and weight (p >0.05). After assessing 
isometric quadriceps strength (90° of knee flexion) bilaterally in both groups, they 
reported significant group differences in quadriceps strength LSI (p = 0.03). The 
healthy controls demonstrated nearly symmetrical quadriceps strength (LSI = 97 
± 14%), whereas the ACLr patients still exhibited persistent asymmetry beyond 
two years after surgery (LSI = 85 ± 21%). The persistent quadriceps weakness 
that is observed in patients with a history of ACLr is likely the result of a 
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combination of multiple factors. First, this may mean that patients are being 
released from rehabilitation prematurely and the current quadriceps 
strengthening interventions used in rehabilitation are not efficacious. Secondly, 
patients may have achieved the recommended 90% LSI for quadriceps strength 
at their date of clearance to return to activity/sport, but they failed to maintain that 
symmetry years after their ACLr. Lastly, patients may have developed sequelae 
such as patellofemoral pain or early knee osteoarthritis, which have also been 
associated with quadriceps strength deficits.59,182 
It must be mentioned that the attenuation of quadriceps strength that has 
been consistently observed in the involved limbs of patients after unilateral ACLr, 
has also been reported in these patients’ uninvolved limbs.32,42,45,51,52 Although 
more research is needed to understand the manifestation of contralateral 
quadriceps weakness in patients after unilateral ACLr, the available evidence 
relative to this matter is sufficient to deserve clinical consideration. Chung et al.45 
recently assessed the temporal changes in bilateral isokinetic quadriceps 
strength (concentric at 60 deg/s) of 75 patients at three, six, 12, and 24 months 
after unilateral ACLr. In addition, they compared the peak KET values of the 
ACLr patients to 75 healthy controls who were of equal age, sex, height, weight, 
and pre-injury physical activity level (via Tegner activity scale). In the ACLr 
group, the uninvolved limb’s peak KET was significantly higher than that of the 
involved limb at three (266.1 ± 43.7 Nm vs. 178.8 ± 51.2 Nm), six (276.4 ± 42.7 
Nm vs. 224.2 ± 58.5 Nm), 12 (276.7 ±44.9 Nm vs. 235.4 ± 56.9 Nm), and 24 
months (276.6 ± 42.8 Nm vs. 242.8 ± 55.5 Nm) after ACLr (p < 0.05). However, 
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when these values were compared to that of the healthy control group (290.9 ± 
40.1 Nm), both the involved and uninvolved limbs of ACLr group demonstrated 
significantly lower peak KET at each follow-up time point (p < 0.05). Evidence 
such as this suggests that using the uninvolved limb as the reference when 
assessing quadriceps strength in patients after unilateral ACLr may 
underestimate the magnitude of quadriceps strength deficits. Therefore, the 
quadriceps strength LSI could mask true quadriceps weakness and deceive 
clinicians when making the decision to return patients to their pre-injury 
activity/sport after ACLr. For example, a patient may demonstrate greater than 
90% quadriceps strength LSI, but if the quadriceps strength of their uninvolved 
limb has also declined since the initial ACL injury, then the recovery of 
quadriceps strength on the involved limb may be overestimated by an LSI.  
Clearing a patient to return to their pre-injury activity/sport prior to 
restoring bilateral quadriceps strength may place both of their limbs at risk for 
subsequent knee-joint injury, and expose the knee to increased contact forces 
due to the decreased force absorption capabilities from the quadriceps. To 
unmask the quadriceps strength deficits in the involved limbs of patients and 
account for the potential deficits of their uninvolved limbs, clinicians are 
encouraged to not depend on an LSI when assessing the recovery of quadriceps 
strength in patients after unilateral ACLr. Alternatively, it is recommended that 
clinicians compare the bilateral peak KET data of their ACLr patients to those of 
healthy individuals who are of similar age and stature (preferably normalized to 
bodyweight: Nm/kg or Ft·lbs/lbs). If data from healthy individuals are not 
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available to clinicians, the second best alternative is to compare the patients’ 
postoperative bilateral quadriceps strength to the preoperative quadriceps 
strength of their uninvolved limbs after the initial ACL injury. Although acute ACL 
injury is known to elicit deficits in ipsilateral quadriceps strength, there is no 
evidence to suggest that acute ACL injury affects quadriceps strength in the 
contralateral limb. Using these alternative comparison strategies provides 
clinicians with a clearer representation of quadriceps strength recovery in the 
involved limbs of patients after ACLr, and allows clinicians to determine if 
postoperative quadriceps weakness is present in the uninvolved limbs so that 
adjustments can be made in rehabilitation to correct bilateral quadriceps strength 
deficits. 
2.1.2 Consequences of Quadriceps Weakness 
 Given the ubiquitous nature of quadriceps weakness in patients who have 
undergone ACLr, and its tendency to remain years after surgery, it is important to 
understand the consequences of persistent quadriceps weakness. Since the 
quadriceps are the largest muscle group of the lower extremity, which function to 
facilitate movement and absorb external forces, it is expected that weakness in 
this muscle group would lead to functional limitations in patients after ACLr. The 
following section will discuss the consequences of quadriceps weakness on the 
functional performance, self-reported function, lower extremity biomechanics, 




 Single-leg hop (SLH) testing is one of the more common methods used by 
clinicians to assess lower extremity functional performance in patients after ACLr. 
This testing consists of either a single hop for distance,183-185 a timed 6-meter 
hop,183 a straight triple hop for distance,185 a cross-over triple hop for distance,185 
or a combination of the four. SLH testing is regularly used in conjunction with 
quadriceps strength testing for return to activity/sport decision making, with the 
same criteria (≥ 90% LSI) being used to determine a patient’s physical readiness 
to return to their pre-injury level of physical activity. In fact, growing evidence has 
shown that quadriceps strength and SLH performance is higher (or more 
symmetrical) in patients who return to activity/sport after ACLr compared to those 
who do not.180,186,187 
Numerous studies have reported that quadriceps weakness negatively 
affects a patient’s performance on SLH tests after ACLr.3,7-9,28,39,53-59 Keays et 
al.28 assessed the isokinetic peak KET (concentric at 60 and 120 deg/s), single 
hop for distance, triple hop for distance, and performance on several agility tests 
in 31 patients before unilateral ACLr and at their 6-month postoperative follow-
up. The authors then sought to determine whether quadriceps strength was 
correlated with functional performance before and after ACLr. Before ACLr, 
significant correlations were observed between isokinetic quadriceps strength (at 
both speeds) and performance on single (60 deg/s: r = 0.55, 120 deg/s: r = 0.53; 
p < 0.01) and triple hop tests (60 deg/s: r = 0.55, 120 deg/s: r = 0.59; p < 0.01). 
However, significant correlations were reported for the agility tests at six months 
after ACLr (60 deg/s: r = 0.47 – 0.53, 120 deg/s: r = 0.46 –  0.52; p ≤ 0.01), and 
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stronger correlations were also observed between quadriceps strength and the 
single (60 deg/s: r = 0.66, 120 deg/s: r = 0.74; p < 0.00) and triple hop tests (60 
deg/s: r = 0.62, 120 deg/s: r = 0.74; p < 0.001). This study not only demonstrated 
the relationship between quadriceps strength and lower extremity functional 
performance, but that this relationship is even stronger in patients following ACLr. 
A recently published study by Palmieri-Smith and colleagues54 reported that 
isokinetic quadriceps strength LSI (concentric at 60 deg/s) significantly predicted 
25% (r2 = 0.25; p < 0.002) of the SLH for distance LSI in patients six to eight 
months removed from ACLr.  
There is also some evidence to suggest that postoperative quadriceps 
strength is related to vertical jump height in patients after ACLr.4,7 Laudner et al.4 
recently assessed isokinetic peak KET (concentric at 60 and 300 deg/sec), and 
both single and double leg vertical jump height in 26 patients who were an 
average of eight (7.8 ± 1.9) months post-ACLr and 26 healthy controls (matched 
by height and weight). The bilateral differences in single leg vertical jump height 
and peak KET (at both speeds) were significantly greater in patients than in the 
healthy controls (p = 0.001). Furthermore, they found that isokinetic peak KET 
was significantly correlated with both single (60 deg/s: r = 0.71, 300 deg/s: r = 
0.74; p < 0.05): and double leg (60 deg/s: r = 0.64, 300 deg/s: r = 0.63; p < 0.05) 
vertical jump height in patients. This data suggest that quadriceps weakness not 
only mitigates single-leg jump performance in the horizontal direction, but in the 
vertical direction as well. 
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Altogether, this evidence demonstrates the importance of restoring 
quadriceps strength in patients after ACLr in regards to improving lower extremity 
functional performance and preparing them to return to activity/sport. Therefore, 
clinicians should continue to emphasize quadriceps strengthening in the later 
stages of rehabilitation to facilitate improvements in lower extremity function.  
Self-Reported Function 
 Self-reported function is another outcome used by clinicians to determine 
how well patients perceive their knee-joint pain, symptoms, and function following 
ACLr. It is used to determine how successful ACLr and postoperative 
rehabilitation are as treatments for ACL injuries. Questionnaires are used to 
assess self-reported function and collect data on patients before and/or after 
ACLr. The questionnaires that are currently used to assess self-reported function 
in patients who have undergone ACLr are the International Knee Documentation 
Committee (IKDC) form and Knee Osteoarthritis Outcome Score (KOOS). The 
IKDC is a valid and reliable questionnaire for assessing self-reported function in 
patients after ACL injury or reconstruction.188,189 The KOOS consists of 18 
questions that pertain to knee-joint symptoms, and performance during dynamic 
and daily activities. Excellent validity and reliability has been reported for the 
KOOS in both ACL injury and ACLr patient populations.190-193 It consists of 42 
questions that are categorized into five domains: knee-joint symptoms, knee-joint 
pain, function with activities of daily living, function with sports/recreation, and 
quality of life. Both the IKDC and KOOS (total) are scored on a 0-100 scale, with 
100 representing the highest self-reported function. However, clinicians are 
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urged to analyze and interpret each domain of the KOOS separately. Therefore, 
each KOOS domain is typically scored separately on a 0-4 scale and 
transformed into a percentage (0-100%). 
 Both the IKDC and KOOS,8,48,55,60-63 as well as other questionnaires 
pertaining to self-reported function (Cincinnati Knee Score, Lysholm, and Tegner 
activity scale),11,39,64,65 have been shown to be related to quadriceps strength of 
patients after ACLr. Perhaps the most impressive study that supported this 
relationship was that done by Pietrosimone and colleagues.61 They assessed 
isometric peak KET (at 90° of knee flexion) and IKDC scores in 15 patients who 
were an average of 54.4 (± 40.9) months removed from ACLr, and performed a 
linear regression analysis to determine the amount of variability in self-reported 
function that could be explained by their quadriceps strength. They discovered 
that isometric quadriceps strength predicted over 60% (r2 = 0.61; p = 0.01) of the 
variance in the IKDC scores of patients who have a history of ACLr. This finding 
demonstrates that the majority of self-reported function (via IKDC) in patients 
after ACLr can be explained by their quadriceps strength, and that quadriceps 
weakness can severely limit these patients’ perceived function. 
Lower Extremity Biomechanics  
 Assessing a patient’s lower extremity biomechanics after ACLr is also 
important to determine whether there are kinematic and/or kinetic patterns that 
give insight into specific weaknesses or place patients at risk for subsequent 
injury. 3-D motion analyses are known as the gold standard for assessing 
biomechanical patterns in individuals. They can provide information relative to 
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joint angles, joint moments (internal and external), and vertical ground reaction 
forces during various dynamic tasks (i.e., walking, running, jumping, etc.). 
Although 2-D motion analyses are less expensive and can provide similar 
information, they do not possess the same level of validity and reliability as 3-D 
motion analyses. Therefore, a 3-D motion analysis is typically used by 
researchers when assessing lower extremity biomechanics in patients before 
and/or after ACLr. 
 Unilateral ACLr has been repeatedly shown to alter lower extremity 
biomechanics in patients during walking,13 running,14,15 and jumping/landing 
tasks.16-20 However, several studies have demonstrated that quadriceps 
weakness contributes to the biomechanical alterations observed during these 
tasks.54,63,66-72 Ithburn and colleagues63 recently conducted a study comparing 
the isometric quadriceps strength LSI (at 60° of knee flexion) and single-leg drop-
landing biomechanics of 93 patients (mean age, 17.3 years) who were eight 
months post-ACLr, and 47 age-matched healthy controls (mean age, 17.0 years). 
After assessing the quadriceps strength of the ACLr group, they subdivided 
patients into high-strength (≥ 90% LSI) and low-strength (< 80% LSI) groups, and 
then compared the biomechanical data between the three groups (high-strength 
ACLr, low-strength ACLr, and healthy control). They reported that both ACL 
groups demonstrated greater knee-joint biomechanical asymmetries during 
landing compared to the healthy controls. Specifically, decreased knee flexion 
excursion (low-strength, p < 001; high-strength, p = 0.02) and peak internal knee 
extension moments (low-strength, p < 001; high-strength, p < 0.01), and peak 
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increased trunk flexion angle (low-strength, p < 001; high-strength, p = 0.03) 
were observed in the involved limbs of the ACLr groups. However, knee flexion 
excursion (p = 0.03) and peak internal knee extension moments (p = 0.03) were 
further decreased, and peak trunk flexion angle was increased (p < 0.01) in the 
involved limbs of the low-strength ACLr group compared to the high-strength 
ACLr group. The authors also performed a linear regression analysis, and 
reported that isometric quadriceps strength LSI was a significant predictor for 
knee flexion excursion (r2 = 0.12, p < 0.001), peak internal knee extensor 
moment (r2 = 0.10, p < 0.001), and peak trunk flexion angle (r2 = 0.15, p < 0.001). 
Similar results have been previously reported by Lewek et al.68 They discovered 
that quadriceps strength LSI in patients after ACLr significantly predicted peak 
knee flexion angles (r2 = 0.25, p < 0.05) and peak internal knee extension 
moments (r2 = 0.38, p < 0.01) during a jogging task. 
In another study by Schmitt et al.,67 they reported that external 
biomechanical forces are also distributed differently between the limbs of patients 
at the time of return to activity/sport after unilateral ACLr. Similar to Ithburn et 
al.,63 they divided patients into high (≥ 90% LSI) and low-strength (< 85% LSI) 
groups, and compared biomechanical data to that of an age-matched, healthy 
control group. However, instead of performing single-leg landing task, the 
participants performed a double-leg drop vertical jump task. Compared to the 
high-strength ACLr and healthy control groups, the low-strength ACLr group 
demonstrated greater asymmetry in peak external knee flexion moments (p < 
0.001, p < 0.001, respectively), peak vertical ground reaction forces(p < 0.001, p 
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< 0.001, respectively), and peak loading rates (p < 0.01, p < 0.05, respectively). 
Specifically, all three biomechanical measures were significantly lower in the 
involved limbs and higher in the uninvolved limbs of the low-strength ACLr group. 
There were no significant differences between the high-strength ACLr group and 
healthy control group in regards to biomechanical limb symmetries (p < 0.05). 
Knee-joint excursion and internal knee extension moments are 
biomechanical measures that are believed to be controlled through an eccentric 
contraction of the quadriceps.68 Therefore, a reduction of these two measures 
may be an indicator of quadriceps weakness. The increased trunk flexion angle 
observed in ACLr patients is said to be a compensatory biomechanical strategy 
to accommodate for quadriceps weakness by shifting ground reaction forces 
anterior to the knee.16 Furthermore, the asymmetrical distribution of external 
forces between limbs of patients who exhibit quadriceps weakness after ACLr 
has been theorized to place both knee-joints at risk for subsequent knee-joint 
injury.67,194 While the ipsilateral quadriceps weakness exhibited in patients after 
unilateral ACLr may decrease their ability to absorb shock at the surgical knee-
joint, their increased reliance on the contralateral limb may also overload the 
nonsurgical knee-joint. Although ACLr alone has an effect on lower extremity 
biomechanics, quadriceps weakness seems to further contribute to 
biomechanical alterations in these patients. 
Knee-Joint Health 
 The development of knee OA is a common side effect in patients who 
sustained ACL injuries.195,196 Although ACLr is a successful treatment for 
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restoring knee-joint stability in these patients, it is largely ineffective at preventing 
the development of knee OA. Within the first decade after ACLr, it has been 
reported that over one third of patients develop knee OA, and this prevalence 
approaches 50% by the second decade.23 Furthermore, patients who undergo 
ACLr are found to have a 29% higher odds of developing knee OA compared to 
those who are ACL-deficient.23 These statistics are interesting given that ACLr 
has also been shown to exacerbate quadriceps weakness in patients who 
sustain ACL injuries, which is why many researchers have hypothesized 
quadriceps weakness to be a risk factor for the onset and progression of knee 
OA in these patients.73-75,197 
 During normal gait, three to four times the bodyweight of a healthy 
individual is transmitted through their knee-joint.73 To limit excessive joint loading, 
the quadriceps serve as the primary shock absorber for the knee-joint. During 
ground contact (weight acceptance), the quadriceps contract eccentrically to 
absorb the majority of external forces at the knee.73-75 As a result, the forces 
transmitted through the knee-joint become dissipated, and minimal stress is 
placed on articular cartilage.76,77 Therefore, weakness of the quadriceps would 
likely cause higher loads to be transmitted at the knee-joint, and expose the 
articular cartilage to more contact. Two studies76,198 used a femoral nerve block 
to temporarily paralyze the quadriceps of healthy individuals, and assessed the 
change in loading rate at the knee during gait. After quadriceps paralysis, the 
loading rate at the knee during heel-strike increased to more than twofold in 
these individuals. The authors concluded that the increase in knee-joint loading 
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was a direct reflection of the inability of the quadriceps to absorb external forces 
during weight acceptance.  
 Since quadriceps weakness was first hypothesized to be related to the 
onset and progression of knee OA, considerable research has been devoted to 
determining the legitimacy of this relationship. As of today, there are numerous 
studies that have been able to establish an association between quadriceps 
weakness and knee OA in patients.78-83,182,199-214 Slemenda and colleagues212 
were one of the first groups to demonstrate the integral role quadriceps strength 
has on lowering the risk of knee OA in patients. They assessed isokinetic KET 
(concentric at 60 deg/s) and radiographic tibiofemoral knee OA in 462 individuals 
who were over the age of 65 years. Those individuals with Kellgren-Lawrence 
grades greater or equal to 2 were classified as having knee OA, and those who 
graded less than 2 were classified as healthy controls. Compared to the healthy 
controls, those individuals with radiographic knee OA had approximately 20% 
less quadriceps strength (p < 0.01). In addition, they reported that for every 10 
ft·lb increase in isokinetic KET, there was a 20% lower odds of radiographic knee 
OA (OR = 0.80, CI = 0.71-0.90) and 29% lower odds of symptomatic knee OA 
(OR = 0.71, CI = 0.59-0.87). Thus, higher quadriceps strength served as a 
protector against knee OA in older individuals. These results were later 
supported by Baker et al.,210 who reported high isometric KET (at 90° of knee 
flexion) to be a significant protector against mixed knee OA (tibiofemoral and 




However, the limitation of these two studies is that their assessments were 
cross-sectional, which is the case for the majority of studies in this area.199-
203,205,207-209,211,213,214 In other words, these studies are unable to discern whether 
OA precedes quadriceps weakness, or quadriceps weakness precedes OA. 
Therefore, longitudinal follow-up studies are ideal for determining the true effect 
quadriceps weakness has on the onset and progression of knee OA. There have 
been a handful of longitudinal studies that have been able to demonstrate that 
quadriceps weakness is a significant contributor to the onset of knee OA in 
patients.78-83,212 Tourville and colleagues79 assessed tibiofemoral joint space 
narrowing and isokinetic KET (concentric at 60 deg/s) in 38 patients prior to ACLr 
(baseline) and four years postoperatively. After follow-up testing, the authors 
separated patients into narrow and normal joint space groups based upon their 
4-year radiographs. They also compared the ACLr patients’ quadriceps strength 
to that of 32 healthy controls of similar age, body mass index, and physical 
activity level. At baseline, the quadriceps strength in both ACLr groups was lower 
than that of healthy controls (p < 0.001). However, the quadriceps strength of the 
narrow ACLr group’s peak KET was also significantly lower than that of the 
normal ACLr group (p = 0.04). Four years after ACLr, the quadriceps strength of 
the normal ACLr group (95 ± 10.3% LSI) improved and was not significantly 
different compared to healthy controls (99 ± 11.6% LSI, p > 0.05), while the 
narrow ACLr group’s quadriceps strength (83 ± 23.1% LSI) remained lower than 
both the normal ACLr group (p = 0.04) and healthy controls (p = 0.01). A more 
recent systematic review and meta-analysis by Oiestad et al.78 reported that 
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initial quadriceps weakness increased the odds of patients developing knee OA 
(radiographic and/or symptomatic) by 65% (OR = 1.65, CI = 1.23-2.21). While 
this study concluded that quadriceps is a significant risk factor of knee OA, their 
analyses only consisted of five longitudinal studies.82,83,212,215,216  
Compared to the handful of longitudinal studies that have been able to 
support that the onset of knee OA in patients is related to a history or quadriceps 
weakness, there are even fewer longitudinal studies available that demonstrate 
that quadriceps weakness influences the progression of knee OA.204,206 Both 
studies assessed initial isokinetic peak KET (concentric at 60 deg/s) in patients 
diagnosed with knee OA, and divided them into tertiles according to quadriceps 
strength (low, med, and high strength). At 30-month follow-up, the severity of 
knee OA was assessed in both studies to determine whether initial quadriceps 
strength contributed to the progression of knee OA. In the earlier study, Amin and 
colleagues206 reported that compared to the patients in the lowest tertile of 
quadriceps strength at baseline, the patients in the highest tertile had a 60% 
lower odds of progressive patellofemoral osteoarthritis 30 months later (OR = 
0.40, CI = 0.2-0.9). A later study, by Segal et al.,204 reported that women in the 
lowest tertile of quadriceps strength at baseline had a 69% odds of having 
tibiofemoral joint-space narrowing at their 30-month follow-up (OR = 1.69, CI = 
1.26-2.28). Although these results are impactful, more studies are needed to 
confirm the influence quadriceps weakness has on both the onset and 




  In addition to quadriceps weakness being associated with poor knee-joint 
health, there is also some evidence showing that quadriceps weakness affects 
the general health of individuals.217-220 The progressive loss of quadriceps 
strength over a period of 11 years has been reported to increase the risk of 
fragility fracture in men and women who are over 60 years of age.217 
Furthermore, quadriceps strength has been shown to protect against mortality in 
patients with chronic obstructive pulmonary disorder because it is believed to 
improve their exercise capacity.218 Evidence such as this portrays the importance 
of restoring quadriceps strength in patients after ACLr in order to improve their 
quality of life and longevity. 
 
2.2 EXPLAINING QUADRICEPS WEAKNESS 
 Although age, physical activity level, and surgical factors can affect 
quadriceps strength in patients after ACLr, there are several neuromuscular 
changes that occur in the quadriceps that can explain the persistent quadriceps 
weakness observed in this patient population. The remainder of this review will 
be devoted to the providing evidence on the neuromuscular changes that occur 
in the quadriceps after ACLr, understanding the mechanisms and ramifications of 
these changes, and discussing the disinhibitory interventions that can be used to 
correct these changes and restore quadriceps strength in patients after ACLr. 
2.2.1 Modified Quadriceps Morphology 
Evidence of Quadriceps Atrophy 
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Along with quadriceps weakness, atrophy of the quadriceps can be just as 
evident on the involved limbs of patients following unilateral ACLr. Quadriceps 
atrophy has been consistently reported in the literature for patients who have 
sustained an ACL injury and/or have undergone subsequent ACLr. Thigh 
circumference,47,221-226 quadriceps cross-sectional area (CSA) and volume are all 
measures that have been shown to decrease following knee-joint trauma in these 
patient populations.33,47,52,91,169,170,225,227-235 Quadriceps CSA and volume are 
typically assessed using magnetic resonance imaging (MRI) or computed 
tomography (CT), whereas thigh circumference is typically assessed using a 
cloth tape measurer. Of these measures, quadriceps CSA and volume are the 
gold standard for assessing quadriceps atrophy, because unlike thigh 
circumference, they can partition out adjacent musculature, bone, and adipose 
tissue. However, the elevated financial costs associated with using an MRI or CT 
to assess quadriceps CSA and volume are not as economically or clinically 
feasible as a thigh circumference assessment. A tool that may provide a middle-
ground between sensitivity and economy when it comes to assessing quadriceps 
atrophy is that of diagnostic ultrasound. Diagnostic ultrasound has recently been 
shown to detect differences in muscle thickness at the quadriceps of patients 
after ACLr.236 Its lower cost compared to an MRI and CT, combined with its 
higher sensitivity compared to thigh circumference make diagnostic ultrasound 
an attractive alternative tool, yet more research is needed to determine the 




Although it is the recommended treatment for restoring knee-joint stability 
in patients who have sustained ACL injuries, unilateral ACLr does not seem to be 
an effective treatment to attenuate quadriceps atrophy. Lindstrom et al.230 
recently assessed quadriceps CSA (combining the four quadriceps muscles) in 
male and female patients who had a history of ACL-deficiency and underwent a 
subsequent unilateral ACLr. Prior to surgery, the quadriceps CSA was 
significantly smaller on the involved limb (males: 616.5 ± 24.4 cm2, females: 
441.1 ± 12.5 cm2) compared to the uninvolved limb (males: 638.4 ± 21.7 cm2, 
females: 474.4 ± 12.7 cm2; p < 0.001) of patients. Quadriceps CSA was 
reassessed in patients one year after unilateral ACLr, and significant quadriceps 
atrophy was still observed in the involved limb (males: 616.7 ± 24.7 cm2, females: 
433.9 ± 18.6 cm2) when compared to the uninvolved limb (males: 644.7 ± 20.7 
cm2, females: 473.5 ± 17.9 cm2; p < 0.001). Several studies have supported 
these findings, demonstrating ipsilateral quadriceps atrophy in patients who are 
one year or more removed from unilateral ACLr.47,221,227,236 In fact, Arangio et 
al.47 reported differences in quadriceps CSA (averaging the four quadriceps 
muscles) between limbs in patients who were an average of four years (48.7 
months) removed from unilateral ACLr (involved: 51.3 ± 1.3 cm2, uninvolved: 
55.8 ± 1.27 cm2; p < 0.001). 
Interestingly, significant quadriceps atrophy has not been consistently 
observed in patients who are ACL-deficient.231 Within the past decade, several 
studies have been performed to determine whether or not differences in 
quadriceps atrophy exist between ACL-deficient patients who are classified as 
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non-copers and those classified as copers.228,231,232 Non-copers represent the 
majority of ACL-deficient patients. They are defined as patients who report 
recurrent episodes of knee-joint instability and reduced physical function. 
Therefore, these patients often undergo ACLr to restore knee-joint stability and 
improve their physical function. Conversely, copers represent a small cohort of 
ACL-deficient patients who are able to maintain their pre-injury physical function, 
without experiencing episodes of knee-joint instability.237-240 Copers are said to 
adopt neuromuscular strategies that effectively compensate for their ACL-
deficiency, and allow them to return to their pre-injury levels of physical function 
without requiring ACLr.231,238,240 A study done by Williams et al.231 compared 
quadriceps volume and CSA between ACL-deficient non-copers, ACL-deficient 
copers, and healthy controls. In ACL-deficient non-copers, quadriceps volume (p 
= 0.003) and CSA (p = 0.017) were significantly smaller on the involved limb 
compared to the uninvolved limb. However, between-limb differences in 
quadriceps volume and CSA were not observed in either the ACL-deficient 
copers or healthy controls. When comparing quadriceps volume and CSA limb 
symmetries (involved/uninvolved) between the three groups, quadriceps volume 
was significantly smaller in the ACL-deficient non-copers (0.90 ± 0.09) compared 
to both the ACL-deficient copers (1.01 ± 0.16) and healthy controls (1.01 ± 0.06). 
These findings suggest that ACL-deficient copers not only adopt neuromuscular 
strategies to maintain physical function, but they are able to avoid the 
development of significant quadriceps atrophy. Therefore, the ability of ACL-
deficient copers to bypass ACLr may also help to reduce their risk of developing 
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quadriceps weakness and atrophy that are commonly observed in patients after 
ACLr. 
Evidence of Fiber-Type Changes 
 Along with muscle atrophy, variations in muscle fiber type have also been 
demonstrated in the quadriceps of patients following ACL injury or ACLr. Skeletal 
muscles consists of two primary muscle fiber types: slow-twitch muscle fibers 
(type I) and fast-twitch (type II) muscle fibers. Type I muscle fibers are slow-
oxidative fibers, and they are believed to be responsible for muscle endurance 
and posture maintenance due to their high resistance to fatigue. Type II muscle 
fibers can be subdivided into fast-oxidative-glycolytic fibers (type IIa) and fast-
glycolytic fibers (type IIx). Both of these type II fiber subtypes are less resistant to 
fatigue than type I fibers, but type IIa fibers are more resistant to fatigue than 
type IIx fibers due to their oxidative characteristics. As a whole, type II fibers are 
believed to be responsible for rapid and powerful muscle contractions, with type 
IIx being the faster of the two subtypes. 
 The gold standard for analyzing skeletal muscle fiber types in humans is 
by taking muscle biopsies and performing immunohistochemical analyses. 
Muscle biopsies of the quadriceps are typically performed on patients during their 
arthroscopic ACLr, where muscle samples can be taken from the vastus medialis 
oblique and/or vastus lateralis muscles while the patient is under anesthesia. 
These muscle samples are then cross-sectioned and mounted on glass slides. 
Immunohistochemical analyses are performed to differentiate muscle fiber types 
under the microscope. This involves staining the muscle samples with antibodies 
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so that the myosin heavy-chain isoforms associated with slow-twitch and fast-
twitch muscle fibers can be correctly identified. Since most quadriceps muscle 
biopsies are taken from patients during their ACLr procedure, the majority of 
these data has come from patients with an ACL-deficiency.235,241-244 Both slow 
and fast twitch fibers have been reported to be atrophied in the quadriceps of 
patients who have previously sustained and ACL injury.235,241-244 However, the 
majority of the evidence demonstrates that type II fibers within the quadriceps are 
selectively atrophied more than type I fibers in this patient population.241-243   
 An alternative method that has been used to assess skeletal muscle fiber 
type changes within the quadriceps of patients after ACL injury and ACLr is EMG 
median frequency analyses. Although this method is a more crude assessment 
of muscle fiber type compared to a muscle biopsy, it is much less invasive and 
more comfortable for patients. A Fast Fourier Transform analysis is performed to 
convert the EMG signals during an MVIC into a frequency domain, and a power 
density spectrum is calculated. The power density spectrum is then divided into 
two regions of equal power to determine the median frequency of motor unit 
action potentials within the muscle/s of interest. Type I motor units innervate type 
I (slow-twitch) muscle fibers, and type II motor units innervate type II (fast-twitch) 
muscle fibers. Type I motor units fire at a lower frequency than Type II motor 
units, and are the first to be recruited during a voluntary muscle contraction. 
Therefore, assessing the median frequency of the quadriceps during an MVIC 
provides information regarding the distribution of muscle fiber types in patients 
after ACL injury or ACLr, and whether they differ from healthy individuals. Due to 
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its noninvasiveness, EMG median frequency analyses can conveniently be 
performed on patients before or after they undergo ACLr. Therefore, as opposed 
to muscle biopsies, there is much more data from EMG median frequency 
analyses on patients following ACLr. Furthermore, the evidence has 
demonstrated a distinct pattern of lower EMG median frequency in the 
quadriceps on the involved limbs of patients who are ACL-deficient and/or have 
undergone ACLr.56,65,86,223 Drecshler et al.86 compared EMG median frequencies 
in the quadriceps of patients post-ACLr to those of healthy (sport-matched) 
controls. They reported a significantly lower mean EMG median frequency in the 
ACLr group compared to the control group at both one and three months after 
ACLr (p < 0.05). Other studies have reported reduced quadriceps EMG median 
frequencies in the involved limbs of patients who were six months or longer 
removed ACLr compared to their uninvolved limbs.56,65 The reduced quadriceps 
EMG median frequency observed on the ACLr limb suggests that type II motor 
units are less activated in these patients, and that the EMG median frequency is 
predominately represented by the activation of type I motor units. This 
interpretation may help to explain the findings from the aforementioned muscle 
biopsy studies as to why type II muscle fibers are selectively atrophied in the 
quadriceps of patients. 
 Mechanisms of Modified Quadriceps Morphology  
Muscle atrophy can be commonly categorized into two types: disuse 
atrophy and neurogenic atrophy. Disuse atrophy, given its name, is caused by a 
period of physical inactivity that results in muscle wasting. This type of atrophy is 
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commonly seen in patients who are bedridden, or in those who undergo period of 
joint immobilization, where the surrounding joint musculature is neglected and 
atrophies. Neurogenic atrophy is more serious than disuse atrophy because it 
involves the nerve supplying innervation to the involved muscle. Neurogenic 
atrophy occurs when there is an injury, or disease, of the innervating nerve 
resulting in an inhibition of the muscle and subsequent atrophy. Disuse atrophy is 
the type of atrophy that is most likely present in patients following ACLr; however, 
neurogenic atrophy may also be involved due to the NQD observed in these 
patients; at topic which will be discussed later in this chapter. 
Research efforts of the 21st century have made substantial progress in 
uncovering the complex physiology behind muscle atrophy and hypertrophy.  
Both muscle atrophy and hypertrophy are found to involve multiple signaling 
pathways and molecular mediators, but in general, these processes are 
regulated by protein turnover within the muscle fibers.245-247 With muscle 
hypertrophy, the diameter of muscle fibers are increased through protein 
synthesis (or decreased protein degradation) and the addition of contractile 
proteins (in parallel) within muscle fibers. Conversely, muscle atrophy is the 
result of protein degradation (or decreased protein synthesis), which elicits a 
breakdown of these contractile proteins, and ultimately, a reduction in the 
diameter of muscle fibers. A recent study by Mendias et al.26 sought to assess 
the fluctuations in pro-atrophy biomarkers circulating in the blood of patients both 
before and after ACLr. Blood draws were performed on 18 patients prior to 
surgery and multiple time points after ACLr (3 days, 2 weeks, 5 weeks, 12 
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weeks, 18 weeks, and 26 weeks). The primary pro-atrophy biomarkers of interest 
were myostatin and transforming growth factor-β. Both of these cytokines have 
been shown to directly induce muscle atrophy and reduce muscle force 
production.246,248 The authors reported elevated levels of myostatin in patients at 
three days post-ACLr, and elevated levels of both myostatin and transforming 
growth factor-β at 2-weeks post-ACLr. Both myostatin and transforming growth 
factor-β returned to baseline levels at 5-weeks post-ACLr, and they remained 
stable until 26 weeks post-ACLr. These results indicate that ACLr has an acute 
excitatory effect on these pro-atrophy biomarkers, which may explain why these 
patients have persistent quadriceps atrophy and difficulty restoring quadriceps 
strength. 
The mechanisms behind the muscle fiber type variations observed in the 
quadriceps of patients after ACL injury and/or ACLr is less understood. Stockmar 
et al.241 assessed the metabolic profiles (oxidative vs. glycolytic activity) within 
the vastus medialis oblique muscle biopsies of six patients with ACL-deficiency in 
addition to immunohistochemical analyses. They reported a decreased muscle 
fiber diameter that was similar between type I (88.7%, p < 0.008) and type II 
muscle fibers (85.9%, p < 0.015) within the quadriceps on the involved limb 
compared to the uninvolved limb. However, a reduction in glycolytic activity and 
an oxidative shift was observed within the muscle fibers of the vastus medialis 
oblique on the involved limb compared to the uninvolved limb. This oxidative shift 
suggests that a number of type II (fast twitch) muscle fibers either shifted to a 
type IIa (fast-oxidative) profile, or they transformed into type I (slow twitch) 
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muscle fibers (less likely). Either way, the fast force production of the quadriceps 
was sacrificed in these patients. 
An alternative (and perhaps combined) mechanism that may explain the 
differences in muscle fiber type behavior observed within the quadriceps of 
patients after ACL injury and/or ACLr, is a reduced sensitivity of Ia afferents 
located at the muscle spindles. Adequate feedback from Ia afferents is necessary 
for the recruitment of high-threshold (type II) motor units at the quadriceps.249-252 
Therefore, an attenuation of Ia afferent feedback from the muscle spindles within 
the quadriceps, may contribute to the selective atrophy of type II muscle fibers 
that has been reported in these patients due to the prolonged inhibition of type II 
motor units. Reduced Ia afferent sensitivity within the muscles spindles of the 
quadriceps is believed to be the result of gamma loop dysfunction and/or 
presynaptic inhibition that occurs in patients after ACL injury and ACLr. Gamma 
loop dysfunction is believed to occur in these patients as a result of damage to 
the mechanoreceptors located within the knee-joint capsule and ACL. The 
afferent feedback from these knee-joint mechanoreceptors are thought control 
the activation of gamma motor neurons located within the spinal cord that 
function to regulate the tautness of the muscle spindles. The extensive work 
done by Konishi and colleagues52,221,253 has confirmed the presence of gamma 
loop dysfunction in the quadriceps of patients who have undergone unilateral 
ACLr. By delivering a vibratory stimulus to the patellar tendon, a reduction in 
quadriceps strength is observed in healthy individuals due to slackening of the 
muscle spindles and desensitization of Ia afferents, which inhibits their ability to 
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recruit type II motor units. However, when the same vibratory protocol is 
performed on patients after ACLr, the force producing capability of their 
quadriceps is unchanged compared to their pre-vibratory state. These findings 
suggest that gamma loop dysfunction exists within the quadriceps of these 
patients because the damage done to knee-joint mechanoreceptors disrupts 
gamma motor neuron activation, leading to a persistent slackening of muscles 
spindles and a desensitization of Ia afferents. As a result, the ability of these 
patients to recruit fast force producing, type II motor units is reduced, and 
selective atrophy of type II muscle fibers may be observed due to prolonged 
disuse.253 
Pre-synaptic inhibition is a potential mechanism for the quadriceps 
inhibition that is commonly observed in patients after knee-joint trauma, but it 
may also contribute to selective atrophy of type II muscle fibers within the 
quadriceps. Pre-synaptic inhibition pertains to a diminished synaptic feedback 
from Ia afferents that prevent the activation of alpha motor neurons within the 
spinal cord. It is believed to be induced by a repetitive activation of Ia 
afferents,254 which depletes the amount of neurotransmitters released at the 
spinal cord.255-257 Interestingly, the depolarization of joint afferents has also been 
shown to influence the pre-synaptic behavior of Ia afferents.258-260 Therefore, it is 
possible that ACL injury and/or ACLr induces pre-synaptic inhibition due to the 
disruption of knee-joint mechanoreceptors. If this is true, then pre-synaptic 
inhibition may work in conjunction with gamma loop dysfunction as a 
mechanisms of the selective atrophy of type II muscle fibers observed within the 
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quadriceps of these patients. A further description of the neurophysiology behind 
gamma loop dysfunction and pre-synaptic inhibition will be discussed later in this 
chapter. 
Ramifications of Modified Quadriceps Morphology 
 The quadriceps weakness that is observed in the involved limb of patients 
following ACLr may be partially attributed to these morphological changes that 
occur within quadriceps. Since muscle hypertrophy improves muscle force 
output, it is logical to assume that muscle atrophy would lead to strength deficits. 
Several studies have confirmed the relationship between quadriceps atrophy and 
quadriceps strength in patients with ACL-deficiency232 or in those who have 
undergone ACLr.40,47,57,91,230 A recent study by Thomas et al.91 assessed 
isometric quadriceps strength (at 90° of knee flexion) and quadriceps CSA in 20 
patients who were recently cleared to return to full physical activity after 
undergoing unilateral ACLr (Mean ± SD = 212.89 ± 31.62 days post-ACLr). Both 
quadriceps strength (148.39 ± 37.91 Nm vs. 212.98 ± 62.57 Nm; p < 0.001) and 
quadriceps CSA (68.81 ±17.8 cm2 vs. 81.1 ± 21.58 cm2; p < 0.001) were 
significantly decreased on the surgical limbs of patients compared to their non-
surgical limbs. The authors then used a linear regression analysis to determine 
the association between quadriceps atrophy and quadriceps strength in these 
patients. The analysis revealed that quadriceps CSA explained nearly 31% of the 
variance in isometric quadriceps strength in patients following ACLr (r2 = 0.307; p 
= 0.011).  
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Furthermore, the amount of quadriceps atrophy observed in patients after 
ACLr has also been correlated with functional tests commonly used by clinicians 
to determine an athlete’s readiness to return to sport.230 Lindstrom and 
colleagues230 assessed quadriceps CSA and one-leg hop function in 37 patients 
prior to unilateral ACLr and at one year following surgery. Quadriceps CSA was 
significantly smaller in the involved limb than the uninvolved limb at both pre-
ACLr (involved/uninvolved = 0.96 ± 0.01; p < 0.001) and one year post-ACLr 
(0.95 ± 0.02; p < 0.001), with no significantly changes being observed across 
time. One-leg hop distance improved from pre-ACLr to post-ACLr in both the 
involved (102.6 ± 7.0 cm to 136.9 ± 6.9 cm; p < 0.001) and uninvolved limbs 
(123.4 ± 6.7 cm to 146.7 ± 6.5 cm; p < 0.001) of patients, with improvements in 
the involved limb being greater than the uninvolved limb (p = 0.001). The most 
interesting finding was the significant correlations observed between quadriceps 
CSA and one-leg hop function of patients. At one year post-ACLr, the 
involved/uninvolved quadriceps CSA ratio were strongly correlated with one-leg 
hop distance involved/uninvolved leg ratio (r = 0.63; p < 0.001), triple-hop 
distance involved/uninvolved leg ratio (r = 0.68; p < 0.001), and 6-m timed-hop 
involved/uninvolved leg ratio (r = 0.7; p < 0.001). Therefore, the negative effect 
that quadriceps atrophy has on a patient’s quadriceps strength after ACLr may 
translate to decreased performance during physical activities that involve 
explosive movements. 
There is much less evidence demonstrating the association between 
muscle fiber type changes and quadriceps strength in patients after ACL injury 
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and/or ACLr. This is largely due to the difficulty of translating microscopic cellular 
changes to a macroscopic level. However, the available evidence on the 
ramifications of EMG median frequency changes in quadriceps of these patients 
does hold some merit. In an older study by McNair and Wood,261  they assessed 
for differences in quadriceps EMG median frequency between patients with ACL-
deficiency who demonstrated different quadriceps strength profiles. Seventeen 
patients with chronic ACL-deficiency were separated into minimal quadriceps 
weakness and maximal quadriceps weakness groups. After analyzing each 
patient’s quadriceps EMG median frequency (vastus lateralis) on their involved 
limb, a significantly higher EMG median frequency was observed in the minimal 
quadriceps weakness group compared to the maximal quadriceps weakness 
group (p < 0.05). The authors concluded that the group differences were due to a 
greater degree of type II muscle fiber atrophy present within the maximal 
quadriceps weakness group. A later study by McHugh and colleagues56 found 
that preoperative quadriceps EMG median frequency was moderately correlated 
with postoperative isometric quadriceps strength in patients who were six months 
removed from ACLr (r = 0.54, p < 0.001). Surprisingly, this same study found 
preoperative quadriceps EMG median frequency to be significantly correlated 
with one-leg hop distance in patients at six months post-ACLr (r = 0.35; p < 0.05). 
These findings are supported by a more recent study that reported moderate 
correlations between knee function (via Cincinnati Knee Score) and EMG median 
frequency limb symmetries (involved/uninvolved) of the vastus lateralis (r = 0.48; 
p = 0.018) and vastus medialis oblique (r = 0.67; p = 0.001) muscles in thirteen 
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athletes who were six to nine months removed from unilateral ACLr an cleared to 
return to sport.65 More studies are necessary to determine the global impact 
muscle fiber type changes have on both the quadriceps function and lower 
extremity function of patients following ACLr. 
2.2.2 Neural Quadriceps Dysfunction 
Evidence of Quadriceps Inhibition 
In addition to the morphological alterations taking place in the quadriceps 
after ACLr, there are concurrent neural alternations occurring both within the 
quadriceps and throughout various levels of the nervous system. The most 
evident neural deficit observed in patients after ACLr is their inability to voluntary 
activate the quadriceps on the involved limb.32,34,51,84-86 The decrease in voluntary 
activation can be explained by a diminished ability to fully recruit the motor units 
innervating the quadriceps and a reduced motor neuron firing frequency.87 
Healthy individuals without a history of knee injury or surgery have the ability to 
volitionally activate at least 95% of the available motor units innervating the 
quadriceps.88 Therefore, a volitional activation of 95% has been generally 
accepted as the cutoff value for determining whether or not a patient has neural 
inhibition of their quadriceps following ACLr.89,90  
Force-based measurements are the preferred method for assessing 
voluntary muscle activation in a healthy or pathological population.262,263 As an 
individual performs a maximal voluntary isometric contraction (MVIC) of their 
quadriceps, supramaximal, electrical stimulation is percutaneously applied over 
the femoral nerve trunk or intramuscular nerve branches to elicit a superimposed 
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twitch. An individual’s voluntary quadriceps activation level is determined by 
assessing the extent in which the electrical stimulation increases their peak KET 
during a MVIC (typically expressed as a percentage).262,263 Theoretically, if the 
electrical stimulus evokes little to no increase in KET during the MVIC, then that 
participant is considered to have full quadriceps activation (≥95%).90,264 
Conversely, if there is a large increase in torque after the electrical stimulus has 
been delivered to the quadriceps, then it is assumed that the participant has 
some level of inhibition present at their quadriceps (<95% of quadriceps 
activation).90,264 
Decreased volitional quadriceps activation that is present in patients 
following ACLr can be labeled as either arthrogenic muscle inhibition (AMI) or 
quadriceps activation failure (QAF). Arthrogenic, in its Greek form, translates to 
“generated (-genic) from the joint (arthro-)”. Thus, the term AMI pertains to 
inhibition of surrounding joint musculature that is due to the distention or damage 
present within the joint.265 AMI of the quadriceps can be observed in patients 
immediately after ACL injury or reconstruction even though there is no structural 
damage imposed to the muscle or innervating nerve. AMI has been theorized to 
be a reflexive neural phenomenon that is organically built in as a protective 
mechanism after joint injury.96 In other words, AMI is intended to prevent 
individuals from causing further joint damage after initial injury by inhibiting the 
primary muscle acting on the involved joint.  
AMI has been known primarily as a lower extremity event occurring in 
those muscles involved in weight bearing tasks. The majority of AMI has been 
‐ 46 ‐ 
 
observed in the muscles surrounding the knee or ankle after joint-injury.172,266-270 
While it is well known that the quadriceps are the main upper-leg muscle group to 
become inhibited after knee-joint injury, the lower-leg muscles most inhibited 
after ankle-joint injury are less specific. Of the muscles surrounding the ankle-
joint, the tibialis anterior and fibularis (peroneals) muscles have been found to 
demonstrate AMI the most in patients with chronic ankle instability or acute ankle 
sprain,268-270 but there is no consensus on which muscle group is predominantly 
inhibited. An explanation of why AMI is less specific after ankle-joint injury versus 
knee-joint injury may be due to the structural differences between the two joints. 
The knee-joint (tibiofemoral joint) is primarily a hinged-joint constructed for the 
movements of flexion and extension. Since the neuromuscular function of 
quadriceps are a key component during weight-bearing activities, it is intuitive 
that they are the primary upper-leg muscle group to fall prey to AMI after knee-
joint injury. Conversely, the ankle-joint is actually made up of two joints: a hinged-
joint (talocrural joint) that allows for ankle plantarflexion and dorsiflexion, and a 
condyloid-joint that allows for ankle inversion and eversion. Therefore, the multi-
jointed structure of the ankle-joint may explain why more than one lower-leg 
muscle group demonstrates AMI after ankle-joint injury. 
QAF is similar to AMI in that it pertains to quadriceps inhibition observed in 
patients after knee-joint trauma. However, the term QAF is used to describe 
those patients who persistently exhibit quadriceps inhibition long after the joint 
damage has subsided. There have been several studies that have reported 
persistent quadriceps inhibition in patients who are more than two years from 
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ACLr.32,34,84,97,271 In a recent study by Pietrosimone et al.,34 they reported residual 
neural quadriceps deficits present in patients who were an average of 4 years 
(48 ± 36.2 months) removed from unilateral ACLr. They discovered that the 
patients’ ability to voluntary activate the ipsilateral quadriceps remained inhibited 
(88 ± 12%) and was significantly lower than that of healthy controls 4 years post-
ACLr. At this time period after ACLr, it is expected that patients’ should be 
relatively asymptomatic unless they have developed a subsequent knee-joint 
pathology. Therefore, using QAF instead of AMI to describe these patients is 
more appropriate because their quadriceps inhibition is no longer arthrogenic in 
nature, but a habitual inhibition. There is less evidence for QAF than there is for 
AMI, but this is mainly due to the longer follow-up studies that are needed to 
capture QAF. In addition, it is difficult to find patients with true QAF, because 
many patients who have a history of knee-joint injury or surgery express lingering 
orthopaedic symptoms and/or go on to develop subsequent knee-joint 
pathologies (i.e., anterior knee pain, early-onset OA, etc.). In this scenario, AMI is 
still considered to be the culprit of the quadriceps inhibition observed in these 
patients because their knee-joints are currently symptomatic and/or re-injured. 
The evidence supporting the existence of quadriceps inhibition in patients 
following ACLr has been well documented over the past 15 years with the use of 
the aforementioned force-based measurements. Prior to this time period, it was 
well established that the incidence of a knee-joint injury such as an ACL injury 
elicits a neural inhibition of the quadriceps on the involved limb.90,264,267 
Therefore, it is logical to assume that the surgical knee-joint trauma imposed by 
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ACLr would resemble the neural inhibition observed in the quadriceps after the 
initial ACL injury. Urbach and colleagues32 were the first to demonstrate true 
neural inhibition (<95% voluntary quadriceps activation) in the quadriceps of 
patients after ACLr using the IT technique. They longitudinally assessed the 
voluntary quadriceps activation in 12 patients with ACL injuries prior to ACLr, and 
assessed the same sample of patients two years after having undergone ACLr. 
The mean (± SD) quadriceps activation of the patients prior to ACLr was 74.9% 
(± 3.5). At two years after ACLr, the patients’ quadriceps activation improved to 
85.3% (± 2.5), demonstrating that neural activation had recovered, but an 
inhibition of approximately 15% still remained. 
An observation that most researchers did not foresee when first assessing 
voluntary quadriceps activation in patients after unilateral ACL injury or ACLr was 
the presence of quadriceps inhibition in the contralateral (uninvolved) limb. A 
bilateral quadriceps activation deficit after ACL injury and subsequent ACLr has 
been consistently reported in the literature and is now considered to be a natural 
neural response in patients after unilateral knee-joint injury.32,51,90,91,145,172 
Furthermore, the amount of neural inhibition present within the quadriceps of the 
contralateral limb has been reported to be equivalent to that of the ipsilateral 
(involved) limb following unilateral ACLr. In a recent study by Thomas et al.,91 
voluntary quadriceps activation was assessed bilaterally in the limbs of patients 
who were seven months removed from ACLr. The mean voluntary quadriceps 
activation level of the patients’ involved limbs was 87% (± 12), while the 
uninvolved limbs demonstrated a quadriceps activation level of 85% (± 14). 
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Therefore, the joint trauma present within the surgically reconstructed knee-joint 
of these patients was modulating the neural quadriceps activation of their healthy 
limb to the same extent as the quadriceps of their reconstructed limb. Scientists 
have yet to fully explain the reason for the bilateral neural quadriceps inhibition 
observed after unilateral ACLr. The most popular explanation is that of a neural 
crossover effect that occurs in the central nervous system due to altered afferent 
information being transmitted from the involved knee-joint.42,145,272 Due to this 
bilateral deficit, physicians are cautioned when using a patient’s uninvolved limb 
as a comparison when assessing the recovery of neuromuscular quadriceps 
function in the involved limb and making return-to-activity decisions after ACLr. 
Consequently, physicians should be advised to consider a healthy-matched 
control as a comparison, and clinicians should place further attention on the 
uninvolved limb during the rehabilitation of patients following ACLr.  
Evidence of Reduced Spinal-Reflexive Excitability 
Another neural deficit that has been observed in patients following ACLr is 
a reduction in spinal-reflexive excitability at the quadriceps.34,51,273 The gold 
standard for accessing the spinal-reflexive excitability of a muscle is the Hoffman 
reflex (H-reflex) technique.274,275 In its basic form, the H-reflex is the electrical 
variant to the mechanically induced stretch-reflex.274 However, the H-reflex 
technique better isolates the monosynaptic reflex and allows for more specific 
assessment of spinal-reflexive activity. Unlike the stretch-reflex, the H-reflex 
technique bypasses the muscle spindle by applying a submaximal electrical 
stimulus at the muscle’s peripheral nerve. The stimulation of the nerve activates 
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Ia afferent (sensory) fibers that transmit signals to the spinal cord, causing a 
depolarization of alpha motor neurons (aMN) and efferent (motor) fibers.274,276-278 
The end result is myoelectric response observed at the muscle, labeled as the H-
reflex.  A muscle’s H-reflex activity is quantified via voltage amplitudes on surface 
EMG. A reduced H-reflex that is observed in the quadriceps of patients following 
ACLr signifies that there are inhibitory mechanisms present within the spinal cord 
that are partially responsible for the NQD.259,260,265,279 Therefore, the quadriceps 
H-reflex has become a valuable measure for accessing the spinal-reflexive 
behavior in patients before and/or after they have undergone ACLr. 
 Although the H-reflex has been used in research for over a century,280 
there have only been a handful of studies that have used the H-reflex to assess 
the spinal-reflexive excitability of the quadriceps in patients following 
ACLr.34,51,84,97,273,281 The majority of quadriceps H-reflex assessments have been 
reported in studies that used an artificial knee effusion model by injecting saline 
fluid into the knee-joint capsule of healthy participants.259,260,282-284 It has been 
well established that artificial knee-joint effusion inhibits the quadriceps H-reflex 
in healthy individuals. This is a widely accepted model for demonstrating the 
neural effect that knee-joint effusion has on spinal-reflexive excitability, but it fails 
to represent the additional structural damage, inflammation, and pain that is 
present after true knee-joint trauma such as ACLr. Therefore, the few studies that 
have assessed the quadriceps H-reflex in patients after ACLr are particularly 




 There have been a total of six published studies that have assessed the 
quadriceps H-reflex in patients following ACLr.34,51,84,97,273,281 Of these six studies, 
Lepley et. al.,51 were the only group to demonstrate a reduced quadriceps H-
reflex in the involved limbs of patients post-ACLr compared to a healthy control 
group. Conversely, there were also two separate studies that have reported an 
increased quadriceps H-reflex in ACLr patients compared to healthy controls.34,97 
The primary difference between these two studies and the aforementioned study 
is the timing of when the postoperative H-reflex assessments were performed. 
The two studies that reported an elevated quadriceps H-reflex performed their 
assessments on patients who were an average of four years removed from 
ACLr.34,97 Whereas, the patients in the study by Lepley et al., performed H-reflex 
assessments only two weeks after undergoing ACLr.51  
These findings demonstrate that there may be a difference in spinal-
reflexive excitability of patients who are in the acute stage after ACLr compared 
to those who are in the chronic stage after ACLr. Studies that have used the 
artificial knee effusion model concur that quadriceps H-reflex is acutely 
suppressed following knee-joint trauma because they reported reductions in the 
quadriceps H-reflex immediately after injecting the knee-joint capsule with saline 
fluid.259,260,282-284 Artificial knee effusion models cannot support the elevated 
spinal-reflexive excitability observed in the quadriceps patients who are in the 
chronic stage after ACLr because the majority of the patients do not present with 
knee-joint effusion. It has been theorized that heightened spinal-reflexive 
excitability observed in these patients after ACLr may be a neural adaptation that 
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progressively develops to compensate for their persistent quadriceps 
dysfunction. 
It must be noted that half of the studies which have assessed spinal-
reflexive excitability in patients after ACLr did not report significant differences in 
H-reflex compared to healthy controls.84,273,281 This demonstrates that the 
science is still far away from determining if and how spinal-reflexive excitability is 
modulated after ACLr in humans, and additional studies assessing the 
quadriceps H-reflex in these patients are needed to progress this area of 
research. It is important to determine if the spinal-reflexive excitability is 
suppressed in patients after ACLr because it not only impedes their recovery of 
neuromuscular function, but it may put them at risk for future injury. A reduced 
spinal-reflex may hinder a patient’s neuromuscular system to appropriately 
respond to environmental stimuli. For example, if this patient were walking and 
experienced an external perturbation causing their surgical knee to collapse into 
knee flexion, their quadriceps may not appropriately contract in response to 
being rapidly stretched due to the reduced spinal-reflexive excitability. Therefore, 
the patient may be at a higher risk for straining a muscle or falling. 
Evidence of Corticomotor Excitability Alterations 
 One of the more recent neural adaptations that is beginning to gain 
traction in this area of research is the modified cortical activity that is observed in 
patients after ACLr.  Specifically, corticomotor excitability associated with the 
quadriceps has been shown to be altered in patients following unilateral 
ACLr.34,51,84 Corticomotor excitability is typically assessed by applying single-
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pulse transcranial magnetic stimulation (sTMS) to the area of the primary motor 
cortex where the majority of the MNs projecting to quadriceps via the 
corticospinal tract are represented, and measuring the subsequent motor evoked 
potential (MEP) observed at the quadriceps through surface EMG.92-95 The 
corticomotor excitability measures most commonly used with sTMS are motor 
thresholds and MEP recruitment curves. Both of these measures provide slightly 
different information, yet complement each other in regards to the corticomotor 
excitability of the MNs in the motor cortex representing a given muscle group. 
Motor thresholds are believed to reflect membrane excitability and local density 
of a central core of pyramidal neurons and interneurons.92,95,285 As the activation 
threshold of these neural elements increases, more sTMS output is needed for 
the motor threshold to be reached. Therefore, an increased motor threshold is 
interpreted as a decreased corticomotor excitability in that region of the motor 
cortex. MEP recruitment curves are thought to demonstrate the extent in which 
the alpha-motor neuron pool is activated with increasing sTMS intensities, as well 
as the spatial distribution of neural elements within a region of the motor 
cortex.94,286,287 The steepness of the MEP recruitment curve is attributed to the 
extent of motor representation for a given muscle group (steeper the curve = 
greater representation of muscle group, and vice versa). 
 The majority of studies assessing corticomotor excitability in patients after 
ACLr have used motor thresholds to quantify the magnitude and/or change of 
excitability in the area of the motor cortex represented by the 
quadriceps.34,51,61,84,97,288  As opposed to the aforementioned types of NQD, 
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modifications in corticomotor excitability relative to the quadriceps of patients do 
not seem to arise until at least six months after unilateral ACLr.51 Lepley and 
colleagues51 have provided the only research to date that has longitudinally 
assessed the changes in corticomotor excitability of patients before and after 
undergoing unilateral ACLr. Bilateral assessments of motor thresholds of the 
quadriceps were measured in 20 patients over three time points: five weeks prior 
to ACLr, two weeks post-ACLr, and six months post-ACLr. Prior to surgery, there 
were no differences in motor thresholds between limbs or when compared to 
healthy controls. The motor thresholds were significantly increased 
(corresponding to decreased corticomotor excitability) in both limbs two weeks 
after ACLr, but were no different compared to the control group. However, the 
motor thresholds in both limbs were significantly higher than the healthy controls 
at 6 months post-ACLr, as well as when compared to the threshold values 
expressed before surgery and two weeks post-ACLr. The corticomotor excitability 
of the patient’s uninvolved limbs seemed to follow the same time trajectory after 
unilateral ACLr as the surgical limb, which further supports the existence of a 
neural cross-over effect. These patients not only demonstrated a reduced 
corticomotor excitability associated with the quadriceps of patients recovering 
after ACLr, but these attenuations were not truly evident until 6 months after 
surgery. The absence of corticomotor excitability attenuations after acute knee-
joint disruption is not completely unexpected. In a previous study by Lepley et 
al.288, an artificial knee-joint effusion elicited an immediate reduction in voluntary 
quadriceps activation, while it failed to attenuate corticomotor excitability. These 
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findings suggest that more time is needed for neural changes to be observed in 
supraspinal regions of the nervous system compared to spinal regions. 
 Two additional studies have reported decreases in corticomotor excitability 
in relation to the quadriceps of patients following unilateral ACLr,34,84 but their 
motor threshold assessments were conducted years after the patients underwent 
surgery. However, both of these studies reported significant differences between 
limbs at this extended time point, with lower corticomotor excitability being 
exhibited in the quadriceps of the surgical limb.34,84 This finding suggests that 
although the corticomotor excitability of the contralateral quadriceps 
demonstrates similar reductions as the ipsilateral quadriceps after unilateral 
ACLr, this neural deficit may not persistent for as long in the contralateral limb 
and it naturally recovers. An alternative theory is that the corticomotor excitability 
of the contralateral limb is improved over time after unilateral ACLr because 
patients tend to place more reliance on this limb during ambulatory tasks. 
Conversely, the mechanics and postural control of the surgical limb is modified in 
patients after unilateral ACLr, which may explain the cortical reorganization and 
reduced corticomotor excitability of the ipsilateral quadriceps. More prospective 
studies assessing longitudinal corticomotor excitability in patients recovering from 
ACLr are needed to better determine when these neural alterations begin to 
arise, and understand how long they tend to persist and/or resolve in both limbs.  
Timeline of Neural Quadriceps Dysfunction post-ACLr 
The temporal manifestation of NQD that is observed in ACL-injured 
patients before and after they have undergone ACLr has yet to be fully 
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understood and agreed upon among researchers. However, a general timeline of 
the neural quadriceps deficits observed after ACLr can be developed via a 
thorough review of the literature. The evidence regarding the onset and 
progression of quadriceps inhibition that is observed in patients after ACL injury 
and reconstruction is the most mixed in the literature compared to the other 
neural quadriceps deficits. This can be partially attributed to the different 
techniques used to assess voluntary quadriceps activation. As mentioned 
previously, the SIB and IT techniques are the most common methods for 
assessing quadriceps activation, but each uses a different equation to calculate 
activation, and can therefore provide slightly different information in regards to 
the amount of inhibition present within the quadriceps of these patients.  
Significant deficits in bilateral voluntary quadriceps activation (54-83%) 
has been reported patients after ACL injury,32,51,99,145,264,266,289 but some studies 
have reported quadriceps activation levels in these patients approaching those of 
healthy individuals (~ 95%).24,27,89,172,290 Likewise, deficits in bilateral voluntary 
quadriceps activation (75-88%) have been reported in patients after 
ACLr,27,32,34,48,91,97,291,292 while other studies have reported little to no voluntary 
quadriceps activation deficits in patients after ACLr (~95%).24,51,55,86,290,293,294 This 
mixed evidence may be solely due to differences in measurement techniques 
used to assess voluntary quadriceps activation. However, it may also be due to 
differences in when voluntary quadriceps activation was assessed in patients. In 
general, the majority of studies that reported deficits in voluntary quadriceps 
activation,32,34,48,97,99,264,292 assessed patients who were more than one year 
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removed from ACL injury or reconstruction; whereas the majority of studies that 
reported little to no deficits in voluntary quadriceps 
activation,24,27,51,55,86,89,172,232,290 assessed patients who were less than eight 
months removed from ACL injury or reconstruction. It can be expected that some 
level of quadriceps inhibition is present in patients immediately after ACL injury 
and reconstruction based on the principles of AMI. During this acute state of joint 
trauma, the effusion, pain, and inflammation present within the knee-joint is 
sufficient to inhibit the involved limb’s quadriceps, and cross-over to the 
uninvolved limb as well. However, force-based measures of voluntary quadriceps 
activation are typically contraindicated in the involved limb of patients within the 
first two months after ACL injury and reconstruction due to increased pain, 
inadequate range-of-motion, and/or post-surgical guidelines that are enforced to 
protect the graft from being stressed prematurely (post-ACLr only). AMI of the 
quadriceps seems to resolve during the first few months after ACL injury and 
reconstruction, with voluntary quadriceps activation approaching near normal 
levels in patients at one year post-injury/surgery. However, voluntary quadriceps 
activation seems to relapse into an inhibited state years later. This delay in 
quadriceps inhibition may described as presence QAF, or it could be quadriceps 
inhibition that is due to the insidious onset of a subsequent knee-joint pathology, 
such as knee OA. Like patients after ACL injury or reconstruction, patient with 
knee OA have been reported to exhibit bilateral deficits in voluntary quadriceps 
activation.295 However, further research is need to explore this theory, and to 
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determine whether deficits in voluntary quadriceps activation after ACL injury and 
reconstruction are truly time-dependent. 
The time course of spinal-reflexive alterations that occur in patients before 
and after ACLr has been described more consistently throughout the literature. 
Lepley et al.51 has been the only study to assess the H-reflex in patients both 
before and after ACLr. Compared to their preoperative assessment, the H-
reflexes of patients two weeks after undergoing unilateral ACLr was lower in both 
limbs; therefore, implying that the joint damage caused by the surgery attenuated 
spinal-reflexive excitability to a greater extent than the ACL injury itself. This 
observation is similar to the differences seen in patients’ voluntary quadriceps 
activation before and after ACLr, with the surgery inflicting more quadriceps 
inhibition than the injury. Unlike the time course observed with quadriceps 
inhibition after ACLr, the recovery of spinal-reflexive excitability in patients seems 
to be more rapid. Studies have found that the quadriceps H-reflex of patients 
three to six months after ACLr is not only higher than that of more acute 
assessments (2-4 weeks post-ACLr),51,273 but it is no different than that of healthy 
matched controls as well. Furthermore, four years removed from ACLr, patients 
have higher spinal-reflexive excitability than healthy individuals.34,84 These 
findings demonstrate that although the quadriceps H-reflex is reduced bilaterally 
in patients acutely following unilateral ACL injury and ACLr, it seems to rapidly 
recover and heighten over time. This heightened spinal-reflexive excitability 
observed in patients who are years removed from ACLr may serve as a 
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compensatory mechanism for the additional neuromuscular deficits that are 
exhibited in these patients. 
There have not been enough longitudinal studies to draw a conclusion on 
the time course of corticomotor excitability alterations in patients after ACL injury 
and reconstruction. However, a general pattern of time can begin to be observed 
by combining studies that have assessed corticomotor excitability. Corticomotor 
excitability changes have been demonstrated bilaterally in patients after unilateral 
ACLr,34,51,84,97 but these changes have not been apparent until at least six 
months post-surgery.51 Corticomotor excitability in the uninvolved limb has been 
shown to return to baseline in patients who are over a year removed from 
unilateral ACLr, whereas the corticomotor excitability in the surgical limb remains 
decreased.34,84 Decreased corticomotor excitability is one of the few neural 
quadriceps deficits that has been shown to remain in patients after ACLr. 
However, the clinical importance of corticomotor excitability and the effect it has 
on the recovery of quadriceps function in patients after ACLr has yet to be 
determined. Therefore, more research is needed to determine the temporal 
behavior of cortical excitability and how it contributes to other neuromuscular 
quadriceps deficits observed in patients after ACLr. 
The corticomotor excitability changes that have been reported in patients 
prior to ACLr is not as clear as what has been reported after ACLr. Lepley et al.51 
assessed corticomotor excitability in patients who were five weeks from initial 
ACL injury. The motor thresholds of these patients were no different between 
limbs or when compared to healthy controls, signifying that corticomotor 
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excitability was unaffected by the acute knee-joint injury. An earlier study 
conducted by Heroux and Tremblay296 reported opposing findings in a group of 
ACL-deficient patients. They bilaterally assessed corticomotor excitability 
associated with the quadriceps of 10 patients who previously sustained a 
unilateral ACL injury without undergoing subsequent ACLr. They found the motor 
thresholds of the injured limb to be significantly lower (higher corticomotor 
excitability) than that of the uninjured limb, whereas no differences were 
observed between limbs in the healthy control group. Although these findings 
contradict those of Lepley et al.,51 there are two methodological differences that 
may explain their lack of agreement. To begin with, Heroux and Tremblay296 
assessed motor thresholds with the patients’ quadriceps being in a relaxed state, 
while Lepley et al.296 assessed motor thresholds during a slight quadriceps 
contraction (5% of MVIC). This procedural variation between studies may have 
influenced the dependent variables enough to result in conflicting results. The 
second and more promising explanation is that the patients were assessed at 
different time points after initial ACL injury. As stated above, Lepley et al.51 
assessed preoperative corticomotor excitability at an average of five weeks after 
ACL injury; where, Heroux and Tremblay296 assessed patients who were nearly 
two years (median = 22 months) removed from ACL injury. Therefore, the 
heightened corticomotor excitability demonstrated in the involved limb of patients 
who participated in the study by Heroux and Tremblay may have been a result of 
time itself. The authors hypothesized that because their patients were ACL-
deficient for an extended period of time, more cortically-driven control over the 
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knee musculature was required to manage the external demands of daily 
activities and maintain knee-joint stability.296 Therefore the increased 
corticomotor excitability associated with the injured limb’s quadriceps may serve 
as a coping mechanism for individuals with ACL-deficiency. 
Although a general timeline can be developed to portray the expected 
onset and duration of the aforementioned neural quadriceps deficits in patients 
following ACLr, clinicians must interpret it with caution. Like any disease, there 
will be outliers that fall outside the expected, “normal” timeframe of symptoms. 
Therefore, clinicians must remember to take an individualistic approach when 
treating neural quadriceps deficits in patients after ACLr. These deficits may 
manifest and progress differently between patients, making it important for 
clinicians to treat patients until neural quadriceps function is restored. The 
presence of bilateral neural quadriceps deficits in patients after unilateral ACLr 
provides additional justification for clinicians to incorporate both limbs when 
designing rehabilitation protocols, and to not rely on a bilateral comparison alone 
when making return-to-activity decisions. Comparing a patient’s post-operative 
neuromuscular function to that of a healthy, matched control is preferred when 
determining readiness to return-to-activity. Furthermore, there are multiple 
factors that contribute to the persistent quadriceps weakness observed in 
patients after ACLr. Once NQD has been resolved in patients, clinicians should 
continue to target any structural modifications that remain within the quadriceps 
in efforts to restore the muscle mechanics and strength to a healthy state. 
Mechanisms of Neural Quadriceps Dysfunction 
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The underlying mechanisms of NQD are multi-faceted, and there has 
been a growing body of research within the past decade dedicated to exploring 
this area. Since NQD was first determined to be a natural condition that occurs in 
patients after ACLr, researchers have developed and tested theories in attempts 
to explain the neurophysiology behind the observed neural quadriceps deficits. 
Because of this research, understanding of NQD has evolved and improved over 
the years. Therefore, the neural mechanisms that have been most supported by 
research will be highlighted and described in this review. 
 Before the mechanisms of NQD can be discussed, it is important to 
establish an understanding of the various sensory receptors located within the 
knee-joint. These sensory receptors are commonly divided into two main groups, 
those that are innervated by larger, myelinated afferents, and those that are 
innervated by small, unmyelinated (or lightly myelinated) afferents.102,297 Large, 
myelinated afferents hold precedence over small, unmyelinated (or lightly 
myelinated) afferents due to their lower activation thresholds and higher 
conduction velocities.  Therefore, the hierarchy of knee-joint afferents can be 
appreciated by their numerical classification type.  
Type Ia and Ib afferents are at the top of the large, myelinated afferent 
group because they have the largest fiber diameters and highest conduction 
velocities. Type Ia afferents innervate muscle spindles and are depolarized after 
a rapid muscle stretch. Type Ib afferents innervate Golgi tendon organs and are 
typically depolarized following a strong muscle contraction. Type II afferents also 
fall under the large, myelinated afferent group, and are depolarized by 
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mechanical pressure and tension.297-299 In the muscle, type II afferents innervate 
intrafusal fibers (nuclear chain) and respond to stimuli in the absence of muscle 
length changes (non-adaptive). Since they respond to instantaneous muscle 
length and not change, they are thought to contribute to an individual’s joint 
position sense. The sensory receptors innervated by Type II afferents include 
Ruffini endings, Pacinian corpuscles, and Golgi-like endings. Although they have 
also been found to exist in the human knee-joint, the proportion of Type II 
afferents in the knee-joint is unknown and is believed to be relatively small based 
on data from animal studies.298 
 Type III and IV afferents fall under the small, unmyelinated (or lightly 
myelinated) variety, and they innervate the second group of knee-joint 
receptors.297,298,300 The articular branch of the tibial nerve is the largest articular 
nerve supplying the human knee-joint.300 Of the sensory fibers comprised in the 
articular branch of the tibial nerve, 70% of them are reported to be Type IV 
afferents.300 Both Type III and IV afferents innervate free nerve endings 
possessing high activation thresholds, which respond to strong mechanical, 
thermal, or chemical stimuli. Therefore, the primary function of Type III and IV 
afferents is believed to be nociceptive in nature. However, animal studies have 
found that a portion these afferents can be activated by non-painful, passive 
knee-joint motion, suggesting that these findings may be observed within the 
human knee-joint as well.301 
Gamma Loop Dysfunction 
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 The gamma loop comprises the monosynaptic reflex and is thought to be 
dysfunctional within the quadriceps of patients after ACLr.133,150,221,253 The 
function of the gamma loop is to monitor the rate of change in a muscle’s length 
and recruit high-threshold (type II) aMNs during an MVIC. Gamma motoneurons 
(yMNs) within the spinal cord regulate the tautness of the muscle spindles within 
the intrafusal fibers of skeletal muscle. The tautness of the muscles spindles 
correspond to the sensitivity of the Ia afferents. As a muscle is rapidly stretched, 
the muscles spindles depolarize Ia afferents, which transmit signals to the spinal 
cord to activate aMNs and induce a reflexive contraction within the muscle. The 
sensitivity of the Ia afferents at the muscle spindles also dictate the recruitment of 
high-threshold motor units during an MVIC.249-252,302 Therefore, it is considered to 
be physiologically impossible to recruit type II aMNs during an MVIC without a 
functional gamma loop.  
 Joint afferents are thought to influence aMN recruitment by controlling the 
activity of yMNs within the spinal cord.303 Therefore, damage to the 
mechanoreceptors within the knee-joints of patients after ACLr could be 
responsible for the observed gamma loop dysfunction. The mechanoreceptors 
located within both the knee-joint and ACL are thought to directly influence the 
activation of the yMNs associated with the muscle spindles located within the 
quadriceps.303 After the ACL has been ruptured and subsequently reconstructed, 
the consequent damage to the mechanoreceptors attenuates the activity of 
yMNs, and the recruitment of high-threshold aMNs is inhibited due to the reduced 
sensitivity of Ia afferents. Thus, the persistent quadriceps weakness that is 
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exhibited in patients following ACLr has been partially attributed to gamma loop 
dysfunction.133,150,221,253 Furthermore, the selective atrophy of type II muscle 
fibers combined with the lack of force attenuation after quadriceps fatiguing 
exercise,56,65,86,292,304 which have been observed in these patients, may be 
explained by Ia desensitization. 
Dr. Yu Konishi has done the majority of work in this area, and his research 
largely supports the above hypothesis.133,221,253,272,305 In one of his earlier 
studies,305 he worked to determine the effect that altered knee-joint afferents had 
on neuromuscular quadriceps function. His group assessed MVIC and EMG 
activity of the quadriceps in three groups: patients with ACL deficiency, healthy 
participants with anesthetized joints (via lidocaine injection), and in healthy 
controls. These neuromuscular assessments were performed both before and 
after each group had vibratory stimuli applied to their infrapatellar tendon. In the 
control group, the prolonged tendon vibration caused an immediate reduction in 
both MVIC and EMG activity. However, the same vibratory protocol failed to elicit 
neuromuscular reductions in both the ACL-deficient and anesthetized groups. 
Exposing the tendon to a prolonged vibration creates a physiological, habitual 
response within the gamma loop by increasing the activation threshold of yMNs, 
slackening the muscle spindles, decreasing the sensitivity of the Ia afferents, and 
consequently inhibiting the activation of high threshold (type II) aMNs.250,252,306,307 
At the same time, the prolonged vibratory stimulus is thought to further reduce 
the sensitivity of Ia afferents by increasing their respective activation thresholds 
and/or depleting neurotransmitters at their terminal endings;307 thus, preventing 
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the recruitment of type II aMNs. As a result, the reduced neuromuscular output 
from the quadriceps is the expected response after prolonged infrapatellar 
tendon vibration. Conversely, the lack of reduced neuromuscular output 
observed in the quadriceps of the ACL-deficient and anesthetized groups post-
vibration indicated that gamma loop dysfunction was present in those individuals, 
confirming the hypothesis that altered afferent signaling from within the knee-joint 
disrupts gamma loop function. Although physiology of gamma loop dysfunction 
can be debated, some researchers believe that damage to the ACL causes a 
reduction in excitatory feedback from ligamentous mechanoreceptors to yMNs 
and/or supraspinal centers which diminishes the alpha-gamma coactivation 
during and MVIC.264,303,305,308 However, the sparse innervation of sensory 
receptors within the ACL compared to other knee-joint structures has raised 
uncertainty.298,299 An alternative theory that may also work in conjunction is that 
the afferent discharge of nociceptive originating from the knee-joint after trauma 
contributes to gamma loop dysfunction. Animal studies have discovered that prior 
depolarization of Type IV afferents within the knee-joint suppresses any ensuing 
excitatory feedback from other sensory receptors to yMNs.309 In order for this 
theory to gain legitimacy, these findings must be replicated in humans. 
 There have been several follow-up studies that have been able to 
reproduce the above findings within the quadriceps of an ACLr patient 
population.133,150,221,253 Similar to the bilateral quadriceps inhibition that is 
observed in patients after ACLr,90,145,266 gamma loop dysfunction has been found 
to exist bilaterally in the quadriceps of patients following unilateral ACLr.221 
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However, the gamma loop dysfunction in the contralateral quadriceps was only 
present for 12 months post-ACLr, whereas this dysfunction persisted in the 
ipsilateral quadriceps beyond 18 months. It is thought that the disruption of 
afferent signaling present in the ipsilateral knee-joint after ACLr has an effect on 
both spinal and supraspinal centers.221,272,303 As a result, the gamma loop 
dysfunction observed in the contralateral quadriceps after unilateral ACLr may be 
due to descending inhibitory signals projecting towards the contralateral limb.  
Furthermore, Konishi and colleagues133 recently compared the extent of 
gamma loop dysfunction between patients with unilateral ACL ruptures, patients 
with unilateral ACLr, and healthy controls. The MVIC and EMG activity was 
significantly decreased after infrapatellar vibration in the control group’s involved 
quadriceps. However, these same neuromuscular measures remained 
unchanged post-vibration in both limbs of the ACL-ruptured group and ACLr 
group. Although the percentage change in MVIC and EMG activity between the 
ipsilateral quadriceps of both groups was not significantly different, the ACL-
ruptured group’s contralateral quadriceps showed a greater change than that of 
the ACLr group’s contralateral quadriceps. This finding suggests that ACLr 
further disrupts gamma loop function of the contralateral quadriceps compared to 
an ACL rupture. Therefore, the initial ACL rupture induces bilateral gamma loop 
dysfunction in the quadriceps of patients, but the invasion of additional knee-joint 
structures (i.e., skin, capsule, menisci, etc.) via surgery further compounds the 
dysfunction present within the contralateral quadriceps via central 
mechanisms.133,303,310 The duration gamma loop dysfunction persists after ACLr 
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remains unknown because there has not been another study that has assessed 
this outcome in patients who are beyond 18 months post-ACLr. Since gamma 
loop dysfunction tends to linger in patients after ACLr, it may explain the 
persistent quadriceps weakness and QAF observed in this patient population as 
well.  
Nonreciprocal (Ib) Inhibition 
 Nonreciprocal (Ib) inhibition pertains to the group of interneurons located 
in lamina VI and VII of the spinal cord.311 This group of interneurons receives 
input from the Ib afferents transmitted from Golgi tendon organs (GTOs) that 
originate within the musculotendinous junction. GTOs are proprioceptive sensory 
receptors that function to monitor changes in muscle tension.312 As a muscle 
begins to contract, the tension at the musculotendinous junction increases, 
causing a deformation of the GTOs housed within the junction.313 The 
deformation of GTOs elicits a depolarization of Ib afferents which propagate 
signals to the spinal cord. Ib afferents then synapse with Ib inhibitory 
interneurons, that also project information to supraspinal centers, and an 
inhibitory reflex is elicited at the muscle.313,314 This inhibitory reflex suppresses 
efferent activity to promote elongation of the muscle,315 and is best characterized 
as a sudden relaxation of a muscle after experiencing a state of high tension. 
Interestingly, Ib interneurons have also been found to receive input from a 
variety of knee-joint afferents. Through the use of animal models, researchers 
have been able to demonstrate that a polysynaptic pathways exists between 
knee-joint afferents and Ib interneurons.316,317 This research has been supported 
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in humans through the work of Iles and colleagues.318 They used an artificial 
knee-joint effusion model by infusing saline into the knee-joint capsules of 
healthy individuals. Through the use of a spatial facilitation technique, they 
concluded that capsular pressure caused by the effusion depolarized type II 
afferents and triggered nonreciprocal (Ib) inhibition of the quadriceps H-reflex. It 
remains unknown whether pathways also exist between type III and IV knee-joint 
afferents and Ib interneurons in humans, but nonreciprocal (Ib) inhibition is still 
considered to be a potential mechanism of the NQD observed in patients after 
ACLr.102 
Flexion Reflex 
 The presence of AMI in the quadriceps of patients after knee-joint injury 
has been well supported throughout the literature. However, several studies have 
also reported increased neural activity in the hamstrings of these patients,319-321 
described as a flexion reflex. The flexion reflex is characterized as a facilitation of 
flexor muscles and an inhibition of extensor muscles after joint injury.322 Although 
it is considered to be a natural phenomenon, the neural pathways associated 
with the flexion reflex have not been fully explored. Wide dynamic range (WDR) 
interneurons are thought to play a key role in mediating the flexion reflex.323,324 
These interneurons originate in lamina V of the spinal cord and receive 
nociceptive input from a variety of peripheral receptors, including free nerve 
endings within knee-joints.325 The influx of inflammation and pain that is present 
after knee-joint injury activates free nerve endings, triggering a discharge of input 
from type III and IV afferents to the WDR interneurons. As inflammation and pain 
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continue to reside in the knee-joint, the free nerve endings and WDR 
interneurons become hyperexcitable, and their activation thresholds are 
lowered.301,326-328 Not only does this result in a persistent hypersensitivity to 
noxious stimuli at the knee-joint, but a heightened response to mechanical (non-
noxious) stimuli at the joint. This phenomenon is described as a pain 
sensitization. Specifically, peripheral sensitization pertains to the hypersensitivity 
of free nerve endings located within the involved joint,301,326,327 whereas central 
sensitization pertains to the WDR interneurons.328 Peripheral sensitization can be 
observed in patients who exhibit painful reactions to movement with their 
involved knee-joint, which would otherwise not be perceived as painful.301,326,327 
Central sensitization is a much more complex and widespread condition due to 
the involvement of WDR interneurons. Patients with central sensitization not only 
exhibit painful reactions to movement with their involved knee-joint, but non-
noxious stimuli from adjacent regions such as the quadriceps are perceived as 
painful.328 Therefore, WDR interneurons are believed to contribute to persistent 
NQD observed in patients after unilateral ACLr, most likely by mediating the 
flexion reflex.102 
The flexion reflex was first demonstrated in animal studies which 
assessed the neuromuscular behavior of the extensor and flexor musculature 
surrounding the knee-joint after induced knee-joint trauma.329-331 Furthermore, 
the flexion reflex has been found to be present following activation of the 
mechanoreceptors within the ACL of animals. Raunest et al.330 reported 
increased EMG amplitudes of the knee flexor muscles, and suppressed 
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amplitudes in the knee extensor muscles of sheep after shear forces were 
applied to the ACL. These findings demonstrate that the mechanoreceptors and 
corresponding afferents within the ACL have both inhibitory and excitatory 
influences on the neural activity of the quadriceps and hamstrings, respectively. 
 Although the flexion reflex is well supported in animal studies, the 
evidence of a flexion reflex in humans is less abundant. However, human studies 
have shown enhanced activity in the hamstrings of patients with knee-joint 
injuries compared to healthy controls.319-321 Additionally, the activity of the 
hamstrings have been shown to be heightened in patients after ACL injury.320 
The hamstrings function synergistically with the ACL to control anterior tibial 
translation in the knee-joint; therefore, it is intuitive that their activity be 
heightened after ACL injury as a strategy to maintain knee-joint stability. The 
flexion reflex has also been shown to be reestablished in patients after ACLr. By 
electrically stimulating the ACL grafts of patients with an arthroscopic technique, 
Tsuda et al.332  reported that the majority of patients demonstrated increased 
EMG activity in the hamstrings, suggesting that the ACL grafts underwent 
sensory re-innervation. The results justify the existence of the flexion reflex in 
humans, and support that it may also be a potential mechanism of NQD in 
patients after ACLr. 
Pre and Post-synaptic Inhibition 
 Interneurons account for the majority of all neurons that are located in the 
spinal cord, and they are key component of the spinal circuitry. The basic 
function of an interneuron is to relay information between ascending and 
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descending pathways, as well as to other interneurons. However, interneurons 
also play an integral role in transmitting excitatory and inhibitory signals to 
interneurons, aMNs, and yMNs.333,334 Therefore, it is believed that a portion of 
NQD that is observed in patients after ACLr is attributed to the 
neurophysiological behavior of interneurons. Specifically, NQD observed in 
patients is thought to be a result of inhibitory mechanisms that occur at the pre-
synaptic afferent terminals (pre-synaptic inhibition),259,260,265 and/or at the post-
synaptic cleft between interneurons and MNs (post-synaptic inhibition).335-337 
Both of these mechanisms are believed to be under the supraspinal control, 
which influence activity via descending pathways.256,338 
 Pre-synaptic inhibition is attributed to a decrease of neurotransmitters 
released from Ia afferent terminal endplates.255-257 Prior activation of the 
monosynaptic reflex has been shown to dampen the release of neurotransmitters 
at the pre-synaptic cleft, resulting in an inhibition of the reflex pathway.254,339 The 
attenuated Ia afferent discharge caused be pre-synaptic inhibition may also 
contribute to the aforementioned gamma loop dysfunction.102 However, the 
neurophysiological factors that are specifically responsible for pre-synaptic 
inhibition are not completely understood. It is thought to involve an interference of 
the calcium influx at the Ia afferent terminal, possibly due to inhibitory,257 GABA-
ergic interneurons. Calcium plays a key role in the binding of vesicles containing 
neurotransmitters, which are carried across the pre-synaptic cleft to the 
interneuronal membrane so that vesicular exocytosis can occur and signals can 
be transmitted to the appropriate neurons.257 
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 The depolarization of joint afferents has also been shown to influence pre-
synaptic inhibitory mechanisms.258-260 Therefore, it can be assumed that knee-
joint injury triggers pre-synaptic inhibition through the disruption of joint 
mechanoreceptors. Palmieri et al.260 tested this hypothesis by using an artificial 
knee-joint effusion model in healthy individuals. To determine the effect of knee-
joint effusion on spinal-reflexive excitability, Hmax amplitudes were assessed 
before and after saline infusion. In addition, they used a modified H-reflex 
protocol,340 which consists of applying two stimuli (15% of Mmax) to the femoral 
nerve at an 80ms interpulse interval, and then evaluating the H-reflex amplitude 
elicited from the second stimulus (conditioned reflex) relative to the H-reflex 
elicited by the first stimulus. If the conditioned reflex is of a lower amplitude, it is 
referred to as the paired reflex depression and represents the modulation of 
processes controlling rate-dependent reflex depression and the influence of the 
reflex activation history. Compared to conditioned reflexes elicited prior to 
undergoing artificial knee-joint effusion, both the Hmax and conditioned reflexes 
observed post-effusion were significantly lower, suggesting that pre-synaptic 
mechanisms contribute to the reduced spinal-reflexive excitability after knee-joint 
injury.260 However, these results should be interpreted with caution due to 
methodological limitations. 
 Antidromic signals from efferents have been shown to attenuate the 
excitability of aMNs in the spinal cord.337 This phenomenon is defined as post-
synaptic (recurrent) inhibition, and it is caused by the activation of recurrent 
collaterals in the spinal cord that excite a specific group of inhibitory interneurons 
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known as Renshaw cells.335,336 While pre-synaptic inhibition is specific to the 
synapse of Ia afferents,255 post-synaptic inhibition has a more widespread 
inhibitory effect on neuronal synapses in the spinal cord. The activation of 
Renshaw cells not only leads to an inhibition aMNs,335,336 but it has also been 
shown to affect Ia inhibitory interneurons and yMNs;341-343 therefore, making 
post-synaptic inhibition a potential contributor to gamma loop dysfunction. The 
net result of post-synaptic inhibition is the reduction of efferent activation in a 
muscle and its synergists, as well as an excitation of its antagonists.259,265 
However, more research is needed exploring post-synaptic inhibition in humans 
for it to be considered as a legitimate mechanism of NQD in patients after ACLr. 
Supraspinal Mechanisms 
 The underlying mechanisms of NQD that have been reviewed to this point 
pertain to the spinal cord and peripheral nervous system. However, knee-joint 
afferents project input to both spinal and supraspinal centers;344-346 thus, it is 
probable that supraspinal mechanisms also contribute to the observed neural 
dysfunction in patients after ACLr. In particular, supraspinal mechanisms are 
thought to contribute to the persistent NQD that has been observed in these 
patients, such as QAF and reduced corticomotor excitability. 
 Since alterations in corticomotor excitability associated with the 
quadriceps have only recently been discovered in patients following unilateral 
ACLr, the research exploring the cortical mechanisms behind this condition is in 
its infancy. Corticomotor alterations are most likely the result of cortical 
neuroplasticity after knee-joint trauma. After knee-joint trauma such as that 
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caused by ACLr, there is an afferent discharge from the knee joint due to the 
onset of effusion, inflammation, and pain. However, the knee-joint damage 
elicited during the arthroscopic surgery likely damages (or destroys) 
mechanoreceptors responsible for joint proprioception.345 Several studies have 
reported joint position sense discrepancies in patients after ACLr that are thought 
to be the result of damage to knee-joint mechanoreceptors.344,347-349 Therefore, 
the deprivation of proprioceptive input to the somatosensory cortex may elicit 
neuroplastic changes in the primary motor cortex pertaining to reduced 
corticomotor excitability. These neuroplastic changes may involve a 
reorganization of motor maps in the primary motor cortex, and/or a suppression 
of corticomotor areas. Cortical reorganization is likely due to compensatory 
movement strategies that are adopted in patients after ACLr. Numerous studies 
have reported altered lower extremity biomechanics in patients after primary, 
unilateral ACLr,17,350-352 which are thought to be strategies adopted by patients to 
compensate for neuromuscular deficits, avoid exposing the reconstructed joint to 
mechanical stress, or the result of pain and effusion. Alternatively, or perhaps 
concurrently, these avoidance strategies my also result in a long-term depression 
of corticomotor areas.353 From a simplistic point of view, as the involved limb’s 
quadriceps continue to be underused in these patients, synapses begin to 
deteriorate within the primary motor cortex, and their maps become invaded by 
neighboring muscles; therefore contributing to reduced corticomotor excitability. 
However, substantial research is needed to test these theories and determine the 
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exact neural mechanisms of corticomotor alterations observed in patients after 
ACLr. 
 The brainstem is also believed to contribute to the mechanisms of NQD in 
patients after ACLr.102 The brainstem not only functions to regulate vitals such as 
heart rate and respiratory rate, but it serves an important role in relaying input 
from the spinal cord to the cerebrum and cerebellum, and vice versa. The 
inflammation and pain that is present after joint injury greatly enhances 
descending input from the brainstem (pain modulation),354-357 which can both 
inhibit and facilitate mechanisms at the spinal cord. Based on current evidence, 
knee-joint pathology is thought to be associated with brainstem dysfunction 
specific to the modulation of WDR interneurons involved in the flexion 
reflex.258,354,356 In addition, the QAF that remains in patients after ACLr has been 
partly attributed to the brainstem’s influence on central sensitization of the WDR 
interneurons.102 Nevertheless, supraspinal mechanisms play a significant role in 
the NQD observed in patients after ACLr, and additional supraspinal regions 
deserve to be explored to gain a better appreciation of their contributions. 
Ramifications of Neural Quadriceps Dysfunction 
 The ramifications of NQD demonstrated in patients after ACLr are not as 
well-known in the literature as that of quadriceps weakness. However, within the 
past decade, clinical research has begun to uncover the contributions NQD has 
on quadriceps strength, and the resulting consequences it has on physical 
function and well-being of these patients. The following review will highlight the 
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correlation and predictive ability of the aforementioned measures of NQD on 
quadriceps strength, biomechanics, and patient-reported outcomes.  
Quadriceps Strength 
 One of the most established relationships reported in the literature is that 
between isometric quadriceps strength (MVIC) and voluntary quadriceps 
activation (via SIB technique) in patients who have sustained knee-joint 
trauma.86,97,232,358-364 Significant, strong correlations between these two 
neuromuscular outcomes in patients post-ACLr have been consistently reported 
across studies, with Pearson product correlation coefficients ranging from r = 
0.67 to r = 0.8.86,97  Furthermore, voluntary quadriceps activation has been 
reported to predict up to 87% of the variance in quadriceps MVIC via regression 
analyses.358 The relationship between other measures of NQD (spinal-reflexive 
excitability and corticomotor excitability) and quadriceps strength in patients after 
ACLr has been underinvested, but recent evidence has shown that relationships 
may exist.97,296  
A study conducted by Lepley et al.97 investigated the predictive 
capabilities of voluntary quadriceps activation, spinal-reflexive excitability, and 
corticomotor excitability (AMT) on isometric quadriceps strength (MVIC) in 
patients who have undergone ACLr. The authors performed the above 
neuromuscular assessments on patients who were an average of four years 
removed from primary, unilateral ACLr, and used multiple linear regression 
analyses to determine the amount of variance in MVIC values that could be 
explained by the variance in voluntary quadriceps activation, spinal-reflexive 
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excitability and corticomotor excitability outcome measures. Prior to the 
regression analyses, they examined correlations within the measures of neural 
quadriceps function, and between the measures of neural quadriceps function 
and quadriceps strength. As expected, a strong, positive correlation existed 
between quadriceps activation and MVIC (r = 0.78; p < 0.001). There was also a 
moderate, positive correlation between quadriceps H-reflex and MVIC (r = 0.66; p 
< 0.05), and a moderate, negative correlation between quadriceps AMT and 
MVIC (r = -0.64; p < 0.05). When all three neural quadriceps measures were 
entered into the regression model, they were able to predict 49% of the variance 
in isometric quadriceps strength of patients after ACLr (r2 = 0.49; p < 0.01). 
However, quadriceps activation (r2 = 0.37; p < 0.001)) and spinal-reflexive 
excitability (r2 = 0.1; p < 0.05) were the only variables that demonstrated 
significant predictive capabilities, and quadriceps AMT only increased the 
predictability of the regression model by 2% (r2 = 0.02; p = 0.4).  
It should be noted that when correlations were assessed among the 
neural quadriceps measures in this study,97 voluntary quadriceps activation and 
AMT were the only measures to demonstrate a significant correlation (r = -0.64; p 
< 0.05); whereas, insignificant correlations existed between quadriceps activation 
and spinal-reflexive excitability (r = 0.44; p = 0.3), and spinal-reflexive excitability 
and AMT (r = -0.4; p = 0.41). These findings imply that the insignificant 
predictability of corticomotor excitability on quadriceps strength may be the result 
of collinearity. Since voluntary quadriceps activation and corticomotor excitability 
are both central measures of neural quadriceps function, it is intuitive that a 
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correlation exist between the two, resulting in a potential overlap of their 
predictive capabilities within the regression model. Conversely, the lack of 
correlation between voluntary quadriceps activation and spinal-reflexive 
excitability suggests that they assess different aspects of NQD; therefore, they 
represent different pieces of the regression model in relation to predictive 
capabilities on quadriceps strength. However, further research is needed to 
explore the association of various neural quadriceps measures on quadriceps 
strength in patients after ACLr. 
Biomechanics 
 Researchers are just beginning to understand the implications of NQD on 
lower extremity biomechanics following ACLr. To this date, the only publications 
to investigate the effects of NQD on lower extremity biomechanics have been 
from studies using an artificial knee-joint effusion model.282,358,365 Although the 
artificial knee-joint effusion model is a supported method for inducing NQD, 
which allows for a controlled assessment of its biomechanical consequences, its 
clinical validity and generalizability to an ACLr patient population is limited. 
Therefore, the results from these applied studies must be interpreted with 
caution. 
Several studies have reported altered lower extremity biomechanics after 
artificially inducing effusions in the knee-joints of healthy individuals.282,358,365 
Torry et al.365 was the first study to use an artificial knee-joint effusion model to 
elicit quadriceps inhibition and investigate subsequent biomechanical gait 
alterations. Compared to the pre-effusion state, the participants demonstrated 
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increased flexion angles at both the knee and hip during the stance phase of gait. 
However, there were opposing extensor moments between the knee and hip 
during the effused state. Knee extensor moments decreased with larger knee-
joint effusion indicating that less force from the quadriceps was being applied 
across the knee-joint during the first half of stance. Conversely, hip extensor 
moments increased during the first half of stance, suggesting a compensatory 
strategy at the hip due to quadriceps inhibition.  
Palmieri et al.282 used a similar artificial knee-joint effusion model as Torry 
et al.,365 but instead of investigating the effect on gait biomechanics, they 
assessed single-legged drop landing biomechanics. After saline infusion, there 
was an immediate reduction in EMG activity of the vastus medialis oblique and 
vastus lateralis; thus, resulting in a successful induction of AMI in the quadriceps. 
Compared to a non-effused state, large knee-joint effusion (60 mL of saline) 
elicited decreased knee-flexion angles, decreased knee-extension moments, and 
increased vertical ground reaction forces in participants upon landing. 
Furthermore, regression analyses revealed that quadriceps EMG activity 
accounted for a significant portion of the variance in the knee-flexion angle (r2 = 
0.29; p < 0.05), sagittal plane knee moment (r2 = 0.37; p < 0.05), and the vertical 
ground reaction force (r2 = 0.83; p < 0.05). In a similar study,358 quadriceps 
inhibition (via SIB technique) was reported to explain lower extremity 
biomechanics during stair descent. Voluntary quadriceps activation significantly 
explained the variance for both knee-extension moment (r2 = 0.29; p < 0.01) and 
vertical ground reaction force (r2 = 0.25; p < 0.05). The biomechanical pattern 
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that has been observed at the knee after joint effusion and quadriceps inhibition 
is indicative of “quadriceps avoidance” strategy.282 As the involved limb accepts 
full support of the body during landing or stair descent, the quadriceps work 
eccentrically to attenuate forces at the knee-joint. Therefore, the observed 
decrease in knee-flexion angle and knee-extension moment suggests that the 
quadriceps are avoiding eccentric activity, which consequently allows for more 
force to be transferred to the knee-joint as portrayed by the increased vertical 
ground reaction force. 
Based on the ramifications reviewed thus far, NQD may influence the 
development and/or progression of knee osteoarthritis in patients after ACLr as 
well. Quadriceps weakness,78,79,216 altered knee-joint biomechanics,366-368 and a 
history ACLr have all been shown to be strongly associated with knee 
osteoarthritis.23,369 Therefore, NQD has been hypothesized to increase the risk of 
knee osteoarthritis in patients after ACLr.370 However, this connection has yet to 
be supported by the literature, demanding the need for further research to be 
done in this area. If researchers are able to establish this connection, the 
inclusion of disinhibitory interventions in the rehabilitation of patients after ACLr 
would be warranted to not only combat subsequent NQD, but protect against the 
development of early knee osteoarthritis as well. 
Self-Reported Knee Function 
 Perhaps the most clinically relevant relationship to discuss is that between 
NQD and patient-reported outcomes (PROs) after ACLr. PROs are patient-
centered assessments that provide insight into a patient’s perceived level 
‐ 82 ‐ 
 
function and quality of life after an injury or intervention. PROs are routinely 
administered to patients following ACLr as a methodology to determine perceived 
success. NQD may influence a patient’s perception of recovery after ACLr, and 
therefore, may influence PROs.  
The effect of NQD on PROs after knee-joint injury is beginning to be 
revealed in realms of orthopaedic research.32,61,84,86,134 Voluntary quadriceps 
activation has previously been reported to moderate the relationship between 
quadriceps strength and function in patients with knee osteoarthritis.134 Fitzgerald 
et al.134 assessed quadriceps activation and MVIC, and lower extremity function 
(Western Ontario and McMaster Universities Osteoarthritis Index combined with 
Get Up and Go test) in 105 patients with radiographically diagnosed knee 
osteoarthritis. After performing regression analysis, the authors found that adding 
the quadriceps activation by MVIC interaction to the regression model resulted in 
the highest prediction of function (r2 = 0.22; p < 0.01); therefore, quadriceps 
inhibition was believed to serve as a moderator between quadriceps strength and 
function. For example, patients who exhibited higher levels of quadriceps 
weakness and quadriceps inhibition, had lower levels of function than those with 
comparable strength and less inhibition. Conversely, patients who exhibited 
lower levels of quadriceps weakness and higher levels of quadriceps inhibition, 
had higher levels of function compared to those of comparable strength and less 
inhibition. Although the authors could not explain why stronger patients with more 
quadriceps inhibition had higher levels of function, they hypothesized that if a 
patient has good quadriceps strength, the presence or absence of quadriceps 
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inhibition may not play an important role in affecting their function.134 If a patient 
has enough strength to function well, they may not need to fully activate their 
quadriceps. In contrast, if a patient has significant quadriceps weakness and 
quadriceps inhibition, the combination of the two may be sufficient enough to 
affect their function. Regardless, this was one of the first studies to demonstrate 
the effect NQD has on a patient’s objective and subjective function after knee-
joint injury, which has promoted the significance of restoring neural quadriceps 
function in patients after ACLr. 
To date, there have only been two known studies that have reported a 
relationship between NQD and PROs in patients following ACLr.32,48 A 
prospective study by Urbach et al.32 assessed the correlation between the 
recovery of quadriceps activation and restoration of physical activity levels in 
patients who have undergone ACLr. Voluntary quadriceps activation (via ITT 
technique) and physical activity level (using the Tegner activity scale) were 
longitudinally assessed in 12 patients prior to ACLr and at two years post-ACLr. 
Significant improvements over time were reported for both outcomes, and a 
strong correlation existed between the two (r = 0.71; p < 0.01), suggesting that 
voluntary quadriceps activation has an influence on the restoration of physical 
activity levels in patients following ACLr. In a more recent study by Kuenze et 
al.,48 the authors used receiver-operator-characteristic (ROC) curves as a 
method to establish clinical thresholds for neuromuscular measures of 
quadriceps function associated with PROs in patients who were at least six 
months removed from unilateral ACLr. Interestingly, they found that symmetrical 
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voluntary quadriceps activation (limb symmetry index > 99.2%; area under curve 
= 0.67) was more effective than ipsilateral quadriceps activation in identifying 
patients with better patient-reported function post-ACLr, based on their total Knee 
Osteoarthritis Outcome Score (KOOS total). The results from this study suggest 
that near complete voluntary quadriceps activation limb symmetry may be an 
additional indicator for clinicians to use when determining whether patients are 
ready to return-to-activity following unilateral ACLr and rehabilitation. 
 
2.3 ASSESSING NEURAL QUADRICEPS DYSFUNCTION 
2.3.1 Voluntary Quadriceps Activation 
Voluntary muscle activation represents both the extent of motor unit 
recruitment, and the firing rate of motor units within a given muscle (or muscle 
group); yet, it does not discern the two. Over the past half-century, force-based 
measures have been the preferred method for assessing the voluntary muscle 
activation in both a healthy and clinical population. The force-based assessment 
of voluntary muscle activation was first described in 1928 by Denny-Brown,371 
and was later tested in 1954 by Merton.372 By superimposing supramaximal, 
percutaneous electrical stimuli to the adductor pollicis muscle during an MVIC, 
Merton372 observed no differences in force output between superimposed twitch 
and voluntary contractions from healthy participants. However, when the 
participants were asked to perform submaximal muscle contractions, the 
electrical stimuli evoked an increment in twitch force at the adductor pollicis. After 
plotting the increment of the superimposed twitch force against the force 
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produced a varying MVIC percentages, he observed a negative linear 
relationship between the two variables. In other words, as participants 
approached 100% MVIC, the increment in superimposed twitch force began to 
diminish. It was determined that complete activation of a muscle can be achieved 
in healthy individuals when maximal voluntary effort is provided. Conversely, a 
visible increment in superimposed twitch force during maximal voluntary effort is 
attributed either to fatigue (central and/or peripheral) or neural inhibition. These 
results were confirmed in subsequent studies involving the biceps brachii,373,374 
tibialis anterior.373,375 and quadriceps.376,377 
 More recent evidence has demonstrated that the ability of healthy 
individuals to completely activate a muscle is less common than what was 
originally reported by Merton. This discrepancy is mainly attributed to advances 
in high resolution analyses of voluntary muscle activation. A voluntary quadriceps 
activation level ≥ 95% has been consistently reported in research on healthy 
(non-fatigued) individuals; thus, this level is often used as the standard in studies 
investigating voluntary quadriceps activation in patients after ACLr.88 The 
remaining motor units in the quadriceps that are commonly left inactivated (5% or 
less) by healthy individuals are thought to represent a reserve within the central 
nervous system that protects muscles from being overloaded. Furthermore, the 
relationship between voluntary quadriceps activation and quadriceps strength 
(relative to %MVIC) has been discovered to not be linear, but curvilinear.263,378 As 
depicted in Figure 2.1, a sharp incline in quadriceps activation can be observed 
at the initiation of an MVIC, but the curve then begins to level off at approximately 
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50% MVIC, and it flattens as 100% MVIC is approached. Therefore, the 
activation-strength curve is best explained by a 2nd order polynomial.263,378 
 
Figure 2.1. Central activation ratio (CAR) data plotted as a function of the 
percentage of maximum voluntary isometric contraction (% MVIC). The 
relationship is curvilinear and best fit by a second-order polynomial. Taken from 
Stackhouse SK, Dean JC, Lee SC, Binder-Macleod SA. Measurement of central 
activation failure of the quadriceps femoris in healthy adults. Muscle Nerve. 
2000;23:1706–1712.378 
 
 The following review will discuss the force-based techniques 
corresponding procedures that are used to assess voluntary quadriceps 
activation. This will include the recommended electrode placement, subject 
positioning, and parameters for each technique. In addition, the reported 





The force-based techniques that are most commonly used to assess 
voluntary quadriceps activation are the interpolated twitch (ITT) technique and 
the superimposed burst (SIB) technique.262,263 Both of these techniques consist 
of supramaximal, percutaneous electrical stimulation being delivered to the 
quadriceps to evoke an increase in torque while a subject performs an MVIC of 
their quadriceps. With the ITT technique, a single stimulus or a pair of stimuli 
(doublet) is applied over the femoral nerve trunk both at the peak of the subject’s 
MVIC and while they are at rest (either 2-5 seconds before or after the MVIC).263 
Applying an electrical stimulus to a relaxed muscle is a method adopted by the 
ITT technique intended to assess the peripheral/morphological mechanisms of a 
muscle or muscle group.294 This resting stimulus is commonly referred to as the 
control twitch when quantifying a subject’s voluntary quadriceps activation with 
the ITT technique, because it is used to normalize the superimposed twitch 
torque increment observed during their MVIC. Conversely, the SIB technique 
involves a single train of stimuli being applied over the muscle bellies of a 
subject’s quadriceps (via intramuscular nerve branches) at the peak of their 
MVIC.262 
Due to the methodological differences between the SIB and ITT 
techniques, separate calculations are used when quantifying voluntary 
quadriceps activation with each technique. For the SIB technique, a central 
activation ratio (CAR) is calculated by dividing the peak torque elicited during the 
MVIC by the superimposed torque elicited by the train of stimuli (CAR = 
[MVICTorque/SIBTorque] *100).262,378 For the ITT technique, percent activation 
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(%ACT) is calculated by comparing the ITT torque increment elicited from the 
single stimulus (or doublet) at peak MVIC to the control twitch torque elicited at 
rest (%ACT = 1 – [ITTTorque/ControlTorque]*100).263,379 The SIB technique and CAR 
are thought to specifically assess the neural mechanisms (i.e., descending aMN 
recruitment) underlying voluntary quadriceps activation, whereas the ITT 
technique and %ACT take into account both the neural and morphological (i.e., 
potentiation and series elastic components) mechanisms.294 It is important for 
researchers not to intermix the procedures and equations associated with the 
SIB and ITT techniques when assessing voluntary quadriceps activation in 
attempt to protect the validity of these measures.380 
Electrode Placement 
For the SIB technique, two large electrode pads (self-adhesive or carbon-
impregnated) are typically adhered to the participant’s skin at the proximal 
(anode) and distal (cathode) aspects of the quadriceps, and bipolar stimulation is 
used. The specific electrode placement can either be to a vastus muscle (vastus 
lateralis and vastus medialis oblique) or rectus muscle (proximal and distal rectus 
femoris) configuration. No differences in CAR have been discovered between 
these two electrode configurations when using the SIB technique.381 The 
electrode placement for the ITT technique is much more intricate compared to 
the SIB technique. For the ITT technique, unipolar stimulation is used by 
adhering a smaller (2x2 inch) active electrode (anode) at the superior-lateral 
corner of the femoral triangle, and a dispersive electrode (cathode) at the distal 
quadriceps or posteriorly at the gluteal fold. This electrode configuration is 
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intended to target the femoral nerve during stimulation because it provides 
innervation to the quadriceps. Finding the optimal location to stimulate the 
femoral nerve can be difficult for the examiner; therefore, some researchers have 
adopted an electrode configuration similar to that used with the SIB technique 
when using the ITT technique. By placing the electrodes over the muscle bellies 
of the quadriceps instead of over the femoral nerve, subjects have reported less 
discomfort with percutaneous electrical stimulation,382 and higher reliability with 
%ACT.263 However, using quadriceps stimulation over nerve stimulation with the 
ITT technique can be challenged based on methodological grounds regarding its 
validity. Specifically, twitch torque increments with the ITT technique are shown 
to be higher with nerve stimulation compared to quadriceps, suggesting that a 
single stimulus or doublet is not sufficient enough to activate the quadriceps with 
quadriceps stimulation, and spatial recruitment of motor units at the quadriceps is 
superior with ITT nerve stimulation.382 Therefore, femoral nerve stimulation is the 
preferred electrode configuration when using the ITT technique to assess 
voluntary quadriceps dysfunction. 
Subject Positioning 
The recommended subject positioning is identical for both ITT and SIB 
techniques. When comparing isometric, concentric, and eccentric contraction 
types in healthy individuals, isometric quadriceps contractions have 
demonstrated highest voluntary quadriceps activation levels.383 Subjects are 
seated on a dynamometer chair with their hip-joints fixed at 85° of flexion and the 
knee-joint of interest fixed at 90° of flexion. Assessing voluntary quadriceps 
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activation at 90° of knee-joint flexion has been shown to elicit the highest 
quadriceps activation levels in healthy subjects;384-387 thus, optimizing the ability 
to detect quadriceps inhibition in patients after ACLr. Furthermore, this angle is 
believed to put less strain on the surgical grafts of patients who are recovering 
from ACLr, because of the higher anterior shear forces that are generated from 
the quadriceps at lower knee-joint angles.388,389  
To help subjects achieve higher knee extension torques when performing 
MVICs of their quadriceps, they are advised to rapidly push their lower leg 
against the lever arm pad on the dynamometer at maximal effort, while the 
examiner simultaneously provides verbal encouragement. In addition, it is 
important to isolate the subject’s quadriceps during their MVIC. Utilizing torso 
belts to secure the patient to a dynamometer chair helps subjects to maintain an 
upright posture, which limits paraspinal activity during the MVIC.390 Subjects 
should also be instructed to cross their arms over their chest during the MVIC to 
prevent them from pulling on the chair with their arms.390 The ITT technique does 
require subjects to completely relax their quadriceps when the control twitch is 
applied. Surface EMG can be used to monitor myoelectric activity in the 
quadriceps and ensure that subjects are fully relaxed prior to delivering the 
control twitch.  
Parameters 
The stimulation parameters that are commonly used with ITT can be 
observed in Table 2.1. To determine the stimulation intensity used with the ITT 
technique, a control twitch test is commonly performed on subjects before  
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Table 2.1. Interpolated Twitch Technique Parameters 
Parameter Common Range 
# of Stimuli 2 
Pulse Duration 0.05 – 1 ms 
Interpulse interval 10 ms 
Pulse Frequency 50 – 100 Hz 
Voltage 400 V 
 
performing ITT trials. The control twitch test consists of delivering a single or 
paired (doublet) stimulus to the femoral nerve while the subject is at rest, and 
incrementally increasing the amperage until there is a plateau in twitch torque. 
The amperage (mA) that produced the highest resting twitch torque in the subject 
is then used for their subsequent ITT trials. This amperage varies from subject to 
subject because of the intrinsic differences in muscle morphology between 
individuals. The control twitch test can be very tedious and uncomfortable for 
subjects because they are receiving an indefinite number of stimuli at rest prior to 
performing ITT trials. As a result, some researchers are beginning to promote the 
use of a standardized amperage when assessing voluntary quadriceps activation 
with the ITT technique.380,391 A recent study by Grindstaff et al.380 assessed 
differences in control twitch torque at the quadriceps when using various 
amperages. They reported that using an amperage of 450 mA was sufficient 
enough to evoke maximum control twitch torque for the majority of participants, 
whereas 500 mA achieved maximum control twitch torque for all participants. 
Submaximal amperages have previously been shown to produce %ACT levels in 
the quadriceps that are comparable to those observed with maximal 
amperages.391 Amperages that are 50-90% of the intensity used to produce a 
maximal control twitch torque have demonstrated valid %ACT levels at the 
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quadriceps that are no different than those used with maximal amperages.391 
Furthermore, Bampouras et al.391 reported that 50% of maximal amperage was 
the lowest intensity to produce a valid %ACT level at the quadriceps, and it was 
more comfortable for subjects based on a 10mm visual analog pain intensity 
scale. 
The number of stimuli delivered to the femoral nerve when assessing 
voluntary quadriceps activation with the ITT technique has been a topic of debate 
within the literature. A single stimulus, doublet, triplet, quadruplet, and quintuplet 
have all been used to assess voluntary activation, but the differences in %ACT 
between them are negligible.263,379,385 However, differences in twitch torque and 
%ACT have been demonstrated when more than one stimulus is applied to the 
femoral nerve.392-394 Compared to using a single stimulus, doublets have been 
shown to increase superimposed twitch torque during an MVIC,263 improve the 
reliability of both twitch torque and %ACT,392,394 and be less influenced by 
potentiation.393 In addition, the post-MVIC control twitch has been recommended 
over the pre-MVIC control twitch when assessing voluntary quadriceps 
activation.395,396 During and after an MVIC of the quadriceps, it is expected that 
the quadriceps will become potentiated, which increases the superimposed 
twitch torques and control twitch torques evoked by electrical stimulation. 
Therefore, the post-MVIC control twitch is recommended when calculating %ACT 
of the quadriceps based on its validity.395-398 The post-MVIC control-twitch torque 
has also been shown to be more reliable than the pre-MVIC control twitch 
torque,395,396 which further supporting its use when calculating %ACT. 
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The stimulation parameters that are commonly used with SIB technique 
can be observed in Table 2.2. As mentioned previously, the SIB technique 
consists of applying a train of (ten) stimuli to the quadriceps when the participant 
reaches their peak torque during an MVIC. Providing a train of stimuli instead of 
a single stimulus or doublet is more uncomfortable for subjects.380 When applying 
electrical stimulation over the quadriceps with SIB technique, longer stimulation 
durations are required to penetrate the muscle and evoke a greater summation of 
motor units. The reason why the ITT technique does not require a train of stimuli 
is because less electrical stimulation is required to activate the quadriceps via the 
femoral nerve (nerve stimulation) compared to activating the quadriceps via its 
intramuscular nerve branches (muscles stimulation).  
 
Table 2.2. Superimposed Burst Technique Parameters 
Parameter Common Range 
# of Stimuli 10 
Train Duration 100 ms 
Pulse Duration 0.2 - 0.6 ms 
Pulse Frequency 100 Hz 
Amperage 450 mA 
 
Since a train of stimuli is more uncomfortable, researchers have explored the 
parameters (train duration, pulse duration, pulse frequency, voltage) used with 
the SIB technique to determine which parameters are the most comfortable for 
subjects without compromising the validity of quantifying voluntary quadriceps 
activation (CAR). Miller et al.399 discovered that a 50 ms train duration was more 
comfortable for subjects compared to a 100 ms train duration, but the 100 ms 
train duration evoked greater superimposed torque during MVIC and was less 
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variable than the 50 ms train duration. However, previous studies have 
determined train durations greater than 100 ms do not evoke further increments 
in superimposed torque, and are therefore unnecessary to use with the SIB 
technique.378,400,401 Pulse durations greater than 0.1 ms have also been found to 
not change superimposed torque increments,399 which suggests that a pulse 
duration of 0.1 ms is sufficient for the SIB technique. Two of the more 
understudied SIB parameters are pulse frequency and stimulation intensity 
(voltage). A pulse frequency greater than 50 Hz has been shown to produce a 
similar quadriceps CAR to that of a 100 Hz pulse frequency, but 100 Hz is the 
preferred parameter to facilitate motor unit summation and the recruitment of all 
fiber types. Miller et al.400 tested stimulation trains at 50 V, 100 V, and 200 V to 
determine which stimulation intensities evoke the largest superimposed torque 
increments during an MVIC. They reported a significant difference in the 
percentage of superimposed torque increments between the four voltages, with 
150 V and 200 V evoking larger increments than 50 V and 100 V. However, there 
was no difference in evoked torque increments between 150 V and 200 V, 
implying that 150 V is a sufficient voltage for the SIB technique. 
A point of concern with using either force-based technique to assess 
voluntary quadriceps activation is that the superimposed stimulus must be 
applied at the participant’s peak MVIC in order to provide a valid measure of 
quadriceps activation. When force-based techniques were first introduced, the 
superimposed stimulus was manually triggered once the examiner observed a 
plateau in force on the oscilloscope. As you can imagine, this method is open to 
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much human error and negatively affects both the validity and reliability of force-
based techniques. One method that has been used to standardize the delivery of 
the superimposed stimulus is a time-based triggering technique. This involves 
delivering the superimposed stimulus at a standard time point during the 
participant’s MVIC. For example, the stimulus automatically triggered three 
seconds after the onset of the participant’s MVIC. However, there is no way to 
insure that the all participants achieve or sustain their peak torque during the 
MVIC at three seconds, which again negatively affects the reliability and validity 
of the measure. The most promising method for standardizing the onset of 
stimulation is a torque-based triggering technique introduce by Krishnan et al.402 
With torque-based triggering, the superimposed stimulus is applied at a specific 
torque during the participant’s MVIC. To insure that the superimposed stimulus is 
applied at the subject’s peak torque during their MVIC, several MVIC trials are 
performed beforehand to determine the subject’s peak torque value. The 
subject’s peak torque value is then used to trigger the superimposed stimulus 
during their MVIC for the quadriceps activation trials. Torque-based triggering 
has improved both the validity and reliability of force-based triggering techniques, 
as well as limiting the number of times a participant is exposed to electrical 
stimulation.402 However, torque-based triggering has only recently been adopted 
in studies assessing voluntary quadriceps activation. Torque-based triggering 
must become the gold standard with force-based assessments of voluntary 
quadriceps activation in order for results to be fairly compared across studies and 




 The reliability of both the ITT and SIB techniques have high test-retest 
reliability for the assessment of voluntary quadriceps activation in healthy 
individuals.88,403-406 However, the majority of these studies assessed intrasession 
reliability; whereas intersession reliability is of more clinical significance because 
it demonstrates whether or not the force-based techniques are consistent 
longitudinally. The intersession intraclass correlation coefficient (ICC) for the ITT 
technique (using %ACT) has been reported to be high (ICC = 0.92 – 0.95), with a 
low standard error of measurement (SEM = 1.0 – 2.84%) and minimum 
detectable change (MDC = 2.8 – 6.6%).403,406 There has only been on study to 
date that has assessed the intersession reliability of the SIB technique (using 
CAR).404 The results demonstrated moderately-high reliability (ICC = 0.86), low 
SEM (2%), and a low MDC (5.5%). These results suggest that both force-based 
techniques have good reliability, and they can be used in longitudinal studies to 
assess voluntary quadriceps activation. It should be noted that none of these 
studies have assessed the reliability of either the SIB or ITT techniques in an 
ACLr patient population. Although this is not absolutely necessary, determining 
the ICC, SEM, and MDC of these techniques in an ACLr patient population would 
ensure their reliability in a clinical population. 
2.3.2 Spinal-Reflexive Excitability 
In 1910, Paul Hoffmann introduced a method to noninvasively assess the 
spinal stretch reflex,280 which was later named as the Hoffman reflex (H-
reflex).275 The H-reflex serves as an electrical variant of the mechanically 
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induced stretch reflex, but contrary to the stretch reflex, the H-reflex bypasses 
the influence of the muscle spindles by directly activating their corresponding Ia 
afferents.276 Therefore, the H-reflex is the preferred technique for assessing 
monosynaptic spinal-reflexive behavior in muscles of humans. More specifically, 
the H-reflex has been used extensively in orthopaedic research as a tool to 
assess presynaptic inhibition279 and spinal-reflexive excitability277 in the 
quadriceps of patients after ACLr,34,51,84,97,273,281 or following a disinhibitory 
treatment.407-409 
Within the past century, the methodology associated with the quadriceps 
H-reflex has evolved to improve the validity and reliability of the technique. The 
following review will discuss the most recent procedures that are associated with 
the quadriceps H-reflex technique used to assess spinal-reflexive excitability. 
This will include the recommended electrode placement, subject positioning, and 
parameters for the H-reflex technique. In addition, the reported reliability of the 
quadriceps H-reflex will be discussed. Please refer to Palmieri et al.274 for a more 
in-depth review of H-reflex methodology. 
Procedures 
When assessing the quadriceps H-reflex, a percutaneous electrical 
stimulus is applied over the femoral nerve, and the evoked myoelectric response 
at the quadriceps is assessed through surface EMG. Since the stimulation is 
being applied to a mixed peripheral nerve, both afferent and efferent fibers have 
the potential to be depolarized.276 The activation threshold of afferent fibers is 
lower than that of efferent fibers due to their larger diameter,410 meaning that Ia 
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afferents are first to depolarize as the stimulation intensity is increased from 
baseline. The stimulation of Ia afferent fibers within the femoral nerve causes 
action potentials to be transmitted to the dorsal horn of the spinal cord, which 
results in the depolarization of aMNs and transmission of action potentials to the 
efferent fibers innervating the quadriceps. Once these action potentials reach the 
neuromuscular junctions and depolarize the sarcolemma, an EMG twitch 
response is observed at the quadriceps, defined as the H-reflex. Therefore, the 
electrically-induced H-reflex measures the efficacy of synaptic transmission as 
the stimulus travels from Ia afferents to the efferent fibers.274,277 
As the intensity of the electrical stimulus is increased from baseline, the EMG 
amplitude of the H-reflex reaches a peak amplitude, termed as Hmax, which is 
believed to represent an individual’s spinal reflexive excitability.  Continuing to 
increase the intensity causes the H-reflex to begin to diminish until it is no longer 
visible.411 However, while the H-reflex diminishes, an earlier muscle response, 
called the M-wave, begins to appear on the EMG tracing, and its amplitude 
steadily increases with the stimulus intensity until it eventually reaches a plateau 
in amplitude, termed as Mmax  265,274 Mmax represents the maximum peripheral 
activation of an individual’s motor units.279 The behavior of the H-reflex and M-
wave is depicted in Figure 2.2.  
The lower threshold of Ia afferents compared to efferent fibers explains 
why the H-reflex is observed at lower stimulus intensities, and the M-wave only 
appears at higher stimulus intensities, but it does not explain why the H-reflex 
diminishes at higher stimulus intensities. As the stimulus intensity increases, the  
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 Figure 2.2. Hoffmann reflex (H-reflex) and muscle response (M-wave) pathways. 
When a short-duration, low-intensity electric stimulus is delivered to the tibial 
nerve, action potentials are elicited selectively in sensory Ia afferents due to their 
large axon diameter (response 2). These action potentials travel to the spinal 
cord, where they give rise to excitatory postsynaptic potentials, in turn eliciting 
action potentials, which travel down the alpha motor neuron (aMN) axons toward 
the muscle (response 3). Subsequently, the volley of efferent action potentials is 
recorded in the muscle as an H-reflex. Gradually increasing the stimulus intensity 
causes action potentials to occur in the thinner axons of the aMNs (response 1), 
traveling directly toward the muscle and recorded as the M-wave. At the same 
time, action potentials propagate antidromically (backward) in the aMN toward 
the spinal cord (response 1) to collide with action potentials of the evoked reflex 
response (response 3), thereby resulting in partial cancellation of the reflex 
response. At supramaximal stimulus intensities, orthodromic (toward the muscle) 
and antidromic (toward the spinal cord) action potentials occur in all MN axons; 
the former gives rise to a Mmax, whereas the latter results in complete 
cancellation of the H-reflex. Taken from Palmieri RM, Ingersoll CD, Hoffman MA. 
The Hoffmann reflex: methodologic considerations and applications for use in 
sports medicine and athletic training research. J Athl Train. 2002;39(3):268-
277.412 
 
activation threshold for efferent fibers is met and signals are transmitted 
bidirectionally to both the muscle (orthodromic) and the spinal cord 
(antidromic).255,274,278 The orthodromic signals are responsible for introducing the 
M-wave, whereas the antidromic signals collide with the efferent signals elicited 
via Ia afferent activation and ultimately “cancel out” the H-reflex; therefore, 
explaining why the H-reflex disappears at higher stimulation intensities. The 
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length of time it takes for the electrical stimulus to elicit an H-reflex and M-wave 
at a muscle (latency) is dependent on an individual’s limb length.413,414 For 
example, the more distal the muscle of interest is from the point of stimulation, 
the longer the H-reflex and M-wave latencies. Since the H-reflex travels both 
afferent and efferent pathways, and the M-wave only travels the efferent 
pathway, it is logical that the H-reflex latency is longer than that of the M-wave 
latency. The average H-reflex and M-wave latencies at the quadriceps has been 
reported to be approximately 17-22 milliseconds265,415 and 11 seconds,265 
respectively. Refer to Figure 2.3 for further description of H-reflex pathways. 
 
 Figure 2.3. Recruitment curves of Hoffman reflex (H-reflex) and muscle 
response (M-wave). Taken from Hopkins JT, Ingersoll CD. Arthrogenic muscle 
inhibition: a limiting factor in joint rehabilitation. Sport Rehabil. 2000;9(2):135-
159.265 
 
H-reflex amplitudes are known to vary between subjects,265,274 making it 
difficult for researchers to compare their results with others studies, and reducing 
the external validity of this measure. Therefore, it is highly recommended that 
researchers normalize H-reflex amplitudes when reporting their results, so to 
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allow for more valid comparisons between subjects and studies.265,274 The H:M 
ratio is common method used to normalize H-reflex amplitudes,265 and it is the 
preferred normalization method when H- reflex data is being collected 
longitudinally.274 The H:M ratio of a given muscle is generated by dividing the 
Hmax amplitude by the Mmax amplitude. Since the MMAX is thought to represent 
maximum muscle activation, the H:M ratio can be interpreted as the proportion of 
the aMN pool capable of being recruited via the monosynaptic pathway.274 
However, the H:M ratio is based on the assumption that Mmax is a stable value. 
The number of aMNs in the spinal cord are thought to remain the same over 
time; thus, it is believed that the H:M ratio is a valid method for researchers to 
use when normalizing H-reflex data.265 
Electrode Placement 
Unipolar stimulation is recommended to observe the H-reflex in absence 
of the M-wave because it is thought to selectively activate Ia afferents at lower 
thresholds.416,417 This involves placing the active electrode (cathode) directly over 
the nerve supplying innervation to the muscle on interest, and the dispersive 
electrode (anode) on the opposite side of the limb. It has been suggested that 
this electrode configuration is better than a longitudinal arrangement because the 
stimulus artifact is less, an anodal block is less likely to develop, and selective 
stimulation of the nerve trunk is easier.417 However, if there are many nerves 
located adjacent to the nerve trunk being targeted, bipolar stimulation should be 
used to selectively activate the nerve trunk without stimulating any of the 
surrounding nerves.416 With bipolar stimulation, both the anode and cathode are 
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contained in one electrode, which allows the stimulation to be more precise. For 
quadriceps H-reflex testing, the active electrode is placed at the superior-lateral 
corner of the femoral triangle, and the dispersive electrode is placed posteriorly 
at the gluteal fold. As mentioned previously, surface EMG is used to record the 
H-reflex and M-wave amplitudes after stimulation. Bipolar electrodes (2 cm inter-
electrode distance) are adhered to the subject’s skin, over the corresponding 
muscle belly and parallel with the muscle fibers.  
Subject Positioning 
Subject positioning is the most technical of the H-reflex testing 
procedures. Factors such as eye movement,415 head position,415,418 joint 
angles,419-422 remote muscle contractions,279,415,423 and muscle length424,425 have 
been shown to affect H-reflex amplitude. As a result, H-reflex data can be highly 
variable between subjects and between studies based on differences in subject 
positioning.426,427 Therefore, specific guidelines pertaining to the testing position 
of subjects have been promoted to control these factors and reduce H-reflex 
variability. Specifically, it is recommended that subjects be positioned in a semi-
reclined, supine position with their head and arms supported and their hands 
being held at their side.417 The knee on the involved limb should be supported at 
approximately 15° of flexion, and their heel should rest on a supportive foot 
rest.428 The position of the extremities and angle of the joints should remain 
constant throughout H-reflex testing,412,423,428 and the subjects should be 





 As mentioned above, the fiber diameter of Ia afferents is larger than that of 
the efferents within a mixed nerve, making the rheobase (activation threshold) 
lower for Ia afferents.429 Therefore, H-reflex of a given muscle can be provoked 
at lower stimulation intensities. In terms of the duration of stimulus used with H-
reflex testing, longer stimulus durations have been previously shown to 
selectively activate Ia afferents;430 whereas, shorter durations preferentially 
activate efferent fibers.429 A stimulus duration of 1 millisecond is suggested to 
elicit an H-reflex.417 Lastly, the rest-period between the deliverance of stimuli 
must be taken into consideration when testing the H-reflex in subjects. If stimuli 
are delivered too closely within each other, the H-reflex amplitude can be 
negatively affected. This is attributed to a neural phenomenon known as post-
activation depression.431 After a stimulus is delivered to a nerve, the Ia afferents 
become depolarized and neurotransmitters are released presynaptically to bind 
with spinal interneurons, which then excite aMNs and evoke a neuromuscular 
response (H-reflex). However, if a second stimulus is delivered before the 
neurotransmitters are replenished in the Ia afferent endplate, the H-reflex 
amplitude will be reduced. Therefore, as a method to avoid these effects of post-
activation depression, stimuli should be delivered at an interval no less than 10 
seconds apart.416,431 
Reliability 
 Due to the variability that has been associated with H-reflex testing, it is 
important for researchers to determine the test-retest reliability of the H-reflex 
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amplitudes, especially when it is being used as a repeated measure in 
longitudinal studies. Ten to twenty measurements have been previously 
advocated as the standard for finding the mean HMAX,417 but as little as 5 
measurements has also been shown to produce sufficient reliability (ICC = 
0.93).432  The intrasession reliability of the quadriceps H-reflex has been reported 
to be very high (ICC = 0.96 – 0.97), with a low SEM (0.001) and MDC (0.002).428 
However, only moderate levels of intersession reliability have been reported, with 
the between-week reliability (4 weeks, ICC = 0.79 – 0.96)428 being lower than that 
of the between-day reliability (5 days, ICC = 0.76).428,433 Consequently, the SEM 
(0.01 – 0.06) and MDC (0.03 – 0.17) of the H-reflex are also higher when 
assessed between testing sessions.428,433 It must be noted that quadriceps H-
reflex reliability assessments (intrasession or intersession) have not been 
conducted in an ACLr patient population; thus it is unknown whether ACLr 
patients have more variable H-reflex amplitudes than that of healthy individuals. 
2.3.3 Corticomotor Excitability 
In 1980, Merton and Morton built a transcranial electrical stimulator (TES) 
that could invasively stimulate areas of the human brain through an intact 
scalp.434 By delivering a high-voltage shock above the area of the brain 
represented by the primary motor cortex, a resulting muscle response, called a 
motor-evoked potential (MEP), could be observed. This invention was a scientific 
breakthrough in the field of neurology because it allowed scientists to assess the 
neural activity of the human brain without disrupting superficial tissues. However, 
the main problem with TES is that it is a painful for subjects due to its electrical 
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properties. Thus, five years later, Anthony Barker developed an alternative 
device that non-invasively stimulated areas of the brain, while providing little to 
no discomfort to subjects.435 This invention is known as transcranial magnetic 
stimulation (TMS). Since its inception, TMS has largely replaced TES and is 
widely used to study both the neuroanatomy and neurophysiology of the human 
brain. With TMS, large electrical current flows through a coil placed on the scalp, 
generating a perpendicular magnetic field that penetrates through the scalp and 
skull, and induces an electrical current flowing parallel to the superficial layers of 
brain (see Figure 2.4).286,436,437 Since the electric current of TMS penetrates 
through the scalp and skull, cutaneous pain receptors are not activated, resulting 
in a relatively painless experience for the subject.438 This is contrary to TES 
whose electrical current passes through the scalp and skull, and subsequently 
activates pain receptors.436,439 Due to the high electrical impedance of the skull, 
the current density required to successfully activate the cortical neurons using 
TES is much higher than that of TMS. The combination of these factors is what 
has made TMS the more popular tool of choice.  
In addition, TMS and TES also activate the neurons within the cerebral 
cortex differently. Since the electrical current of TMS flows parallel to the surface 
of the brain, horizontally oriented neurons are preferentially activated, whereas 
the TES flows in all directions, directly activating neurons at the axon hillock.436  
Low-intensity TES causes a single descending volley, termed the D-wave (direct 




Figure 2.4. Illustration demonstrating the direction the electrical current flows in 
the magnetic coil, the generated magnetic field, and the induced electrical current 
in the brain. Taken from Hallett, M. Transcranial magnetic stimulation and the 
human brain. Nature. 2000;406:147–150.437 
 
intensities of TES are used, greater electrical fields are produced and indirect 
trans-synaptic activation of pyramidal neurons occurs. This leads to a series of 
descending volleys that follow the D-wave termed I-waves (indirect waves). In 
contrast, the parallel nature of the TMS current commonly elicits I-waves due to 
preferentially activated trans-synaptic pyramidal neurons;440 however, higher 
intensities of TMS tend to also elicit D-waves at the corticospinal tract. The 
summation of descending volleys travel to the anterior horn of the spinal cord 
and depolarize the alpha motor neurons. This progressive depolarization 
subsequently induces an action potential, resulting in a MEP within the targeted 
muscle group.436  
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Current TMS models are capable of inducing multiple types of pulses such 
as single-pulse, paired-pulse, or repetitive. Single-pulse TMS is especially useful 
for mapping cortical areas and assessing the integrity of the corticospinal 
tract.94,441 and is generally used to assess corticomotor excitability via motor 
thresholds and MEP amplitudes. Single-pulse TMS involves the delivery of one 
monophasic magnetic stimulus to the brain and recording the resultant MEP. 
This stimulation involves currents that rapidly rise and then decay slowly, 
followed by a long duration low amplitude current of opposite polarity.436,442  
Procedures 
 As TMS is delivered to an area of the motor cortex, the flow of ions 
introduced by the electrical field alters the electrical charge of the cell membrane, 
causing a depolarization and hyperpolarization of neurons.439 The passive ion 
channels within the cell membrane make it permeable to these ions, which 
increases membrane conductance. Experiments have shown that the electrical 
field induced by TMS selectively activates neurons at lower threshold where the 
axons terminate (or bend sharply).443,444 Hence, axons with larger diameters are 
expected to be activated at lower TMS intensities. These neuroanatomical and 
neurophysiological properties of TMS provide rationale for determining the area 
(“hotspot”) of the motor cortex which elicits the highest MEP amplitudes for a 
given muscle group. This “hotspot” theoretically represents the area of the motor 
cortex under the stimulating coil where the electrical field is the strongest and 
acts on the axon terminate (i.e., synapse). 
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Motor threshold is defined as the lowest TMS output needed to elicit 
specific MEP amplitudes at a target muscle group when applying a single-pulse 
stimulus to the motor cortex.445 This measure is believed to reflect membrane 
excitability and local density of a central core of corticospinal neurons 
(specifically pyramidal neurons) and interneurons.285 Motor thresholds can be 
assessed with the subject’s muscles in a relaxed or active state.442 MEP 
amplitudes are typically larger in upper extremity muscles compared to lower 
extremity muscles. Therefore, when assessing motor thresholds at the lower 
extremity, subjects are commonly instructed to sustain a slight muscle 
contraction (5-15% of maximal voluntary force) so to enhance MEP 
amplitudes.442 This is known as an active motor threshold technique. Conversely, 
a resting motor threshold technique (with the subject muscles relaxed) is often 
acceptable to use for upper extremity muscles. The recommended MEP 
amplitude for establishing resting motor thresholds is 50µv, and recommended 
MEP amplitude for active motor thresholds is 100 µv.442 
There are several methods that have been used to measure motor 
threshold, but for the purpose of this review, the method used by the author will 
be discussed.61,97,446 The first step is to identify the ‘hotspot” on the scalp where 
the largest MEP amplitude is produced for the targeted muscle group using 50% 
of TMS output. Once the “hotspot” is identified and marked (on a swim cap), 
stimulus intensity should be increased or decreased in increments of 5% until the 
recommended MEP amplitude is reached (50 or 100 µv).  Once MEP amplitude 
is reached, 5 out of 10 consecutive trials performed at that stimulus intensity 
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should elicit MEPs at or above the recommended amplitude, and 6 out of 10 
trials should fall below the recommended amplitude when the stimulus intensity is 
decreased by 1% of TMS output. Multiple trials are performed to confirm the 
motor threshold level can be trusted due to the inherent variability of MEPs. 
Another measure that is used to assess global corticomotor excitability is 
called a recruitment curve (or input-output curve). It represents gradually 
increasing TMS intensity and recording the resultant change in MEP amplitude. 
Increasing TMS output by increments of 10% motor threshold is one method that 
has been used.288 MEP amplitudes are commonly expressed as a ratio between 
MEP and the maximal M-wave (using peripheral nerve electrical stimulation) of 
the targeted muscle. This stimulus-MEP relationship is then plotted to create a 
recruitment curve. Although this measure is less understood, it is thought to 
demonstrate the extent in which the alpha-motor neuron pool is activated with 
increasing TMS intensities.287 Another hypothesis is that the progression of the 
curve reveals other neurons outside the core group of neurons that are activated 
as stimulation intensity is increases; thus, explaining the larger MEP amplitudes 
observed at high TMS intensities.94,286 
The MEP amplitude elicited through single-pulse TMS is thought to reflect 
both the integrity and excitability of the corticospinal tract in relation to a targeted 
muscle group.442,445 However, the absolute MEP amplitude consists of both 
upper and lower motor neuron activity; thus, making it difficult to assess neural 
activity at just the cortex. A solution to this problem was developed by Rossini et 
al.442 who recommended correlating MEP amplitude evoked by TMS with the 
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amplitude of the compound muscle action potential (or M-wave) via peripheral 
electrical nerve stimulation. The equation involves dividing the MEP amplitude by 
the M-wave amplitude, and then multiplying the product by 100 to provide an 
MEP percentage (MEP%). This MEP% is said to estimate the portion of lower 
motor neurons in the anterior horn of the spinal cord that are activated by TMS. 
As the TMS intensity increases, MEP% of the targeted muscle group increases 
accordingly. Upper extremity muscles demonstrate a steep TMS-MEP% slope, 
while the MEP% in lower extremity muscles is more gradual as TMS intensity is 
increased.447 
Since its inception 30 years ago, uses for single-pulsed TMS have 
continued to grow due to its noninvasive nature and clinical versatility. The 
following review will discuss the most recent procedures that are associated with 
single-pulsed TMS used to assess corticomotor excitability. This will include the 
recommended coil placement, subject positioning, and parameters for single-
pulsed TMS. In addition, the reported reliability of the motor thresholds and MEP 
amplitudes will be discussed.  
Coil Placement 
MEP amplitude largely depends on the location of the TMS coil on the 
scalp and the direction of the induced electrical field.448,449 With all TMS coil-
types, the current within the coils (as viewed from above) should be in a 
clockwise orientation when stimulating the right hemisphere, and a 
counterclockwise orientation when stimulating the left hemisphere.447 Therefore, 
the directions of the induced electrical fields are flipped and the motor cortices of 
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both hemispheres are being stimulated in a posterior-to-anterior fashion. This 
posterior-to-anterior stimulation is found to be optimal for eliciting MEPs at low 
thresholds over the motor cortex.436 
 When using figure-8 coil for focal TMS, the direction of the magnetic field 
is perpendicular to the long axis of the coil. Therefore, large difference in elicited 
MEP can be observed with different figure-8 coil orientations.450 For example, 
when targeting the hand muscles in the motor cortex, the orientation of the 
magnetic field should be perpendicular to the central sulcus,448 whereas the 
orientation should be perpendicular to the longitudinal fissure when targeting leg 
muscles.450 Furthermore, since the stimulation pattern of the figure-8 coil is more 
focalized than the circular coil,450 MEPs are more prone to variability if its coil 
placement is not standardized. This makes it important for examiners to find the 
“hotspot” on the scalp and mark it so that the reliability of the evoked MEPs can 
be improved. 
Prior to performing assessments with TMS, the optimal site of cortical 
stimulation should be determined in relation to the muscle group that is being 
targeted. This “hotspot” corresponds to the location on the scalp that elicits the 
highest peak-to-peak MEP amplitude of the targeted muscle.94,436,442 This 
location is often determined by having the subject wear a swim cap on their head 
that consists of two intersecting, perpendicular lines.94,442 The sagittal line should 
run from the occiput to the tip of the nose, and the coronal line should run from 
one external ear canal to the other. This orientation allows the lines to intersect at 
the vertex of the skull. When targeting muscles of lower extremity (the 
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quadriceps specifically), the first MEP should be recorded with the center of the 
coil at the vertex (using 50% maximal stimulator output).288 This is in accordance 
with the representation of the lower extremity in the primary motor cortex, as 
demonstrated by the motor homunculus. It is important to note that the direction 
of current flow in the coils (clockwise or counterclockwise) should be consistent 
throughout testing.442 This is because the orientation of the induced electrical 
field within the motor cortex is opposite of the coil’s current. Marking the current 
direction on the coil’s frame helps to remind the examiner of the electrical field’s 
orientation and the manner at which they are stimulating the motor cortex (i.e., 
posterior-to-anterior or anterior-to-posterior). After stimulating at the vertex, the 
coil should be repositioned anteriorly and posteriorly (in 0.5-1cm increments) until 
the highest peak-to-peak MEP amplitude is found.288,296 The coil may also be 
repositioned lateral to the midline, on the cortical hemisphere contralateral to the 
targeted limb to search for larger MEP amplitudes. Once the hotspot has been 
located, a tracing of the coil should be drawn on the swim cap with a fine-point 
ink pen or marker.94,436,442,451 This step allows for consistent coil placement 
throughout a given testing session.  
EMG is commonly used to record and measure the MEP elicited through 
TMS. An output cable from a magnetic stimulator is connected to an EMG A/D 
board, which in turn is connected to a computer. EMG software is then used to 
monitor EMG activity of the targeted muscle/s, and record MEPs after TMS is 
delivered. The temporal latency from the onset of stimulation to an MEP is longer 
for lower extremity muscles (~100 ms) compared to upper extremity muscles 
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(~50 ms) due to the longer distance that is needed for the stimulus to travel.442 
Therefore, the recording window of the software’s oscilloscope must be wide 
enough to capture MEPs in the lower extremity (>80 ms). To prevent an MEP 
from not being captured, an effective method is to use the TMS impulse to trigger 
the onset of the recording window on the oscilloscope. This ensures that MEPs 
are not recorded too early or too late, and allows both the stimulus and MEP to 
be observed on the oscilloscope. Surface electrodes are used more often than 
indwelling electrodes when recording MEPs. Bipolar surface electrodes should 
be applied on the subject’s skin (shaved, abraded, and cleaned) overlying the 
target muscle with a 2 cm inter-electrode distance, identical to the procedures 
used when recording compound muscle action potentials or M-waves. Filtering 
should be relatively open, with a low-pass filter recommended to minimize 
stimulus artifacts caused by the TMS.442 MEP amplitudes are measured from the 
highest to lowest peak of the MEP, and these values are commonly recorded in 
microvolts (µv). 
Subject Positioning 
Subjects should be positioned comfortably in either an upright, seated 
position or horizontal, prone position. The examiner must ensure that there is a 
sufficient amount of head space for the coil to be appropriately positioned.436 The 
position of the subject’s head and eyes should be constantly maintained, and the 
examiner should instruct them to relax their body throughout the testing session 
while still being alert. For those measurements that require a voluntary muscle 
contraction during the TMS, subjects should maintain a constant level of 
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contraction during stimulation trials, and be instructed to relax their muscle 
between trails.446  
The size of the MEP amplitude not only depends on the strength and 
number of descending volleys induced through TMS, but also on the physical 
state of the subject’s muscle. When a subject is in a relaxed state, higher 
stimulation intensities are needed to elicit an observable MEP because more 
descending volleys are needed for depolarization.442 On the contrary, if the 
stimulus was delivered while a subject sustained a submaximal voluntary 
contraction of the targeted muscle, a lower intensity would be needed to produce 
an observable MEP due to the resting potential of the inactive motor neurons 
being closer to threshold.442 In other words, when keeping stimulation intensity 
constant, TMS delivered during a voluntary muscle contraction elicits a larger 
MEP compared to that of a resting muscle because a portion of the muscle is 
already primed. Voluntary muscle contractions are often used as a method to 
both enhance MEP amplitudes and lower motor thresholds when assessing 
muscle groups less responsive to TMS.442,452 Voluntary contractions have also 
been found to shorten the MEP latency by 2-3 ms compared to relaxed muscle. 
The reduced latency is suggestive of earlier lower motor neuron firing in 
response to earlier I-waves and D-waves during the contraction.436  In addition, 
voluntary muscle contractions not only make MEP amplitudes easier to observe, 
but they have also been shown to improve the reliability of TMS measures by 
exhibiting more consistent MEP amplitudes across multiple trials.453 Therefore, 
having subjects perform a background voluntary muscle contraction at a constant 
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submaximal level (5-10% of maximum contraction) while delivering TMS is 
recommended to improve MEP measurement quality. 
Parameters 
Magnetic stimulators commercially used for TMS produce magnetic fields 
from 1-2.5 Tesla that last 100 to 200 µs, and induce electrical fields in the cortex 
of up to 150 V/m,439,442 and are be capable of reaching depths of 1.5-3 cm 
beneath the scalp based upon which coil type is used. Circular, Figure-8, and 
double-cone coils are the coil types routinely used for TMS. Circular (round) coils 
induce a circular current that is maximal at the diameter of the coil (8-12 
cm).436,442 As a result, no stimulation occurs at the center of the coil, making it 
suitable for broad stimulation of the brain. For more focal stimulation, Figure-8 
coils consisting of two adjacent coils with opposite current directions are 
recommended. This flat coil configuration allows for a more pinpoint stimulation, 
but lacks the strength to penetrate deeper cortical areas.436,442,454 The coil type 
that provides both strong and focal stimulation is the double-coned coil. The 
double-coned coil has the same configuration as the Figure-8 coil, except that 
the two adjacent coils are angulated at 95° instead of being flat (180°). This 
double-cone figuration increase the power at the intersection, while allowing the 
stimulus to be focused simultaneous.286,442,455 While the circular and Figure-8 
coils are suitable for eliciting MEPs in upper extremity muscles, the double-coned 
coil is recommended for targeting muscles of the lower extremity.436 
The amplitudes of MEPs increase as the TMS output intensity is 
increased. This suggests that application of a stronger stimulus also recruits 
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more upper and lower motor neurons. However, compared to the amplitudes of 
M-waves elicited through peripheral electrical nerve stimulation, the MEP 
amplitudes evoked by TMS are smaller in size. In fact, this stimulus-response 
relationship for M-waves demonstrates a sigmoidal curve, while a gradual, linear 
relationship is observed for MEPs with increasing TMS intensities. The stimulus-
response relationship has been found to vary considerably between subjects. 
When the TMS intensity is standardized to individual MEP motor thresholds (i.e., 
120% motor threshold), significant differences between MEP amplitudes have 
been observed between subjects.456 As a method to normalize MEP amplitudes 
across individuals, a ratio of the MEP amplitude to the M-wave of the targeted 
muscle group has been recommended.442 However, this MEP ratio has also been 
shown to differ between subjects, 59,61 which may be due to the location of the 
peripheral stimulus.59 Applying the electrical stimulation more proximally at the 
nerve (i.e., sciatic nerve) may account for the dispersion that occurs when 
applied more distally (i.e., peroneal nerve).457,458 
Reliability 
It is important to test the intersession reliability of corticomotor excitability 
TMS measures in healthy subjects to determine whether they are both stable and 
sensitive enough to detect changes over time in a pathological population or 
treatment group. The majority of the reliability studies for MEP amplitudes and 
motor thresholds have been performed in upper extremity muscles. Over a 
timespan of 3-14 days, these studies have reported very high intersession 
reliability for motor thresholds (ICC = 0.83 – 0.99),451,459 whereas the reliability for 
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MEP amplitudes range from low to very high reliability (ICC = 0.5 – 0.99).451,460-
462 Recently, Livingston et al.451 assessed the intra-rater reliability of corticomotor 
excitability measures in the hand muscles of 16 healthy subjects. Their subjects 
attended 6 sessions over the span of 15 days, and both MEP% and resting motor 
thresholds were assessed bilaterally during these sessions. They reported very 
high intra-rater reliability with resting motor thresholds (ICC = 0.83 – 0.93), while 
the reliability of MEP% was low to high (ICC = 0.28 – 0.72). Although both 
corticomotor excitability measures appear to demonstrate adequate reliability in 
the upper extremity, MEP amplitudes are more variable than motor thresholds, 
and should therefore be interpreted with caution. 
 The intersession reliability of corticomotor excitability measures in lower 
extremity muscles has been less explored compared to the upper extremity. Of 
the few studies that have examined the reliability of corticomotor excitability 
measures in lower extremity muscles, the intersession reliability for motor 
thresholds was high to very high (ICC = 0.78 – 0.98),463,464 whereas the reliability 
for MEP amplitudes range from very low to very high (ICC = -0.14 – 0.99).463-465 It 
is important to note that the time between sessions for these studies was 10-56 
days, and some of these studies included both healthy subjects and patients 
(stroke and spinal cord injury).464,465 The most recent study by Luc and 
colleagues463 assessed the intersession reliability of active motor thresholds and 
MEP amplitudes in the vastus medialis oblique and peroneus longus (bilaterally). 
Twenty subjects attended a baseline testing session and returned for follow-up 
assessments at 2 and 4 weeks. MEP amplitudes were evaluated at multiple TMS 
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intensities relative to the percentage of active motor thresholds (95%, 100%, 
105%, 110%, 120%, 130%, and 140%). These amplitudes were also normalized 
to the peripheral M-waves to obtain an MEP%. Both muscles demonstrated high 
to very high intersession reliability at both day 14 (ICC = 0.78 – 0.96) and day 28 
(ICC = 0.92 – 0.95). However, the reliability of MEP% was highly variable across 
TMS intensities and between days (ICC = -0.14 – 0.99), demonstrating low to 
very high intersession reliability. These findings for the lower extremity are in 
agreement with what has been reported in upper extremity muscles. Motor 
thresholds are more reliable than MEP amplitudes, and they should be 
preferentially used when conducting longitudinal assessments of cortical 
excitability in subjects. 
 
2.4 DISINHIBITORY INTERVENTIONS FOR NEURAL QUADRICEPS 
DYSFUNCTION 
The influence quadriceps strength has on long-term health and function, 
combined with the limiting effect NQD has on a patient’s ability regain quadriceps 
strength using traditional quadriceps strengthening exercises, has prompted the 
development and evaluation of interventions used to combat NQD exhibited in 
patients after knee-joint injury/surgery. These interventions, termed disinhibitory 
interventions, have grown in variety over the past decade, but not all of them 
have demonstrated efficacy. Disinhibitory interventions can be categorized into 
either sensory-based or motor-based modalities based on their treatment effects. 
Sensory-based modalities serve to disinhibit efferent pathways of the quadriceps 
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after knee-joint injury/surgery, by attenuating the influx of inhibitory afferent 
stimuli arising from the involved knee-joint and/or overriding it with excitatory 
afferent stimuli. Conversely, motor-based modalities serve to facilitate quadriceps 
activation after knee-joint injury/surgery, by activating the intramuscular nerves 
directly and/or targeting the supraspinal efferent pathways projecting to the 
inhibited motorneuron pool. 
The final section of this review will discuss the various sensory and motor-
based modalities that have been used disinhibitory interventions, and their 
effectiveness in mitigating NQD in patients with knee-joint pathology and/or 
surgery. 
2.4.1 Sensory-Based Modalities 
Cryotherapy 
 Cryotherapy involves the application of cooling modalities (i.e. ice bag, 
cold tub, etc.) to a site of musculoskeletal trauma. It is commonly applied after 
acute musculoskeletal injuries to decrease cell metabolism, limit edema 
formation, and control pain during the inflammatory phase.466 However, 
cryotherapy has also been shown to possess disinhibitory capabilities.407,408,467-
471 Studies using artificial knee-joint effusion models were the first to demonstrate 
disinhibition of the quadriceps by applying cryotherapy at the knee,408,470 but 
there have been several studies since then that have replicated these outcomes 
in patients with knee-joint pathology or surgery.407,467-469 Pietrosimone et al.469 
assessed the disinhibitory effect of applying cryotherapy (crushed ice bags) to 
the knees of patients with tibiofemoral OA and quadriceps inhibition (CAR < 
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90%). Compared to the control group that did not undergo the cryotherapy, those 
in the cryotherapy group had a significantly higher percent change in quadriceps 
CAR after applying cryotherapy to their knees for as little as 20 minutes (5.75% ± 
7.25 vs -3.5% ±  8.0, P < 0.01). Furthermore, a strong treatment effect size was 
demonstrated in the cryotherapy group (Cohen’s D = 1.21, 95% CI = 0.28 – 
2.05), implying that cryotherapy has both statistical and clinical significance as a 
disinhibitory modality for patients who exhibit NQD after knee injury/surgery. 
However, the maximum treatment duration of cryotherapy is limited (20-30 
minutes) to protect against peripheral neuropathy, but the residual disinhibitory 
effects of cryotherapy have been reported to last up to 30 minutes after the cold 
modality is removed (attributed to rewarming).408,470,472 Therefore, the true 
potential of cryotherapy is thought to “open” the efferent pathways of the 
quadriceps at the beginning of a patient’s rehabilitation, so that the available 
motoneurons can be “exploited” when they perform quadriceps strengthening 
exercises.407 To test this hypothesis, Hart et al.407 conducted a randomized 
clinical trial on patients with prior ACLr who presented with of quadriceps 
inhibition (CAR ≤ 90%). The patients were randomized into 2-week interventions 
consisting of either cryotherapy treatments, traditional quadriceps strengthening 
exercises, or a combination of cryotherapy and exercises. Those patients in the 
cryotherapy group applied ice bags to their involved knee-joints once a day (20 
minutes/session) for two weeks, and the exercise group performed progressive 
open and closed kinetic chain exercises each of the 14 days (1 hour/session). 
Whereas, the cryotherapy+exercise group performed the same exercise protocol 
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as the exercise group, but they applied the same cryotherapy protocol as the 
cryotherapy group prior to exercising. The authors assessed peak isometric KET 
(at 90° of knee flexion), voluntary quadriceps activation (using the SIB technique 
and CAR), and spinal reflexive excitability (H:M ratio) in groups before and after 
their 2-week interventions. Interestingly, the cryotherapy+exercise group was the 
only group that demonstrated a statistically significant improvement in quadriceps 
function after two weeks, and this was specific to peak isometric KET (pre = 1.6 ± 
0.4 Nm/kg, post = 2.2 ± 0.7 Nm/kg, p = .002). Although voluntary quadriceps 
activation did not achieve statistical significance in the cryotherapy+exercise 
group, clinical significance was observed with the strong treatment effect size 
(Cohen’s D = 1.4, 95% CI = 0.42, 2.4). These results suggest that cryotherapy 
should be administered prior to exercise for patients who exhibit NQD, so that 
they may take advantage of the available motoneurons when exercising their 
quadriceps. 
Transcutaneous Electrical Nerve Stimulation 
 Like cryotherapy, transcutaneous electrical nerve stimulation (TENS) is a 
sensory-based modality originally intended to control arthrogenic pain through 
principles of the gate control theory.473 Non-painful, cutaneous receptors are 
innervated by large diameter, myelinated afferent fibers (type II/A-beta and III/A-
delta); whereas, pain receptors are innervated by small diameter, unmyelinated 
afferent fibers (type IV/C). When both of these fiber types are activated together, 
the non-painful stimuli are preferentially interpreted by the central nervous 
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system, and the afferent signals arising from pain receptors become “gated” (via 
presynaptic inhibition).  
Although cryotherapy and TENS both use these principles to control pain, 
they target different afferent structures. When cryotherapy is applied to a painful 
joint (i.e., ice bag application), cutaneous thermoreceptors detect the abrupt 
changes in skin temperature, causing type III (A-delta) fibers become activated. 
As a result, these signals are transmitted to the central nervous system, and the 
type IV (C) fibers become overridden.474 Depending on how long the cryotherapy 
is applied, and the thickness of subcutaneous tissue superficial to the joint, 
cryotherapy may also work to control pain by decreasing conduction velocities of 
type IV fibers originating from nociceptors within the joint. On the other hand, 
TENS selectively activates larger diameter, type II (A-beta) fibers.475,476 These 
fibers innervate cutaneous mechanoreceptors that respond to touch/pressure. 
Therefore, when TENS is applied to the skin surrounding a painful joint, the 
stimuli arising from the TENS is favored by the central nervous system, and pain 
is diminished due to the inhibition of type IV fibers. 
Given their ability to control pain, it is intuitive to assume that cryotherapy 
and TENS can disinhibit the quadriceps in patients after knee injury/surgery 
because of the contribution knee-joint pain has with AMI (i.e., flexion reflex). 
However, the majority of inhibitory mechanisms at the core of AMI are not driven 
by arthrogenic pain, but by the disruption of joint mechanoreceptors instead. 
Therefore, the gate control theory of pain does not explain why cryotherapy and 
TENS have been shown to increase motor output of the quadriceps after artificial 
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knee-joint effusion. Although some joint discomfort is expected after artificial 
knee-joint effusion, the NQD that is observed in these subjects is primarily 
caused by the disruption of joint mechanoreceptors via capsular distention. Since 
cryotherapy and TENS have been shown to disinhibit the quadriceps after 
artificial knee-joint effusion, they must also have the ability to target the inhibitory 
mechanisms triggered by capsular distention (i.e. Ib inhibition, presynaptic 
inhibition, and post-synaptic inhibition).  
Similar to pain control, cryotherapy and TENS are believed to disinhibit the 
quadriceps in different ways. Applying cryotherapy to a joint transmits excitatory 
stimuli to the central nervous system through activation large diameter afferent 
fibers, which in turn, facilitate the motorneuron pool projecting to the quadriceps. 
In addition, cryotherapy has been shown to slow the nerve conduction velocity of 
afferent fibers,477 and is hypothesized to slow the discharge rate of joint 
mechanoreceptors if applied for a long enough duration.408 Previous reports have 
demonstrated that intraarticular temperature can decrease during and after 
application of cryotherapy to a joint.478,479 Oosterveld et al.479 reported a 
decrease of 16.9°F in intra-articular temperature after a 30-minute cryotherapy 
treatment. Even after the ice was removed, intra-articular temperatures continued 
to decrease for up to 45 minutes. Therefore, by being able to reach the depth of 
the knee-joint, cryotherapy can slow the discharge rate of joint 
mechanoreceptors, which would attenuate the influx of afferent stimuli projecting 
to the central nervous system, and disengage the inhibitory mechanisms. 
Conversely, TENS has been reported to decrease presynaptic inhibition of Ia 
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afferents through stimulation of cutaneous afferent fibers.339 It has also been 
hypothesized that the afferent stimuli from TENS may inhibit the Ib inhibitory 
interneuron, or excite the Ia excitatory interneuron, which would facilitate the 
motoneuron pool.408 Furthermore, both cryotherapy and TENS have been 
thought to disinhibit the quadriceps by triggering supraspinal centers that inhibit 
Ib interneurons through descending pathways.408 Supraspinal centers are known 
to regulate spinal reflexive activity to allow for controlled movement.355,356 
Therefore, the overload of excitatory and inhibitory stimuli arising from the knee-
joint during TENS or cryotherapy treatments, may force supraspinal centers to 
intervene and control the efferent pathways projecting to the quadriceps. 
The disinhibitory effect of TENS was first demonstrated during studies of 
the mid-1980s.480,481 Arvidsson and Eriksson481 assigned 15 knee-surgery 
patients (12 ACLr, 1 meniscectomy, 1 lateral release, 1 MCL repair) to groups 
that consisted of either TENS or placebo-TENS interventions. In both groups, the 
interventions were applied to the involved knee for 15-20 minutes post-surgery 
(at rest). Integrated EMG of the quadriceps was assessed in patients before and 
after the treatment sessions. Compared to baseline, integrated EMG significantly 
increased by 305% in the TENS group after treatment, whereas no significant 
changes were demonstrate in the placebo-TENS group. However, much like 
what was realized with cryotherapy, the true disinhibitory potential of TENS is 
maximized when used in conjunction with exercise.467,482  
Pietrosimone et al.482 randomized 36 patients, with tibiofemoral OA and 
quadriceps inhibition (CAR < 90%), into TENS+exercise, placebo-
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TENS+exercise, and exercise-only groups. The groups were matched by 
voluntary quadriceps activation (CAR) and OA grade (Kellgren-Lawrence score). 
All three groups performed a 4-week exercise program (3 sessions/week) that 
consisted of progressive lower extremity range-of-motion and strengthening 
exercises. Additionally, the TENS and placebo-TENS groups applied treatments 
to their involved knees for eight hours per day when they were the most active. 
Peak isometric KET (at 70° of knee flexion) and voluntary quadriceps activation 
(using the SIB technique and CAR) were assessed in each group at baseline, 
and at weeks two and four of their intervention program. There were no group 
differences observed at baseline for both measures of quadriceps function. 
Voluntary quadriceps activation were significantly higher in the TENS+exercise 
group (CAR = 94%) than the exercise-only group at two weeks (CAR = 82%, p = 
0.02), and significantly higher than the placebo-TENS+exercise group at four 
weeks (CAR = 94% vs. 81%, p = 0.03). Peak isometric KET was higher in the 
TENS+exercise group than the placebo-TENS+exercise group at both two (2.5 
Nm/kg vs. 1.6 Nm/kg, p < 0.01) and four weeks (2.8 Nm/kg vs. 1.6 Nm/kg, p < 
0.01), but not significantly higher compared to the exercise-only group (p = 0.09). 
Although these results imply that the placebo-TENS and exercise-only 
interventions possess disinhibitory effects, the clinical significance of the 
interventions was better conveyed by observing the treatment effect sizes 
(Cohen’s D). The TENS+exercise group demonstrated strong effect sizes for 
peak isometric KET and voluntary quadriceps activation at weeks two (KET: 
1.05, 95% CI = 0.16, 1.86; CAR: 1.93, 95% CI = 0.91, 2.83) and 4 (KET: 1.26, 
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95%, CI = 0.35, 2.09; CAR: 1.81, 95% CI = 0.80, 2.68), while the placebo-
TENS+exercise group was the only other group to demonstrate at significant 
effect size (though moderate) for voluntary quadriceps activation (0.88, 95% CI = 
0.02, 1.68). This observation in the placebo-TENS+exercise group may have 
truly been the result of the “placebo effect”. 
Perhaps the most surprising result of this study was the disinhibition of the 
quadriceps that was maintained in the TENS+exercise group following removal of 
the TENS treatment. Although previous studies have claimed that disinhibition of 
the quadriceps is negated after TENS is removed,408 this was the first study to 
assess the disinhibitory effect of TENS when applied over a period of weeks. 
Thus, the greater exposure to TENS may have generated a lasting disinhibitory 
effect in their patients. The authors hypothesized that the greater exposure to 
TENS may have facilitated synaptic plasticity within the motorneuron pool,483 
which may allow a patient to access previously inhibited motoneurons after 
TENS is removed.482 Hebbian theories suggest that postsynaptic neurons that 
continually depolarize in response to excitatory presynaptic potentials may allow 
for multiple postsynaptic neurons to depolarize together, even when the 
postsynaptic neurons are not directly depolarized by presynaptic potentials.484 
Therefore, after weeks of being able to access motor units of the quadriceps 
through TENS, synaptic plasticity may have ensued within the motoneuron pool, 




Previous reviews support TENS as not only the most effective sensory-
based disinhibitory intervention, but the most effective disinhibitory intervention in 
general.100,101 In one of my earlier publications, I developed a critically appraised 
topic to determine whether TENS or cryotherapy was the more effective 
disinhibitory modality for improving voluntary quadriceps activation (quantified via 
CAR) in patients with knee-joint pathologies.100 I searched the literature to find all 
of the studies that used TENS and/or cryotherapy as a disinhibitory interventions 
for patients with knee-joint pathologies (i.e. osteoarthritis, ACL deficiency, 
patellofemoral pain, etc.). A total of three randomized clinical trials satisfied my 
eligibility criteria and were included in the review.467,469,482 To compare the clinical 
effectiveness between TENS and cryotherapy, I extracted (or calculated) 
Cohen’s D effect sizes (difference in mean CAR from baseline to posttest, 
divided by the pooled standard deviation of the two means) for CAR from the 
intervention groups of each study (see Figure 2.5). TENS consistently exhibited 
stronger effect sizes than cryotherapy, and unlike cryotherapy, maintained 
significant effect sizes at each post-treatment measurement time point. This 
suggests that TENS may be the more clinically effective disinhibitory modality. 
Furthermore, the clinical versatility of TENS is greater than cryotherapy. Unlike 
cryotherapy, there is no limit to treatment duration or dosage with TENS, and 
most all TENS units can be worn during exercise without obstructing movement. 
Therefore, the strong disinhibitory effect and clinical versatility of TENS, gives it 




 Figure 2.5. CAR effect sizes with 95% confidence intervals: Diamonds with solid 
error bars represent effect size point estimates for TENS interventions and 95% 
confidence intervals, whereas circles with broken lines represent effect size point 
estimates for cryotherapy and 95% confidence intervals. All point measures and 
confidence intervals on the right of the vertical solid line represents beneficial and 
statistically significant effects (confidence intervals do not cross 0), whereas the 
left of the line represents non-beneficial and statistically insignificant effects. 
 
Muscle Vibration 
Although cryotherapy and TENS are considered to be the most effective 
sensory-based disinhibitory interventions, muscle vibration is novel modality that 
has demonstrated early promise, and is beginning to receive more attention in 
the literature. Muscle vibration can be applied in two different modes: whole body 
vibration (WBV) or local muscle vibration (LMV). WBV involves having individuals 
stand on a vibratory platform, whilst performing stationary, closed kinetic chain 
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exercises (i.e. squats). LBV, as the name implies, involves a portable, vibratory 
device that is strapped to the muscle of interest while individuals perform lower 
extremity exercises. Although both modes of muscle vibration are equally 
effective at improving neuromuscular function,485 LBV is more cost-effective and 
less restrictive to exercise type. Thus, LBV tends to be more clinically applicable 
compared to WBV. 
The neuromuscular effects of muscle vibration is founded on principles of 
the tonic vibration reflex.486 By applying repetitive vibratory stimuli to a muscle, 
the Ia afferents at the muscle spindles become highly excitable, which lead to a 
heightened motor output of the muscle. Pollock and colleagues487 found that 
immediately after muscle vibration, the recruitment threshold was lowered for 
fast-twitch (type II) motor units and elevated for slow-twitch motor units. This 
suggests that muscle vibration enhances neuromuscular function by specific 
targeting motoneurons projecting to fast-twitch motor units. However, other 
reports have shown that the neural effects of muscle vibration are not confined to 
just motoneurons within spinal cord, but at the motor cortex as well.488,489 Mileva 
et al.489 used TMS to assess the MEP amplitudes at the tibialis anterior muscle, 
while their participants simultaneously underwent a WBV protocol (330 second 
isometric squat). They reported MEP facilitation in all participants during the 
WBV protocol. These results indicate that muscle vibration may improve 
neuromuscular function by increasing corticomotor excitability.  
Since muscle vibration has been shown to facilitate quadriceps activation 
in healthy individuals,490-495 it seems logical that it would produce disinhibitory 
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effects in patients after knee-joint injury/surgery. However, most of the current 
literature involves determining the effects muscle vibration on quadriceps 
strength,496,497 lower extremity function,498,499 and postural stability497,499,500 in 
patients with knee-joint pathologies. Although these measures are important to 
understanding the complete benefits muscle vibration, they do not provide 
information in regard to its disinhibitory effect. Blackburn and colleagues485 
recently sought to determine the disinhibitory effect of muscle vibration using an 
artificial knee-joint effusion model. To induce AMI in the quadriceps, they injected 
the knee-joints of 45 healthy individuals with 60 mL of saline. The individuals 
were then randomized into WBV, LBV, or control groups. Each group performed 
an isometric squat (40° of knee flexion), but the WBV and LBV (at the quadriceps 
tendon) groups received simultaneous muscle vibration (30 Hz, 2g). Voluntary 
quadriceps activation (via SIB technique and CAR) and peak isometric KET (60° 
of knee flexion) were assessed in all groups at post-effusion and immediately 
post-intervention. Artificial knee-joint effusion decreased voluntary activation 
(CAR > 90%) and peak KET in all groups, and there were no significant 
differences between the groups at post-effusion (p > 0.05). Significant 
improvements in voluntary activation were only observed in the WBV (+11.4%, p 
= 0.21), and LBV (+7.3%, p < 0.001) groups immediately post-effusion, but not in 
the control group (+1.3%, p = 0.18). Compared to the control group (1.2%, p > 
0.05), peak KET was also improved to a greater extent in the WBV (16.5%, p = 
0.02) and LBV (23%) groups immediately post-intervention, but the LBV group 
did not achieve statistical significance (p < 0.08). The immediate disinhibitory 
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effects of muscle vibration that were observed in this study provide further 
support for this sensory-based modality as a disinhibitory intervention. However, 
muscle vibration has yet to be investigated as a disinhibitory intervention for 
patients with knee-joint pathology/surgery. Studying muscle vibration in a patient-
based population will provide evidence-based justification for its use as a 
disinhibitory intervention. 
Lastly, heightened neuromuscular function has been reported to remain in 
individuals up to 30 minutes after muscle vibration in healthy individuals.491 
Cryotherapy and TENS are considered to be superior disinhibitory interventions 
largely because of their residual effect on patients. Therefore, if the same 
residual effects can be demonstrated in patients after muscle vibration, it will not 
only promote its legitimacy as a disinhibitory intervention, but it will receive the 
same respect as the above-mentioned sensory-based modalities 
2.4.2 Motor-Based Modalities 
Neuromuscular Electrical Stimulation 
 Neuromuscular electrical stimulation (NMES) is a motor-based modality 
which applies a series of external stimuli to skeletal muscles through surface 
electrodes at the skin. NMES is commonly prescribed for patients who exhibit 
muscle dysfunction or weakness, as a method to reeducate muscle contraction 
and/or augment muscle force. Unlike the physiology of a voluntary muscle 
contraction, NMES elicits muscle contractions by directly activating the 
intramuscular nerve branches.103 In addition, the temporal recruitment order of 
motor units observed during NMES is believed to differ from that of the biological 
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recruitment pattern. The biological recruitment pattern of motor units is 
asynchronous, and based on the Henneman size principle,501 with smaller motor 
units (type I) being recruited prior to larger motor units (type II). With NMES, this 
recruitment is fairly synchronous,502 but larger motor units tend to be 
preferentially recruited before smaller motor units due to their larger surface 
area.115,503,504 
NMES has been well established in the literature as an effective modality 
for restoring quadriceps strength in patients after ACLr.70,104-110 Although these 
strength improvements are easily attributed to the muscle hypertrophy that 
develops during NMES interventions,111-115 it is believed that neural adaptations 
elicited by NMES are partly responsible for the increases in muscle strength.111-
113,116,117 Initial increases in muscle strength during strength training have been 
attributed to neural adaptations within the central nervous system;505-507 thus, it is 
reasonable that the same effects would be observed during the early phase of an 
NMES regimen. Studies assessing the therapeutic effect of NMES interventions 
on healthy individuals, have demonstrated progressive increases in muscle 
strength throughout the intervention period, with muscle hypertrophy only being 
evident during the late phase of the intervention.111-114 Gondin and colleagues113 
reported that after applying four weeks of NMES treatments to the quadriceps of 
healthy individuals, significances increases in quadriceps strength (+11%, p < 
0.001), EMG (+42-44%, p < 0.05), and voluntary activation (+5%, p < 0.05; via 
ITT) were observed, but there were no significant changes in quadriceps CSA 
(+2%, p > 0.05). Between weeks four and eight, further improvements in 
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quadriceps strength (+11%, p < 0.001) were accompanied by changes in 
quadriceps CSA (+4%, p < 0.001). Therefore, quadriceps strength improvements 
with NMES can be attributed to neural adaptions within the central nervous 
system during the early phase of intervention, and muscle hypertrophy during the 
later phase.  
Perhaps the most compelling evidence supporting the neural adaptive 
effect of NMES, is the presence of cross-education in skeletal muscles of the 
extremities.111,138,139,508 Although cross-education has been observed with 
voluntary exercise,509-512 there is evidence to suggest that NMES may induce 
greater cross-education effects than voluntary exercise.138,139 Hortobagyi et al.138 
randomized 32 healthy women to a NMES and control groups, and asked them 
to perform 840 eccentric contractions (control = voluntary, NMES = stimulated) 
over six weeks. Each group was tested before and after six weeks to assess for 
changes in eccentric quadriceps strength. Improvements in quadriceps strength 
of the trained limb were observed in both groups, but the untrained limb of the 
NMES group demonstrated a 60% increase in quadriceps strength, which was 
greater than that of the control group. Since the untrained limb did not received 
the NMES and was unexercised, the bilateral improvement in quadriceps 
strength after a unilateral NMES intervention could only be explained by a neural 
adaptation within the central nervous system. This cross-education effect 
observed after NMES or exercise has been attributed to both spinal and 
supraspinal mechanisms.116,513-516  
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The exact neural mechanism underlying the neural adaptations observed 
with NMES have yet to be fully comprehended. Based on limited evidence, 
NMES does not seem to influence spinal reflexive excitability.117,517 Instead, the 
neural adaptations observed with NMES are believed to involve alterations at the 
supraspinal level.116,136,137 In a study by Blickenstorfer et al.,136 a single session 
of electrical stimulation was applied to wrist extensor and flexor muscles of 
healthy individuals, while cerebral activation patterns were being captured with 
fMRI. During electrical stimulation, there was significant activation noted in the 
contralateral primary motor cortex, primary somatosensory cortex and premotor 
cortex, the ipsilateral cerebellum, bilateral secondary somatosensory cortex, the 
supplementary motor area, and anterior cingulate cortex. Although, longitudinal 
studies are necessary to determine whether neuroplasticity occurs in these 
supraspinal centers after NMES interventions, the current cross-sectional 
evidence demonstrates that they are at least influenced by NMES.  
Hortobagyi and Maffuiletti116 proposed an alternative model in which 
heightened afferent input elicited by NMES may explain the neural adaptations 
observed with NMES. Since NMES cannot bypass the afferent fibers located 
within both the skin and muscle, it is thought to elicit a barrage of afferent input to 
the sensory system. As was discussed with TENS, this discharge of sensory 
information is thought to trigger supraspinal centers to allow for descending 
control motoneurons, which elicits a facilitation of motor output to the involved 
muscle. Although this theory has merit, it must be supported by research before it 
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can be considered as a legitimate mechanism of the neural adaptations 
demonstrated with NMES. 
Due to the neural adaptations it elicits in healthy individuals, it is expected 
that NMES would be considered as an effective disinhibitory intervention for the 
quadriceps in patients after knee injury/surgery. Furthermore, the preferential 
recruitment of type II motor units that has been associated with NMES, make it 
an attractive modality for patients with ACL injury/surgery, since type II muscle 
fibers tend to be most affected in their quadriceps. However, there is conflicting 
evidence concerning the disinhibitory effects of NMES on restoring quadriceps 
function in a patient population. Several studies have reported improvements in 
the voluntary quadriceps activation of patients with NMES interventions.116,118-122 
In a case series by Stevens et al.,118 patients were assigned to one of two 
interventions, four weeks after receiving bilateral, total knee arthroplasty. Three 
patients participated in a 6-week (3 sessions/week), bilateral exercise program 
consisting of range-of-motion exercises, lower extremity strengthening exercises, 
and functional activities. Five other patients participated in the same exercise 
program, while also receiving NMES on the weaker quadriceps. Voluntary 
quadriceps activation (via SIB and CAR) was assessed in all patients at baseline, 
mid-intervention (3 weeks), post-intervention (6 weeks), and at three and six 
months. Due to the small sample size, the authors did not perform a statistical 
analysis. However, a recent systematic review calculated the treatment effect 
sizes (Cohen’s D) for each group to compare the disinhibitory effect of NMES to 
exercise.101 Strong effect sizes were observed at the 3-week (1.66, 95% CI = 
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0.10, 2.90), 6-week (1.65, 95% CI = 0.09, 2.89) 3-month (1.71, 95% CI = 0.13, 
2.96) and 6-month (1.87; 95% CI = 0.24, 3.13) time points in the NMES group. 
Conversely, the effect sizes of the exercise group were weak (-0.08 – 0.-48) and 
insignificant (95% CI crossed 0). Thus, it would seem that NMES is an effect 
motor-based modality for improving voluntary quadriceps activation in patients. 
However, an equal amount of studies have negated the effect NMES has 
on improving voluntary quadriceps activation in patients.123-128 Palmieri-Smith et 
al.125 randomly assigned 30 patients with radiographic knee OA to NMES (4 
weeks; 3 sessions/week) and control groups. The NMES group received NMES 
to their quadriceps three times per week, for a total of four week. Whereas, the 
control group served as the standard-of-care, and did not receive any treatment. 
Voluntary quadriceps activation (via SIB and CAR) was assessed in all patients 
at baseline, and one and 16 weeks post-intervention. Compared to the control 
group, there were no significant differences in MVIC or CAR changes at 5 weeks 
(1 week post-treatment) or 16 weeks (12 weeks post-treatment). The authors 
elected to report treatment effect sizes for each group to compare disinhibitory 
effects between groups. Unfortunately, weak and insignificant effect sizes were 
observed in both the NMES and control groups at five (0.2, 95% CI = -0.53, 0.91 
vs. 0.0, 95% CI = -0.78, 0.78) and 15 weeks (0.42, 95% CI = -0.36, 1.18 vs. 0.33, 
95% CI = -1.15, 0.51). Therefore, the authors concluded that there was no 
additional benefit from NMES for improving voluntary quadriceps activation in 
patients with knee OA. 
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The conflicting results between these studies may have been due to 
different patient populations, but the limitations that are associated with NMES 
are most likely to blame. The two main limitations of NMES are the discomfort 
experienced with high intensities of surface stimulation,518,519 and the limited 
spatial recruitment of motor units.518,520 Coincidentally, stimulation intensity is 
believed to directly affect spatial recruitment.518,520,521 NMES applied at a 
constant intensity, activates the motor units closest in proximity to the stimulating 
electrodes.518 Deeper motor units are targeted by increasing the inter-electrode 
distance,520 but this can also be achieved by increasing the stimulation 
intensity.521 Thus, it is recommended that NMES intensity be progressed to 
prevent against fixed, superficial recruitment.518 However, a new alternative to 
conventional NMES, known as multipath NMES, has recently been shown to 
elicit better improvements in quadriceps strength due to its advanced spatial 
recruitment properties.130 While a single current pathway is applied between an 
electrode pair during conventional NMES, multipath NMES distributes its current 
to multiple pairs of electrodes within single channels. Furthermore, multipath 
NMES has been shown to elicit greater evoked KET from the quadriceps when 
compared to conventional NMES.522 These effects are mainly attributed the 
higher stimulation intensity that is tolerated with multipath NMES, and the wider 
current distribution between multiple pairs of electrodes.  
When applying NMES, the stimulation intensity is typically based on the 
patient’s tolerance. However, the neuromuscular improvements observed with 
lower levels of stimulation intensity are not as large when compared to higher 
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levels of stimulation intensity.104,523 Previous reports suggest that the stimulation 
intensity of NMES needs to evoke 50 to 60% of an individual’s MVIC in order to 
elicit hypertrophy,524,525 and intensities up to 80% MVIC are needed to produce 
strength gains.526 Thus, similar principles may apply for voluntary quadriceps 
activation. Adams et al.502 developed a formula to predict the activated muscle 
cross-sectional area as a function of NMES training intensity. By applying this 
formula, it can be found that at the normal ranges of NMES intensity (40–60% 
MVC), only 29–43% of the total muscle is being targeted. Therefore, patients 
should be familiarized with NMES and encouraged to progress the stimulation 
intensity in order to maximize the neuromuscular benefits of NMES. 
Further research is needed to determine whether NMES is an effective 
disinhibitory intervention, especially in patients who exhibit NQD following ACLr. 
In addition, studies need to determine which stimulation parameters elicit the 
greatest disinhibitory effects, and whether these effects are greater when NMES 
is applied during voluntary relaxation or contraction. The superimposition of 
NMES on voluntary muscle contractions has been hypothesized to facilitate 
neuromuscular outcomes.130,527-529 Since neural adaptions are found to occur 
during the early phase of NMES programs, NMES may be most appropriate 
during the early stages of rehabilitation, when patients are immobile and/or 
grossly inhibited. Studies are needed to determine whether NMES should be 
prescribed to patients based upon neuromuscular status. Lastly, portable NMES 
units have demonstrated promising results in regard to restoring neuromuscular 
function.129-131 The higher volume of NMES combined with the convenience of 
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home-based NMES, make these units attractive modality for postsurgical 
patients. Therefore, research is need to determine whether home-based NMES 
offers a greater disinhibitory benefit for patients after ACL injury and 
reconstruction. 
Electromyographic Biofeedback 
 Electromyographic biofeedback (EMGBF) is another motor-based 
modality that is used to re-educate and strengthen muscle. Like NMES, has been 
shown to enhance quadriceps strength and activation in both healthy 
individuals530-533 and in patients with knee-joint pathology/surgery.127,533-547 
However, EMGBF is believed to have a greater effect on patients since they tend 
to exhibit large deficits in quadriceps strength and activation.533 Interestingly, 
there is evidence to suggest the EMGBF improves quadriceps function more 
than NMES in patients after knee-joint surgery.127,538 Biofeedback is used in 
rehabilitation to reveal internal, physiological events to patients through external 
modalities.548 In other words, EMGBF provides information on the myoelectric 
activity of their muscles (internal) through concurrent, external feedback, so that 
it may be interpreted on a conscious level. 
The methodology behind EMGBF involves surface EMG electrodes which 
are applied to the muscle belly of interest. The active electrodes monitor the 
myoelectric activity within the muscle, while a reference electrode is used filter 
irrelevant stimuli (noise). The EMG signals are transmitted through channels and 
transformed into either auditory or visual cues, which provide a quantifiable 
representation of the underlying myoelectric activity to the patient.549 These 
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external cues are used facilitate neuromuscular control of a muscle by teaching 
patients how to modulate their motor output in real-time. EMGBF is hypothesized 
to enhance quadriceps strength and activation by improving volitional recruitment 
of motor units (temporal and spatial) through corticomotor excitablity.531,550-552 It 
has been discovered that when muscular force is produced, there is increased 
neuronal activity in the motor cortex of the brain.552 Furthermore, when visual 
feedback is provided during a movement task, neuronal activity in the motor 
cortex and production of muscular force are symmetrically enhanced.550 
Pietrosimone et al.551 discovered that corticomotor excitability is enhanced when 
EMGBF is used during an MVIC task. Peak isometric KET (at 90° of knee flexion) 
and MEP amplitudes (normalized to M-waves) were assessed in healthy 
individuals before and after MVIC tasks, between two conditions: with 
(experimental) and without (control) EMGBF being simultaneously applied to the 
quadriceps. Compared to the control condition, the EMGBF elicited greater 
improvements in both MEP amplitudes and KET, suggesting that EMGBF 
enhances quadriceps strength by increasing descending output from the motor 
cortex.  
The positive neuromuscular effects associated with EMGBF may be 
explained by motor learning theories of motor control and development. 
Specifically, the rapid neuromuscular facilitation observed with EMGBF is 
believed to be based upon the principles of focused feedback. Feedback can be 
focused in one of two ways during a motor task: internally or externally. Internally 
focused feedback focuses an individual’s attention on their actions used during a 
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task (knowledge of performance), whereas externally focused feedback focuses 
an individual’s attention on the outcome of their actions used during a task 
(knowledge of results).553-555 In other words, internally focused feedback aims to 
improve performance by having individuals focus on intrinsic movement patterns, 
while externally focused feedback aims to improve performance by having 
individuals focus on extrinsic goals related to movement. Evidence has shown 
that externally focused feedback is superior to internally focused feedback in 
regard to the performance and retention of motor skills.553-557 Therefore, EMGBF 
employs an externally focused feedback approach to enhancing neuromuscular 
performance, by having patients focus on the external cue of myoelectric activity 
from their quadriceps instead of relying on internal cues of a quadriceps 
contraction (i.e. muscle tone). 
EMGBF was originally introduced in the early 1960s as a therapeutic 
modality for neuromuscular dysfunction, after discovering that individuals could 
learn to voluntarily control individual motor units by modulating their motor 
output.558 Since then, it has been widely used in rehabilitation as a method to 
improve neuromuscular control and strength in patients with neuromuscular 
dysfunction. As would be expected, EMGBF is regularly used early on in the 
rehabilitation of patients following ACLr. The severe quadriceps AMI that is 
present in patients acutely after ACLr, often impedes the ability of patients to 
observe a visible contraction of their quadriceps. Administering EMGBF allows 
these patients to better gauge the contractile behavior of their quadriceps. 
Secondly, EMGBF can be used to facilitate motor unit recruitment, by motivating 
‐ 142 ‐ 
 
patients to maximize their motor output during quadriceps-specific exercises. 
Therefore, it is logical to assume that EMGBF may have a disinhibitory effect on 
patients who exhibit NQD following ACLr. 
 Although sensory-based modalities, such as cryotherapy and TENS, are 
believed to disinhibit the quadriceps by targeting inhibitory mechanisms 
originating at the spinal cord, it is believed that EMGBF is a motor-based 
modality that may be able target the supraspinal inhibitory mechanisms 
associated with neural NQD. Not only could EMGBF be used disinhibit the 
quadriceps of patients after ACLr by reversing the reported decreases in 
corticomotor excitability, but it could also do so by overriding the spinal inhibitory 
mechanisms with greater control over the descending pathways projecting to the 
quadriceps. 
 Unfortunately, there have been no studies that have assessed whether 
EMGBF can increase corticomotor or spinal-reflexive excitability in patients who 
exhibit NQD. Although there is evidence demonstrating that EMGBF enhances 
quadriceps activation in these patients, 127,534,539-541,545,547,559,560  only one of these 
studies540 used a force-based measure of voluntary quadriceps activation (ITT), 
whereas the other used EMG measures. Krebs534 was the first to demonstrate a 
disinhibitory effect in the quadriceps of a patient population through the use of 
EMGBF. A total of 26 patients were randomized to EMGBF and/or exercise 
interventions following meniscectomy (20 min/day, 3 days). Both groups 
performed 20 minutes of isometric quadriceps exercises a day for three 
consecutive days, while the EMGBF group also applied EMGBF to their 
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quadriceps while exercising. Peak EMG amplitudes were assessed before and 
after the 3-day intervention period. When comparing the results between the two 
groups, peak EMG amplitude was found to increase 2.5 μV/day in the exercise 
only group, whereas it improved 25 μV per day in the EMGBF group (p<0.001). 
Furthermore, a multiple regression analysis revealed that group membership was 
a significant predictor of the variance in peak EMG changes (β = 0.68, p < 0.01), 
with the EMGBF intervention significantly explaining the improvements in peak 
EMG.  
The lone study that used a force-based measure of voluntary quadriceps 
activation was that of Maitland et al.540 Although the results were only derived 
from one patient, making it difficult to generalize to a population, they were quite 
astounding. A 34 year old patient who was eight months removed from ACLr, 
and experiencing knee-joint instability, underwent 12 weeks of isometric 
quadriceps exercises (seated and standing at 20° of knee flexion) and leg press 
exercises (3 x 10 repetitions) using EMGBF (24 sessions, 2 hours/session). Peak 
isometric KET (at 90° knee flexion) and voluntary quadriceps activation (via ITT) 
were measured on the patient before and after the 12-week intervention period. 
After 12 weeks, left knee MVIC increased by 209%, and quadriceps activation 
decreased by 22%.  
These results offer a glimpse of the disinhibitory potential EMGBF may 
have on patients after ACLr, but more studies using the recommended 
techniques to assess NQD (i.e. TMS, H-reflex, ITT, SIB, etc.) are needed to 
determine its full potential as a disinhibitory intervention. Furthermore, a greater 
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retention of disinhibitory effects in the quadriceps of patients may be elicited 
through EMGBF if a “fading-schedule” is administered during rehabilitation. A 
fading-schedule involves applying more EMGBF early in a patient’s rehabilitation, 
and then tapering it later on when you have observed discernible improvements 
in quadriceps function. Winstein and Schmidt561 used a fading-schedule on 
individuals for a skill acquisition task (feedback on half of the trials), and 
compared their performance to that of a group who received constant feedback 
(every trial). At the end of the intervention, no differences performance were 
observed between the groups, but the group who received feedback on a fading-
schedule had better performance scores on a delayed-retention test. They 
hypothesized that the differences in retention between groups were because the 
fading-schedule forced individuals to rely on other cognitive processes to achieve 
the same outcome, whereas constant feedback may have produced a 
dependency in individuals, where their performance could not be sustained 
without feedback. Therefore, it may be beneficial for patients to perform 
quadriceps-specific exercise without EMGBF immediately after each 
rehabilitation session to foster retention of neuromuscular facilitation. 
Furthermore, the neural and motor learning characteristics of EMGBF indicate 
that neuroplasticity within the CNS may be induced to account for retained 
disinhibitory effects.562  
Eccentric Exercise 
 Traditional rehabilitation programs consisting of isometric or concentric 
modes of exercise to enhance quadriceps strength in patients after ACLr have 
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been largely ineffective.98,99 The lack of quadriceps strength gains that is 
observed in these patients after rehabilitation can be at least partially attributed to 
the limiting effects of concurrent NQD. The inability to fully activate a muscle 
during exercise, it prevents the neuromuscular components from being 
sufficiently overloaded, and the resulting strength improvements are minimal due 
to a lack of neural adaptations and hypertrophy. However, eccentric exercise is 
an alternative mode of exercise that has been shown to be more effective than 
either concentric or isometric exercise for restoring both quadriceps strength and 
hypertrophy in patients after ACLr.290,563-570  
A muscle is eccentrically exercised either when an external force exceeds 
the internal force of a contracted muscle, or when the external force is 
decelerated by the internal  force of a contracted muscle; thus, causing the 
contracted muscle to lengthen (also referred to as negative work). Eccentric 
muscle contractions have been shown to produce two to three times greater 
force than either isometric or concentric muscle contraction.571,572 Therefore, it is 
suggested that the large quadriceps strength gains observed in patients after 
eccentric exercise is due to its ability to overload the peripheral components of a 
muscle to a greater extent. However, applying eccentric exercise to the surgical 
limbs of patients during the early phases ACLr rehabilitation was once 
contraindicated in the practice of sports medicine, because clinicians believed 
that it may overstress the graft or damage muscle fibers. Recent evidence has 
demonstrated the early eccentric exercise is a safe and effective mode of 
quadriceps strengthening in patients after ACLr, when the external forces are 
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gradually progressed,566,567 and exercises are performed in the closed kinetic 
chain.563 
Interestingly, eccentric exercise has been shown to facilitate voluntary 
quadriceps activation in patients after ACLr,290,570 thus demonstrating its potential 
as a disinhibitory intervention. In a study by Brasileiro et al.,570 nine patients, 9 to 
10 months removed from ACLr, were prescribed 12 weeks (2 sessions/week) of 
eccentric quadriceps training. The EMG activity of the vastus lateralis and vastus 
medialis were assessed at baseline, mid-training (6 weeks), and post-training (12 
weeks). The EMG activity of the vastus lateralis and vastus medialis increased at 
mid-training (213±107 to 289±81 μV, p=0.04 and from 207±65 to 229±69 μV, 
p=0.04, respectively), and these activity levels were maintained at post-training. 
More recently, Lepley and colleagues290 aimed to compare the disinhibitory 
effects between eccentric exercise and NMES. The assigned 36 patients to 
either NMES, Eccentric, NMES+Eccentric, or control groups following ACLr. All 
groups received standard ACL rehabilitation. The NMES group began their 6-
week NMES intervention immediately after their first post-operative rehabilitation 
visit, the Eccentric group began their 6-week eccentric exercises six weeks post-
ACLr, and the NMES+Eccentric groups received both interventions (6 weeks of 
NMES, followed by 6 weeks of eccentric exercise), beginning at the same time 
as the NMES group. The control group served as a standard-of-care comparison. 
Voluntary quadriceps activation (via SIB and ITT) was assessed in all patients at 
pre-ACLr, 12 weeks post-ACLR, and at the time they returned to play (RTP). No 
significant group differences were present at pre-ACLr (p = 0.61) or between pre-
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ACLR to 12 weeks post-ACLr time points (p = 0.21). From pre-ACLr to RTP, the 
Eccentric group (2.6 ± 4.1) demonstrated greater improvements in voluntary 
quadriceps activation than both the NMES (-3.4 ± 7.3%, p < 0.05) and control 
groups (-3.2 ± 5.0%, p < 0.05). No differences were observed between the 
Eccentric and NMES+Eccentric (+1.6 ± 3.9%) groups (p = 0.63), but the 
NMES+Eccentric only demonstrated greater quadriceps activation improvements 
than the control group (p = 0.04). Although there were no group differences 
observed during the first 12 weeks, the differences at RTP suggest that eccentric 
exercise is more effective at restoring voluntary quadriceps activation in patients 
after ACLr compared to NMES, and that the neural function of the quadriceps is 
in a better condition when eccentric exercise is administered in rehabilitation. 
The neural mechanisms involved with the quadriceps activation 
improvements observed in patients following ACLr have yet to be understood. It 
has been hypothesized that quadriceps activation is enhanced with eccentric 
exercise due to the preferential effect it has been shown to have on Type II 
muscle fibers.290,573 Given that high threshold (type II) motor units are thought to 
be selectively inhibited in patients after ACL reconstruction (via gamma loop 
dysfunction), it is plausible to believe that eccentric exercise may serve to 
disinhibit these patients’ quadriceps by facilitating the activation of type II motor 
units. Secondly, unilateral eccentric exercise interventions have been shown to 
produce bilateral improvements in quadriceps strength and activation.510,511,574 
The cross-education effect of eccentric exercise is pertinent to clinicians when 
treating patients with acute, unilateral knee-joint injuries, or patients who have 
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recently undergone unilateral knee-joint surgery.  Most of these patients are not 
permitted to perform eccentric exercise on their involved limbs, but they are have 
gross AMI of their quadriceps that needs to be addressed. Until these patients 
are cleared to perform eccentric exercise on their involved limbs, the cross-
education effect of eccentric exercise allows them to perform eccentric exercise 
on their uninvolved limbs to facilitate quadriceps activation on their involved 
limbs. Given that cross-education seems to be a characteristic of most of the 
disinhibitory interventions discussed in this review, it provides further support for 
eccentric exercise as a disinhibitory intervention. However, the evidence of 
cross-education with eccentric exercise has only been from a healthy population. 
More research is needed determine if eccentric exercise can induce cross-
education of quadriceps function in patients after knee-joint injury/surgery. 
Furthermore, additional studies are needed to support the early evidence of 










CHAPTER 3: METHODOLOGY 
 
3.1 RESEARCH DESIGN 
This study was a single-blind (orthopaedic surgeon) randomized clinical 
trial (1:1 sample ratio) that was conducted at the University of Kentucky. Patients 
were recruited from the UK Healthcare Sports Medicine Clinic located in 
Lexington, Kentucky. All assessments were conducted on the University of 
Kentucky’s campus, in the Musculoskeletal Laboratory of the Charles T. 




Patients between the ages of 14-40 years who sought care for a primary 
ACL injury (diagnosed via magnetic resonance imaging) and were scheduled to 
undergo unilateral ACL reconstruction were recruited for this study. Potential 
participants were identified by their treating physician and/or physician’s assistant 
during their clinical visit. To have been eligible to participate in this study, patients 
must have sustained their initial ACL injury within the previous six months leading 
up to their clinical visit with an orthopaedic surgeon. Patients who had a previous 
surgery to either their involved or contralateral hip, knee, or ankle were excluded 
from the study. Furthermore, patients were excluded if they had an injury to their 
involved or contralateral hip, knee, or ankle within the past six months. Patients 
who were currently being treated for low back pain were also be excluded from 
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the study. This was included in the exclusion criteria because of recent evidence 
showing that low back pain alters volitional quadriceps activation.575,576 For safety 
reasons, patients who had heart condition/pacemaker, were planning to get 
pregnant within the next six months (females), or had a history and/or family 
history of seizures/epilepsy were deemed ineligible to participate in the study. 
Those with vestibular or other balance disorders that might affect their test 
performance during a single leg standing task were also excluded. There were 
no exclusions based on sex, race, or other demographic characteristics.      
Potential participants were prospectively identified during their initial 
clinical visit by three orthopaedic surgeons at the UK Healthcare Sports Medicine 
Clinic, Darren Johnson, MD, Christian Lattermann, MD, and Mary Lloyd Ireland, 
MD. Patients that meet the eligibility criteria were then approached by study 
personnel and invited to participate in the study. Informed consent and HIPPA 
authorization was provided to eligible patients after they reviewed the study 
objectives, procedures, and potential risks of participation. Informed written 
consent was obtained from those patients who agreed to participate in the study. 
For those participants who were minors (< 18 years of age), informed written 
consent was obtained from a legal parent/guardian, and informed written assent 
was obtained from the minor. Approval for this study was granted by Institutional 
Review Board at the University of Kentucky (IRB #13-0776-F2L). 
3.2.1 Randomization 
Participants were allocated to either the treatment (home-based NMES) 
group or control (standard-of-care) group via block randomization using a 
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computer-generated randomization program. Randomization was further 
stratified by the time-from-injury (TFI) to baseline testing, and the autograft type 
used to reconstruct the ACL. Each of the stratification factors had two levels (TFI: 
≤ 4 weeks vs. > 4 weeks, and autograft: bone-patellar tendon-bone vs. 
semitendinosus-gracilis tendon). These stratification factors were chosen 
because they have both previously been shown to influence quadriceps function 
in patients after ACLr.577,578  
3.2.2 Power Analysis 
An a priori power analysis (using nQuery software program) was 
completed for voluntary quadriceps activation levels to determine the sample size 
with an alpha level of α = 0.05. At the time of this study, there were no studies 
that investigated the effect of NMES on improving voluntary quadriceps activation 
in patients after ACLr. Therefore, the parameters used for the power analysis 
were taken from observational data on patients before and after. Based on the 
literature,32 the participants’ CARs were expected to be approximately 0.75 (± 
0.12 SD) prior to ACLr. The participants in the treatment group were 
hypothesized to improve their CAR to approximately 0.90 (± 0.12) 12 weeks 
post-surgery, and the control group was hypothesized to improve to 
approximately 0.85 (± 0.12) 12 weeks post-surgery. To achieve a power level of 
at least 0.80, the sample size of at least 40 participants (20 per group) were 
needed based upon a 2-sided power analysis using the above parameters. This 
would allow for a 5% chance of committing a type I error, and a 20% chance of 





  3.3.1 Timeline 
After informed written consent was received and the participant was 
enrolled in the study, baseline measures were assessed by the primary 
investigator before their scheduled ACLr. These assessments included isometric 
quadriceps strength, voluntary quadriceps activation, and corticomotor excitability 
(see section 3.4 for detailed a description of the outcome measures). After 
baseline testing, each participant was randomly allocated to either the treatment 
group or control group. After ACLr, each group was advised to attend physical 
therapy visits as recommended by their orthopaedic surgeon, and to perform 
their assigned home-based programs (NMES or standard-of-care) in addition to 
their standardized postoperative rehabilitation protocol. The groups were not to 
begin their assigned home-based programs until the third day after ACLr, and 
were told to continue their assigned programs for 12 weeks. At the completion of 
their home-based programs (3 months post-ACLr), the outcome measures were 
reassessed by the primary investigator. The participants were then asked to 
return at six months following their ACLr for a final assessment of the outcome 
measures, with the addition of lower extremity postural control and self-reported 
knee function. Each participant was provided the option to review his/her data at 





Figure 3.1. Flowchart of the protocol timeline. 
 
3.3.2 Interventions 
The participants in the treatment (Home-NMES) group received a thigh 
sleeve that has a NMES unit (EMPI Phoenix, DJO Global, Vista, CA) embedded 
into the garment that they controlled during the home-NMES program (see 
Figure 3.2).131,579,580 Superimposed electrical stimuli were delivered 
percutaneously to artificially contract the quadriceps of the treatment 
group.107,123,131,580 Participants were instructed to maintain maximal knee 
extension during the home-NMES treatment. The first two minutes of the Home-




 Figure 3.2. Portable neuromuscular electrical stimulation (NMES) sleeve given to 
the intervention group. (A) NMES thigh sleeve displaying the controller and 




stimulation. After the warm-up period, a 15-minute exercise period followed. 
During the exercise period, the stimulation was delivered to the rectus femoris, 
vastus lateralis, and vastus medialis muscles at a frequency of 75Hz (300 μs 
pulse duration) with a duty cycle of four seconds on and 10 seconds off. The 
treatment group was instructed to perform an isometric quadriceps contraction 
throughout each 4-second stimulation period, and relax their muscles during the 
10-second rest period.130 Beginning on the third day post-operatively, the 
treatment group was instructed to perform their assigned Home-NMES program 
three sessions a day for 15 minutes, and five days a week for 12 weeks.130  
Participants in the treatment group were encouraged to progressively increase 
the intensity of NMES to maximal toleration (max intensity = 100 mA) throughout 
the 12-week Home-NMES program in order to appropriately overload the muscle. 
The participants in the Home-NMES group were blinded to an internal monitor 
within the Home-based NMES unit, which was used to assess total dosage (in 
minutes) at the completion of the study.  
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The control group was treated according to the current standard-of-care, 
performing a home-based treatment of volitional isometric quadriceps 
contractions without the addition of NMES beginning on the third day post-
operatively.  Participants performed 15 minutes of quadriceps contractions 
holding each contraction for four seconds followed by a rest time of 10 seconds 
between each contraction. Like the treatment group, the control group were 
instructed to perform their home-exercise program three sessions a day for 15 
minutes, and five days a week for 12 weeks. This was intended to make the 
exercise volume of the control group comparable to that of the Home-NMES 
group. 
 
3.4 OUTCOME MEASURES 
  3.4.1 Isometric Quadriceps Strength 
 Isometric quadriceps strength was assessed on both legs of each 
participant. An isokinetic dynamometer (Cybex Norm, Humac 2014 System, 
Computer Sports Medicine Inc., Stoughton, MA) was used to measure isometric 
KET. The participants were seated and secured into a stationary chair with their 
hips fixed at 85° flexion and knee fixed at 90° flexion. The knee being tested was 
aligned with the axis of the dynamometer and a resistance pad attached to the 
lever arm was fastened to the front of the lower third of their shin (~ two inches 
superior to the medial malleolus). Participants performed three maximal voluntary 
isometric contraction (MVIC) trials of their quadriceps by pushing their lower leg 
against the resistance pad. The highest isometric KET observed from the first 
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three MVICs was recorded and used as the target torque level during the 
voluntary quadriceps activation testing. To account for the relationship between 
muscle mass and strength, peak KET was normalized to each participant’s body 
weight (Nm/kg). A 60-second rest period was provided to the participants after 
each MVIC trial and before performing voluntary quadriceps activation testing. 
3.4.2 Voluntary Quadriceps Activation  
  Voluntary quadriceps activation was measured on both legs of each 
participant. The same dynamometer used to assess isometric quadriceps 
strength was used for voluntary quadriceps activation testing, and participants 
were seated and secured into the dynamometer chair in the same position as 
described above. Volitional quadriceps activation was assessed on participants 
using a superimposed burst (SIB) technique. The SIB technique involves 
superimposing a brief train of percutaneous electrical stimulation during an MVIC 
of a muscle. A square wave stimulator (Grass S48, Natus Neurology, W. 
Warwick, RI) and stimulation isolation unit (SIU8T, W. Warwick, RI) with a 100 
ms train of 10 stimuli delivered at 100 pulses per second, a pulse duration of 0.6 
ms with a 0.01 ms pulse delay, and a stimulation intensity of 650 mA delivered at 
150 V was used to create the SIB.381 Two, 7x13 cm self-adherent surface 
electrodes (Dura-Stick Plus Chattanooga, DJO Global, Vista, CA) positioned on 
the proximal vastus lateralis and distal vastus medialis were used to deliver the 
electrical stimulus to the quadriceps. Figure 3.3 depicts the participant positioning 
and electrode placement for voluntary quadriceps activation testing. The SIB was 
then used to calculate the central activation ratio (CAR), which compares the  
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 Figure 3.3. Participant positioning (A) and electrode placement (B) for 
superimposed burst (SIB) testing (proximal = vastus lateralis, distal = vastus 
medialis). 
 
amount of superimposed torque produced from the SIB to that of the MVIC 
torque measured just prior to the SIB (CAR = MVIC/superimposed MVIC). To 
familiarize the participants with the stimulation, a graded stimulation warm-up 
was provided prior to the voluntary quadriceps activation test. Participants were 
instructed to perform three submaximal isometric contractions at approximately 
25%, 50%, and 75% of their perceived MVIC. During each of these submaximal 
contractions, a corresponding submaximal electrical stimulus (25%, 50%, and 
75% of 150 V, respectively) was delivered to the quadriceps in attempt to 
acclimate the participants to the stimulation. For the SIB test, participants 
performed one MVIC of their quadriceps and a brief automated stimulus (150 V) 
was triggered once the participants reached their peak knee extension torque 
(derived from their isometric quadriceps strength trials). To provide participants 
with visual feedback of their torque output, a monitor was placed in front of the 
participants during the SIB test with a target torque level set at 120% of their 
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peak MVIC. This target torque level was used to further motivate the participants 
and ensure that they were providing maximal effort. Refer to Figure 3.4 for 
description of SIB protocol and CAR calculation. 
 
 Figure 3.4. Depiction of torque graph from the superimposed burst (SIB) test. 
The dashed line was set on the screen and represents the peak MVIC produced 
during the quadriceps strength testing. The top, solid black line represents 120% 
of the peak maximal voluntary isometric contraction (MVIC) and serves as the 
target torque level. Participants are instructed to attempt to reach the solid black 
line to ensure maximal effort. An automated stimulus was delivered once the 
torque output reached the dotted line. If the participant was unable to reach the 
dotted line during the trial, the stimulus was never delivered and more rest was 
provided between trials. MVIC values and superimposed burst torque values 
were used to calculate a central activation ratio (CAR) as seen by the equation in 
the figure. 
 
3.4.3 Corticomotor Excitability 
For cortical excitability testing, the participants were seated in the same 
position on the dynamometer as the strength and activation tests. All participants 
were fitted with a swim cap so the investigator could mark (with a semi-
permanent marker) specific anatomical landmarks to determine the ideal 
placement of the magnetic coil for eliciting an MEP of the quadriceps. Quarter-
sized areas on the skin over the vastus medialis and the medial malleolus of the 
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ankle were gently abraded with fine-grade sandpaper and cleaned with an 
isopropyl alcohol pad. This step was necessary to remove any oils, lotions, and 
dry skin that may impede the recording of myoelectrical potentials. Surface EMG 
electrodes were then placed over the cleaned areas of the distal quadriceps to 
record MEPs and a ground electrode was placed on the medial malleolus. The 
vastus medialis electrodes were placed approximately 4 cm superior and 3 cm 
medial to the superomedial border of the patella and oriented 55° to the 
vertical.581 These electrodes were secured in place using self-adhesive tape (see 
Figure 3.5).  
 
Figure 3.5. Placement of surface 
electromyography (EMG) electrodes 
for corticomotor excitability testing. The 
red and white wires correspond to the 
active and reference electrodes at the 
vastus medialis (respectively), and the 
black wire corresponds to the ground 











Transcranial magnetic stimulation (TMS) was delivered using the 
MagStim2002 unit synchronized with the Myopac system for amplification and 
filtering. A double-cone coil connected to the MagStim2002 was used to deliver a 
single electromagnetic impulse to the primary motor cortex of the cerebral 
hemisphere contralateral to the limb being used to record MEPs. To find the ideal 
placement of the double-coned coil for each participant, the coil was moved 
anterior to posterior over the vertex (1 cm increments) of the skull while the 
primary investigator applied an electromagnetic impulse (50% of maximal TMS 
output) until the largest MEP is elicited in the quadriceps. This area (“hot spot”) 
was indicated on each participant’s swim cap with a marker for every testing 
session. The coil was held in place during testing by the primary investigator (see 
Figure 3.6).  
 
 Figure 3.6. Depiction of the equipment and participant setup employed during 
corticomotor excitability testing. (A) The “hot spot” was marked with marker (red) 
on a swim cap, and the posterior border of the double-coned coil overlaid the 
marked spot (B) to elicit motor evoked potentials (MEP) at the vastus medialis 
and determine the active motor threshold (AMT). 
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To find the active motor threshold (AMT) of the quadriceps, participants 
performed an isometric knee extension at a normalized intensity of 5% of their 
MVIC observed during isometric quadriceps strength testing. A monitor was 
placed in front of the participants to provide visual feedback of their torque 
output. TMS was first delivered at 50% of the maximum stimulator output (110 – 
120 V)61,296,451 with the stimulating coil placed over the primary motor cortex area 
of the cerebral hemisphere contralateral to the limb being used to record the 
MEPs. The active motor threshold was defined as the minimum stimulus intensity 
at which an electrical response of at least 100 μV is achieved. Active motor 
threshold was obtained by first decreasing the magnetic stimulus by 5% until six 
out of 10 trials had an MEP amplitude of <100 μV. 
The percentage of stimulator intensity was then gradually increased until 
five out of 10 consecutive stimuli produced an MEP of equal to or greater than 
100 μV (see Figure 3.7). The stimulator intensity (% TMS output) used to achieve 
this value was recorded as the active motor threshold for each participant.442 
 
Figure 3.7. Representation of 
transcranial magnetic stimulation 
(TMS) impulse and resultant motor 
evoked potential (MEP) recorded 
via surface electromyography 
(EMG) from the vastus medialis 
muscle. The TMS intensity (% TMS 
output) needed to achieve an MEP 
equal to 100 μV represents a 





3.4.4 Lower Extremity Postural Control 
The Y-balance testTM (YBT; FunctionalMovement.com, Danville, VA) was 
used to assess the patients’ lower extremity postural control at 6 months post-
ACLr. The YBT is the commercialized version of the Star Excursion Balance Test 
(SEBT) that was developed to improve its reliability.582 Both the YBT and the 
SEBT assess an individual’s ability to move from a position of bilateral stance to 
a position of unilateral stance whereby the contralateral limb is used to reach 
maximally in three different directions (anterior, posterolateral, and 
posteromedial) without compromising their balance. Although some evidence 
suggests the YBT and SEBT require different kinematic strategies to achieve 
maximal reach distances,583,584 the two tests continue to be strongly correlated. 
Furthermore, anterior reach distance has been shown to predict lower extremity 
injuries in athletes,585,586 and the integrated EMG activity of the quadriceps is the 
highest with the anterior reach.587 Therefore, the anterior reach direction was 
preferentially assessed in participants of this study. 
The anterior reach distance on the YBT (YBT-A) was measured on both 
limbs of each participant. Participants were instructed to stand unilaterally on the 
center platform of the Y-balance device, and to place their hands on their hips. 
While balancing on the stance limb, the participants were encouraged to slide the 
anterior block with their contralateral limb as far away from the center platform as 
possible while maintaining their balance (see Figure 3.8). Once they achieved 
their maximal reach distance, they returned their contralateral limb to the starting 
position and were allowed to step off of the platform.  If the anterior block was  
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Figure 3.8. Representation of the Y-balance 
test for anterior reach (YBT-A) procedure 












kicked, the stance foot moved, a hand was removed from the hip, or the 
participant lost balance during any point of the trial, the trial was discarded and 
another was allotted until a total of three clean trials were recorded for both 
limbs.  Participants were given three practice trials before the recorded trials in 
attempt to neutralize a learning effect. The average reach distance for the three 
recorded trials were normalized to each participant’s respective leg length 
measured from the anterior superior iliac spine to the medial malleolus (anterior 
reach distance/leg length).   
3.4.5 Self-Reported Knee Function 
 The Knee Injury and Osteoarthritis Outcome Score (KOOS) was used to 
assess the self-reported knee function of the participants at six months post-
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ACLr (see Appendix). The KOOS is a questionnaire intended to assess both the 
short-term and long-term consequences of knee injury or surgery.193 It has 
demonstrated excellent validity and reliability in patients after ACLr.190-193 
Compared to other patient-reported knee questionnaires, the KOOS is meant for 
younger, and more physically active patients who have sustained a knee injury or 
have undergone knee surgery.588 The KOOS consists of 42 questions that are 
separated and scored into five domains [Symptoms, Pain, Activities of Daily 
Living (ADLs), Quality of life (QOL), and Function in Sports/Recreational 
Activities (Sports/Rec)]. Each question includes a Likert scale answer format 
scored from 0 (No Problems) to 4 (Extreme Problems). It takes patients 
approximately 5-10 minutes to complete the entire KOOS questionnaire. Once 
completed, the sum of the item scores for each domain were calculated and 
transformed on a 0-100 scale (0 = lowest function, 100 = highest function). 
 Of the five domains, the QOL and Sports/Rec domains have 
demonstrated the most unidimensionality,589 and are the most sensitive to 
changes over time in patients after ACLr.193 Therefore, the QOL and Sports/Rec 
domains were preferentially assessed in the participants of this study. 
  
3.5 STATISTICAL ANALYSES 
 Statistical analyses were performed using SAS software (version 9.3, SAS 
Institute, Inc., Cary, NC) Shapiro-Wilk tests were performed on all demographics 
and outcome measures to confirm the normality of baseline data (pre-ACLr). All 
of the variables were deemed to possess normal distribution, except for 
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quadriceps CAR. Therefore, quadriceps CAR was transformed 
(arcsin√[CAR/100]) to achieve normal distribution during statistical analyses, but 
it was untransformed to the original units (%) when reporting it in the results 
(sin[transformed CAR2]*100).  
3.5.1 Group Characteristics 
 Independent (Student’s) t-tests were performed on age, height (cm), 
weight (kg), number of concomitant knee injuries, TFI (days), and time from 
surgery (TFS) to 3-month and 6-month testing (months) to assess for 
demographic differences between the treatment and control groups. Fisher’s 
Exact tests were used to assess for demographic differences in sex and 
autograft type between groups. Independent t-tests were also used to detect for 
differences in the outcome measures between groups at baseline. Means and 
standard deviations were reported to represent central tendency and variability of 
the continuous variables. Alpha level was set a priori at P ≤ 0.05. 
  3.5.2 Specific Aim 1 
 A 2x3 (limb x time) mixed model, analyses of variance (ANOVA) with 
repeated measures was performed in the control group to assess differences 
between the involved limb and the uninvolved limb in isometric quadriceps 
strength (peak KET), and voluntary quadriceps activation (CAR) from baseline to 
three months post-ACLr, baseline to six months post-ACLr, and three months 
post-ACLr to six months post-ACLr. A one-way mixed model, ANOVA with 
repeated measures was performed in the control group to assess differences in 
corticomotor excitability (AMT) over time (baseline, 3 months post-ACLr, and 6 
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months post-ACLr). Post-hoc comparisons with simulated P-value adjustments 
were performed when appropriate.590 Model estimates and 95% confidence 
intervals were reported to represent the results. Alpha level was set a priori at P 
≤ 0.05. 
  3.5.3 Specific Aim 2 
 Means and standard deviations were calculated for the lower extremity 
functional outcome measures of the control group at six months post-ACLr. 
Separate, mixed model, linear regression analyses were performed in the control 
group (involved limb) to determine the effect that isometric quadriceps strength 
(normalized peak KET), voluntary quadriceps activation (CAR), and corticomotor 
excitability (AMT) measures assessed at baseline and three months post-ACLr, 
had on lower extremity postural control (YBT-A) and self-reported knee function 
(KOOS-QOL and KOOS-Sports/Rec) assessed at six months post-ACLr. Beta 
estimates and 95% confidence intervals were reported for each baseline and 3-
month post-ACLr neuromuscular variable, corresponding with each 6-month 
lower extremity functional outcome measure. Alpha level was set a priori at P ≤ 
0.05. 
3.5.4 Specific Aim 3 
A 2x2x3 (group x limb x time) mixed model, ANOVA with repeated 
measures was performed to assess group differences between the involved limb 
and the uninvolved limb in isometric quadriceps strength (peak KET), and 
voluntary quadriceps activation (CAR) from baseline to three months post-ACLr, 
baseline to six months post-ACLr, and 3 months post-ACLr to six months post-
‐ 167 ‐ 
 
ACLr. A 2x3 (group x time) mixed model, ANOVA with repeated measures was 
performed to assess group differences in corticomotor excitability (AMT) over 
time (baseline, 3 months post-ACLr, and 6 months post-ACLr). Post-hoc 
comparisons with simulated P-value adjustments were performed when 
appropriate.590 Model estimates and 95% confidence intervals were reported to 


















CHAPTER 4: RESULTS 
 
4.1 GROUP CHARACTERISTICS 
  4.1.1 Demographics 
 A total of 50 patients with ACL injuries volunteered to participate in this 
study (25 Home-NMES group, 25 control group). Baseline group demographic 
data can be found in Table 4.1. There were no statistically significant 
demographic differences between the groups at baseline (p > 0.05). 
 
Table 4.1. Baseline Group Demographics (Means ± SD) 
Demographic Home-NMES 
Group 
(n = 25) 
Control 
Group 
(n = 25) 
P-value 
Sex (Males/Females) 6/19 11/14 0.23 
Age (years) 18.9 ± 5.4 19.4 ± 4.5 0.71 
Height (cm) 170.8 ± 9.7 171.1 ± 11.5 0.90 
Weight (kg) 74.6 ± 18.5 70.7 ± 11.9 0.40 
Time from injury to baseline 
testing (days) 
28.0 ± 20.0 24.9 ± 18.5 0.56 
Time from ACLr to 3-month 
testing (months) 
3.7 ± 0.3 3.4 ± 0.4 0.06 
Time from ACLr to 6-month 
testing (months) 
6.5 ± 0.7 6.3 ± 0.5 0.18 
Graft Choice (BPTB/STG) 18/7 19/6 1.00 
Home-NMES, home-based neuromuscular electrical stimulation program; ACLr, 
anterior cruciate ligament reconstruction; BPTB, bone-patellar tendon-bone autograft; 
STG, semitendinosus-gracilis autograft.
 
  4.1.2 Outcome Measures 
All 50 patients reported for baseline testing. Baseline outcome group 
measures can be found in Table 4.2. There were no group differences between 
baseline outcome measures (p > 0.05), except for normalized peak KET in the 
‐ 169 ‐ 
 
uninvolved limb (p = 0.02). Thirty nine patients (78%) were available for 3-month 
postoperative testing (20 Home-NMES group, 19 control group), and 42 patients 
(84%) were available for 6-month post-operative testing (23 Home-NMES group, 
19 control group). 
 
Table 4.2. Baseline Group Outcome Measures (Means ± SD) 
Outcome Measure Home-NMES 
Group 
(n = 25) 
Control 
Group 
(n = 25) 
P-value
Normalized Peak KET (Nm/kg) - 
Involved 
2.6 ± 0.7 2.9 ± 0.9 0.19 
Normalized Peak KET (Nm/kg) - 
Uninvolved 
2.9 ± 0.6 3.3 ± 0.7 0.02* 
CAR (%) - Involved 94.6 ± 5.5 91.3 ± 8.3 0.12 
CAR (%) - Uninvolved 89.5 ± 8.4 87.7 ± 9.7 0.51 
AMT (%) - Involved 33.9 ± 7.2 39.1 ± 10.2 0.06 
Home-NMES, home-based neuromuscular electrical stimulation program; KET, knee 
extension torque; CAR, central activation ratio; AMT, active motor threshold; YBT-A, 
Y-balance test-anterior reach (reach distance/leg length); KOOS, Knee Injury and 
Osteoarthritis Outcome Score; Sports/Rec, sports and recreation; QOL, quality of life. 
*Significant difference between groups (P ≤ 0.05)
 
4.2 SPECIFIC AIM 1 
  4.2.1 Descriptive Statistics 
 Model estimates and 95% confidence intervals for the temporal 
neuromuscular quadriceps outcome measures in patients before and after ACLr 
(control group) can be found in table 4.3. 
4.2.2 Isometric Quadriceps Strength 
 A significant limb by time interaction was discovered for normalized peak 
KET (F2,18.6 = 29.7, P < 0.001) in patients. Patients demonstrated lower 
normalized peak KET on their involved limbs compared to their uninvolved limbs  
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 Table 4.3. Model estimates (95% CI) of temporal neuromuscular outcome measures 
between limbs (control group). 
Measure Time Point Involved limb Uninvolved limb 
Normalized Peak KET 
(Nm/kg) 
Baseline (pre-ACLr) 2.87 (2.52, 3.22)* 3.36 (3.07, 3.65) 
 3-month (post-ACLr) 1.67 (1.31, 2.03)*† 3.23 (2.94, 3.51) 
 6-month (post-ACLr) 1.97 (1.58, 2.36)*†‡ 3.06 (2.71, 3.40)† 
CAR (%)** Baseline (pre-ACLr) 93.4 (90.2, 96.0) 91.0 (87.8, 93.8) 
 3-month (post-ACLr) 94.1 (91.1, 96.5) 91.8 (88.1, 94.9) 
 6-month (post-ACLr) 92.7 (88.1, 96.2) 90.1 (84.4, 94.6) 
AMT (%) Baseline (pre-ACLr) 39.1 (34.5, 43.8) N/A 
 3-month (post-ACLr) 39.2 (34.3, 44.1) N/A 
 6-month (post-ACLr) 39.7 (35.6, 43.7) N/A 
95% CI, 95% confidence interval (lower bound, upper bound); Home-NMES, home-based 
neuromuscular electrical stimulation program; KET, knee extension torque; CAR, central 
activation ratio; AMT, active motor threshold; TMS, transcranial magnetic stimulation; ACLr, 
anterior cruciate ligament reconstruction 
*Significant difference compared to the uninvolved limb (p ≤ 0.05)  
†Significant difference compared to baseline (pre-ACLr) time point (p ≤ 0.05) 
‡Significant difference compared to 3-month (post-ACLr) time point (p ≤ 0.05)  
**Significant main effect for limb (p ≤ 0.05)
 
at baseline (-0.49 Nm/kg, p = 0.015), three months post-ACLr (-1.56 Nm/kg, p < 
0.001), and six months post-ACLr (-1.09 Nm/kg, p < 0.001). Normalized peak 
KET progressively decreased in the involved limbs of patients from baseline to 3 
months post-ACLr (-1.20 Nm/kg, p < 0.001), baseline to six months post-ACLr (-
0.90 Nm/kg, p = 0.002), and increased from three months to six months post-
ACLr (0.30 Nm/kg, p = 0.016). Normalized peak KET was also decreased in the 
uninvolved limbs of patients from baseline to six months post-ACLr (-0.30 Nm/kg, 
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p = 0.016). No other time-based differences were detected in the uninvolved limb 
(p > 0.05). Refer to Figure 4.1 for visual representation of normalized peak KET 
model estimates. 
 
 Figure 4.1. Model estimates and 95% confidence intervals of normalized peak 
KET (Nm/kg) for the involved and uninvolved limbs at baseline, 3 months post-
ACLr, and 6 months post-ACLr. 
*Significant difference compared to the uninvolved limb (p ≤ 0.05)  
†Significant difference compared to baseline (pre-ACLr) time point (p ≤ 0.05) 
‡Significant difference compared to 3-month (post-ACLr) time point (p ≤ 0.05)  
 
 
4.2.3 Voluntary Quadriceps Activation 
 There was a significant main effect for limb observed with quadriceps CAR 
(F1,24 = 4.68, p = 0.04) in patients, but there was no main effect for time (F2,17.1 = 
0.57, p = 0.58) or limb by time interaction. Irrespective of when it was assessed, 
quadriceps CAR was approximately 2.4% higher (on average) in the involved 
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limbs of patients compared to their uninvolved limbs (p = 0.04). Refer to Figure 
4.2 for visual representation of quadriceps CAR model estimates. 
 
 Figure 4.2. Model estimates and 95% confidence intervals of quadriceps CAR 
(%) for the involved and uninvolved limbs at baseline, 3 months post-ACLr, and 6 
months post-ACLr. 
*Significant main effect for limb (p ≤ 0.05) 
 
 
4.2.4 Corticomotor Excitability 
 There was no main effect for time (F2,16.1 = 0.08, p = 0.93) observed for 
quadriceps AMT in the involved limbs of patients (p > 0.05).  
 
4.3 SPECIFIC AIM 2 
  4.3.1 Descriptive Statistics 
 Means and standard deviations for the lower extremity functional outcome  
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measures of patients at six months after ACLr (control group) can be found in 
table 4.4. The beta estimates and 95% confidence intervals from the linear 
regression analyses for each baseline and 3-month post-ACLr neuromuscular 
variable, corresponding with each 6-month lower extremity functional outcome 
measure, can be found in table 4.5. 
 
Table 4.4. Means (± SD) of lower extremity functional outcome measures in 
patients six months after ACLr (control group).  
Measure 6-month Outcome 
YBT-A (%) - Involved 62.6 ± 8.0 
KOOS-Sports/Rec (/100) 77.7 ± 17.5 
KOOS-QOL (/100) 63.5 ± 18.7 
YBT-A, Y-balance test-anterior reach; KOOS, Knee Injury and Osteoarthritis 
Outcome Score; Sports/Rec, sports and recreation; QOL, quality of life. 
 
4.3.2 Effect of Early Neuromuscular Quadriceps Outcome Measures 
on 6-month Lower Extremity Functional Outcome Measures 
 The normalized peak KET of patients at three months post-ACLr had a 
significant positive effect on their 6-month YBT-A performance (t16 = 12.29, p = 
0.04) and KOOS-QOL score (t17 = 2.14, p = 0.047). For every 1 Nm/kg increase 
in normalized peak KET at three months post-ACLr, an estimated 5.1% increase 
in YBT-A reach distance was expected at six months post-ACLr. Likewise, for  
every 1 Nm/kg increase in normalized peak KET at three months post-ACLr, an 
estimated 8.9 point increase in KOOS-QOL score was expected at 6-months 




Table 4.5. Regression analyses to determine effect of baseline and 3-month post-ACLr neuromuscular variable on 
lower extremity functional outcomes at six months post-ACLr (control group). 
6-month Outcome Variable Time Point Beta Estimate (95% CI) P-value 
YBT-A - Involved     
(%) Normalized Peak KET Baseline 1.9 (-2.9, 6.7) 0.42 
  3-month 5.1 (0.4, 9.8)* 0.04 
 CAR Baseline -13.5 (-39.5, 12.6) 0.29 
  3-month 10.7 (-8.0, 29.4) 0.24 
 AMT Baseline 0.2 (-0.3, 0.6) 0.40 
  3-month 0.2 (-0.3, 0.6) 0.38 
KOOS-Sports/Rec 
(/100) Normalized Peak KET Baseline 1.7 (-8.1, 11.5) 0.72 
  3-month 5.3 (-3.5, 14.1) 0.22 
 CAR Baseline 1.2 (-5.2, 7.6) 0.70 
  3-month -2.4 (-6.1, 1.3) 0.18 
 AMT Baseline 0.1 (-0.7, 1.0) 0.74 
  3-month 0.3 (-0.6, 1.2) 0.50 
KOOS-QOL      
(/100) Normalized Peak KET Baseline 0.8 (-9.7, 11.3) 0.88 
  3-month 8.9 (0.1, 17.7)* 0.047 
 CAR Baseline -0.4 (-7.3, 6.4) 0.90 
  3-month 0.6 (-3.5, 4.7) 0.76 
 AMT Baseline -0.5 (-1.3, 0.4) 0.24 
  3-month -0.6 (-1.5, 0.3) 0.19 
ACLr, anterior cruciate ligament reconstruction; 95% CI, 95% confidence interval (lower bound, upper bound); YBT-A, Y-balance 
test (anterior reach); KOOS, Knee Injury and Osteoarthritis Outcome Score; Sports/Rec, sports and recreation; QOL, quality of 
life; KET, knee extension torque; CAR, central activation ratio; AMT, active motor threshold 
*Significant association with 6-month outcome (p ≤ 0.05)
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effect on 6-month KOOS-Sport/Rec score (p > 0.05). Neither quadriceps CAR or 
AMT (at baseline or 3-month post-ACLr) had a significant effect on any of the 6-
month lower extremity function outcome measures (p > 0.05). 
 
4.4 SPECIFIC AIM 3 
  4.4.1 Descriptive Statistics 
 Model estimates and 95% confidence intervals for the temporal 
neuromuscular quadriceps outcome measures in both the Home-NMES group 
and control group can be found in table 4.6. 
4.4.2 Isometric Quadriceps Strength 
 There was a significant main effect for group observed with normalized 
peak KET (F1,46.4 = 4.5, p = 0.04) in the control group. Irrespective of limb or 
when it was assessed, normalized peak KET was 0.36 Nm/kg higher (on 
average) in the control group compared to the Home-NMES group (p = 0.04). A 
significant limb by time interaction was discovered for normalized peak KET 
(F2,40.3 = 52.17, P < 0.001), regardless of group assignment. Both groups 
demonstrated lower normalized peak KET on their involved limbs compared to 
their uninvolved limbs at baseline (-0.32 Nm/kg, p < 0.001), three months post-
ACLr (-1.35 Nm/kg, p < 0.001), and six months post-ACLr (-0.95 Nm/kg, p < 
0.001). Normalized peak KET progressively decreased in the involved limbs of 
both groups from baseline to three months post-ACLr (-1.07 Nm/kg, p < 0.001) 
and baseline to six months post-ACLr (-0.75 Nm/kg, p < 0.001), and increased 
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Table 4.6. Model estimates (95% CI) of temporal neuromuscular outcome measures between groups and limbs 












2.55 (2.27, 2.82)* 2.94 (2.70, 3.19) 2.91 (2.63, 3.18)* 3.30 (3.06, 3.55) 
 3-month  
(post-ACLr) 
1.48 (1.21, 1.74)*† 2.83 (2.59, 3.07) 1.84 (1.57, 2.11)*† 3.19 (2.95, 3.44) 
 6-month  
(post-ACLr) 
1.80 (1.51, 2.08)*†‡ 2.75 (2.49, 3.01) 2.16 (1.87, 2.45)*†‡ 3.11 (2.84, 3.38) 
CAR (%) Baseline  
(pre-ACLr) 
95.5 (93.1, 97.5)* 91.7 (88.5, 94.4) 93.4 (90.6, 95.7)* 88.9 (85.3, 92.0) 
 3-month  
(post-ACLr) 
95.0 (91.6, 97.6) 92.5 (89.4, 95.1) 92.7 (88.8, 95.9) 89.8 (86.2, 92.9) 
 6-month  
(post-ACLr) 
92.5 (88.7, 95.5) 92.2 (88.7, 95.0) 89.8 (85.5, 93.4) 89.4 (85.5, 92.8) 
AMT (%) Baseline  
(pre-ACLr) 
34.6 (30.8, 38.3) N/A 38.5 (34.8, 42.1) N/A 
 3-month  
(post-ACLr) 
35.8 (31.8, 39.8) N/A 39.8 (35.8, 43.7) N/A 
 6-month  
(post-ACLr) 
36.2 (32.5, 39.9) N/A 40.2 (36.5, 43.8) N/A 
95% CI, 95% confidence interval (lower bound, upper bound); Home-NMES, home-based neuromuscular electrical stimulation 
program; KET, knee extension torque; CAR, central activation ratio; AMT, active motor threshold; TMS, transcranial magnetic 
stimulation; ACLr, anterior cruciate ligament reconstruction 
*Significant difference compared to the uninvolved limb (p ≤ 0.05)  
†Significant difference compared to baseline (pre-ACLr) time point (p ≤ 0.05) 
‡Significant difference compared to 3-month (post-ACLr) time point (p ≤ 0.05)  
**Significant main effect for group (p ≤ 0.05) 
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from three months to six months post- ACLr (0.32 Nm/kg, p < 0.001). Normalized 
peak KET was also decreased in the uninvolved limbs of both groups from 
baseline to six months post-ACLr (-0.19, p = 0.02 unadjusted), but this decrease 
did not achieve statistical significance after the simulated adjustment (p = 0.13). 
No other time-based differences were detected in the uninvolved limb for either 
group (p > 0.05). Refer to figure 4.3 for visual representation for normalized peak 
KET model estimates. 
 
 Figure 4.3. Model estimates and 95% confidence intervals of normalized peak 
KET (Nm/kg) for the involved and uninvolved limbs of both the Home-NMES and 
control groups at baseline, 3 months post-ACLr, and 6 months post-ACLr. 
*Significant difference compared to the uninvolved limb (p ≤ 0.05)  
†Significant difference compared to baseline (pre-ACLr) time point (p ≤ 0.05) 
‡Significant difference compared to 3-month (post-ACLr) time point (p ≤ 0.05)  




4.4.3 Voluntary Quadriceps Activation 
There was no main effect observed for group with quadriceps CAR (F1,48.3 
= 1.83, p = 0.18). Regardless of group assignment, there was a significant limb 
by time interaction (F1,32.6 = 4.52, p = 0.02). At baseline, quadriceps CAR was 
approximately 4.2% higher (on average) in the involved limbs of both groups 
compared to their uninvolved limbs (p = 0.003). No other limb differences were 
observed in either group at three or six months post-ACLr (p > 0.05). Quadriceps 
CAR decreased in the involved limbs of both groups from baseline to six months 
post-ACLr (3.3%, p = 0.02 unadjusted), but this decrease did not achieve 
statistical significance after the simulated adjustment (p = 0.11). No other time-
based differences were detected in the involved limb or uninvolved limb for either 
group (p > 0.05). Refer to Figure 4.4 for visual representation of quadriceps CAR 
model estimates. 
4.4.4 Corticomotor Excitability 
There were no main effects for group (F1,40.2 = 2.25, p = 0.14) or time (F2,33 
= 1.45, p = 0.25) observed with quadriceps AMT in the involved limbs of either 





 Figure 4.4. Model estimates and 95% confidence intervals of quadriceps CAR 
(%) for the involved and uninvolved limbs of both the Home-NMES and control 
groups at baseline, 3 months post-ACLr, and 6 months post-ACLr. The dashed 
red line corresponds to the healthy normative quadriceps CAR (95%) reported by 
Park and Hopkins, 2013, International Journal of Neuroscience, 123 (1), 55-
59.404 
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CHAPTER 5: DISCUSSION 
 
5.1 SPECIFIC AIM 1 
  5.1.1 Modifications in Quadriceps Strength 
 Involved Limb 
As was hypothesized, the group of patients who received the standard-of-
care after ACLr (control group) demonstrated significantly lower quadriceps 
strength on their involved limbs compared to their uninvolved limbs at baseline 
(pre-ACLr), three months post ACLr, and six months post-ACLr. Secondly, the 
magnitude of this side-to-side difference was different depending on when 
quadriceps strength was assessed in these patients. The largest side-to-side 
difference in normalized peak KET was observed at three months post-ACLr (-
1.56 Nm/kg); with the 6-month post-ACLr time point having the second largest 
difference (-1.09 Nm/kg), and the baseline having the least difference (-0.49 
Nm/kg). A criterion that is regularly used by clinicians when determining whether 
a patient is ready to return to activity/sport after ACLr, is if their quadriceps 
strength LSI is equal to or greater than 90%.8,28,68,180,181 If our limb model 
estimates reported for normalized peak KET at baseline, three months post-
ACLr, and six months post-ACLr were converted into quadriceps strength LSI, 
they would correspond to 85%, 51%, and 64%, respectively. Although the 6-
month quadriceps strength LSI of the ACLr patients in our study looks to be lower 
than what has been reported in the ACLr literature,98,132 there are several studies 




The variability of 6-month quadriceps strength LSI that has been reported 
in patients at six months post-ACLr is most likely attributed to methodological 
differences in measurement and surgical techniques between studies. 
Quadriceps strength can be assessed isometrically or isokinetically (concentric or 
eccentric), and at different knee-joint angles or velocities, respectively. Several 
studies have reported insufficient quadriceps strength LSI (≤90%) in patients 
after ACLr when isokinetically testing (concentrically) at an angular velocity of 
60°/s, but when angular velocities of 120°/s or faster were used, these same 
patients meet the criterion (LSI ≥90%).30,31,57,132,133,142,168,178,179 Hsiao et al.31 
recently assessed quadriceps strength LSI in patients after ACLr using a variety 
of angular velocities (isokinetic) as well as knee-joint angles (isometric). When 
compared to the pre-ACLr values, significant decreases in quadriceps strength 
LSI were only observed at the slower angular velocities (concentric at 50°/s and 
100°/s) and the larger knee flexion angles (70° and 90°). Current evidence 
suggests that quadriceps strength should be tested isometrically at 70-90° of 
knee flexion,31 or isokinetically at an angular velocity of 60°/s (concentric) in order 
to detect asymmetries in patients following ACLr.98,132 Quadriceps strength of the 
patients in our study was assessed isometrically at 90° of knee flexion. Secondly, 
studies use different units to assess quadriceps strength LSI, which can alter the 
LSI value that is reported. Quadriceps strength can be recorded as force (i.e., 
Newtons, pounds, etc.) or torque (i.e., Nm, ft·lbs, etc.), or normalized to a 
patient’s bodyweight (i.e., Nm/kg, ft·lbs/lb, %bodyweight, etc.). If quadriceps 
strength is recorded as force, it assumes that the force is applied in a linear 
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direction. However, since quadriceps force is applied across a joint (knee), it 
produces an angular force (torque). Therefore, recording quadriceps strength as 
KET is more valid than force. Furthermore, individuals who are heavier in weight 
are generally able to produce more KET due to higher quadriceps muscle mass. 
Therefore, it is recommended that a patient’s peak KET be normalized to their 
bodyweight, such as what was done in this study. Lastly, the type of autograft 
used to reconstruct a patient’s ACL has been shown to effect postoperative 
quadriceps strength.132,591 A recent systematic review and meta-analysis 
assessed quadriceps strength differences between patients after ACLr, based on 
the type of autograft they received.591 At 12 months post-ACLr, the quadriceps 
strength of patients who received hamstring tendon autografts was an average of 
9% higher than those patients who received bone-patellar tendon-bone 
autografts. As a result, patients who receive hamstring tendon autografts for 
ACLr may have higher quadriceps strength LSI than those who receive bone-
patellar tendon-bone autografts. In our study, the majority of patients (78%) in the 
control group received bone-patellar tendon-bone autografts, which may explain 
the large side-to-side quadriceps strength difference observed at six months 
post-ACLr. However, there were not enough patients who received hamstring 
tendon autografts in our study to determine whether autograft type had an effect 
on normalized peak KET outcomes. Methodological differences in quadriceps 
strength assessments between studies must be considered when comparing the 
results of quadriceps strength LSI in patients following ACLr. 
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The temporal pattern of side-to-side quadriceps strength differences can 
be easily attributed to the unilateral quadriceps strength changes observed over 
time in the involved limb of the patients. We originally hypothesized that 
quadriceps strength would decrease in the involved limbs of patients at three 
months post-ACLr compared to baseline, and then return to baseline values at 
six months post-ACLr. Compared to baseline, quadriceps strength decreased in 
patients at three months post-ACLr (-1.20 Nm/kg), and then increased at six 
months post-ACLr (+0.30 Nm/kg), but this increase did not reach baseline value 
(-0.90 Nm/kg); thus, rejecting our hypothesis. These changes can all be 
described as true change that occurred beyond measurement error (MDC95 = 
0.30 Nm/kg).592 In other words, we are 95% confident that true clinical changes 
occurred with quadriceps strength in the involved limb after ACLr. The V-shaped 
pattern (see Figure 4.1) of quadriceps strength changes observed in our study is 
consistent with what has been reported in a previous study that longitudinally 
assessed quadriceps strength in the involved limb of patients before and after 
ACLr. Zech and colleagues24 assessed the (isometric) quadriceps strength of 
patients before ACLr, and at multiple time points after ACLr, up until 48 weeks 
post-ACLr. At 12 weeks (3 – 4 months) post-ACLr, the patients’ peak KET values 
were 12% (± 14) lower than their pre-ACLr values. However, there were no 
differences between preoperative and postoperative peak KET values observed 
in patients after 24 weeks (5 – 6 months) post-ACLr. Several longitudinal studies 
have supported these authors’ findings of quadriceps strength being restored to 
(or surpassing) preoperative values in the involved limb of patients at 
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approximately six months post-ACLr.149,158,186 Conversely, there are other studies 
that have reported similar results to our study,27,28 with the involved limb having 
less quadriceps strength at six months compared to baseline (pre-ACLr). In a 
recent study by Lepley et al.,27 they reported significantly lower normalized 
(isometric) peak KET in the involved limb of patients at seven months post-ACLr 
(2.2 Nm/kg ± 0.6) compared to their preoperative values (2.5 Nm/kg ± 0.7). Even 
with their post-ACLr time point being a month longer than our study (7.2 months 
vs. 6.3 months), a pre-to-post-ACLr deficit in quadriceps strength was still 
present in the involved limb of patients. 
As stated previously, the contrasting results observed between studies 
concerning time-based differences in ipsilateral quadriceps strength of patients 
after ACLr may be due to methodological variances in measurement and surgical 
techniques. However, the combination of limb asymmetry and persistent 
weakness observed in the involved limb of patients at six months post-ACLr, 
warrants a more conservative approach when clearing patients to return to 
competitive or recreational sport activities. The current timeframe for a patient to 
expect to return to sport is between six and 12 months following their ACLr,593,594 
but if quadriceps strength deficits are still present in the involved limbs of patients 
at six or seven months, this timeframe may need to be extended closer to 12 
months post-ACLr. In our study, the control group consisted of high school 
athletes (15), college athletes (2), and recreational athletes (8). Only one 
(recreational athlete) of the 25 patients was cleared by a physician to return to 
unrestricted sport activity at the 6-month assessment time point. Therefore, this 
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information may help physicians be better informed and possibly employ a more 
conservative approach when deciding when to return patients to unrestricted 
sport activities after ACLr, and providing more time for patients to recover their 
quadriceps strength. 
Although the rate of recovery after ACLr is unique to each patient, and 
other outcomes (i.e., SLH tests, step-down tests, YBT/SEBT, KOOS/IKDC, 
psychological readiness to return to sport, etc.) are necessary when making the 
clinical decision to clear a patient to return to sport, quadriceps strength is an 
important factor to asses from both a performance and health standpoint. 
Restoring quadriceps strength in patients after ACLr is not only beneficial to their 
performance during sport activities, but it can reduce risk of patients developing 
early knee OA. Individuals who have a history of ACL injury and/or ACLr are 
reported to be at a higher risk of developing early knee OA than healthy 
individuals.195,196 Furthermore, evidence has shown that although ACLr is a 
successful treatment for restoring knee-joint stability in these patients, patients 
who undergo ACLr are found to have a 29% higher odds of developing knee OA 
compared to those who are ACL-deficient.23 Within the first decade after ACLr, it 
has been reported that over one third of patients develop knee OA, and this 
prevalence approaches 50% by the second decade.23 Interestingly, there is 
growing evidence demonstrating that quadriceps weakness contributes to the 
onset and progression of knee OA in patients.73-75,197 During normal gait, three to 
four times the bodyweight of a healthy individual is transmitted through their 
knee-joint.73 To limit excessive joint loading, the quadriceps serve as the primary 
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shock absorber for the knee-joint. During ground contact (weight acceptance), 
the quadriceps contract eccentrically to absorb the majority of external forces at 
the knee.73-75 As a result, the forces transmitted through the knee-joint become 
dissipated, and minimal stress is placed on articular cartilage.76,77 Therefore, 
quadriceps weakness is thought to allow higher loads to be transmitted at the 
knee-joint, and expose the articular cartilage to more contact forces. 
Within the past decade, there have been a handful of longitudinal studies 
that have been able to demonstrate that quadriceps weakness is a significant 
contributor to the onset of knee OA in patients.78-82 Tourville and colleagues79 
assessed tibiofemoral joint space narrowing and isokinetic KET (concentric at 60 
deg/s) in 38 patients prior to ACLr (baseline) and 4 years postoperatively. After 
follow-up testing, the authors separated patients into narrow and normal joint 
space groups based upon their 4-year radiographs. They also compared the 
ACLr patients’ quadriceps strength to that of 32 healthy controls of similar age, 
body mass index, and physical activity level. At baseline, the quadriceps strength 
in both ACLr groups was lower than that of healthy controls (p < 0.001). 
However, the quadriceps strength of the narrow ACLr group’s peak KET was 
also significantly lower than that of the normal ACLr group. Four years after 
ACLr, the quadriceps strength of the normal ACLr group (95 ± 10.3% LSI) 
improved and was not significantly different compared to healthy controls (99 ± 
11.6% LSI, p > 0.05), while the narrow ACLr group’s quadriceps strength (83 ± 
23.1% LSI) remained lower than both the normal ACLr group (p = 0.04) and 
healthy controls (p = 0.01). A more recent systematic review and meta-analysis 
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by Oiestad et al.78 reported that early quadriceps weakness increased the odds 
of patients developing knee OA (radiographic and/or symptomatic) by 65% (OR = 
1.65, CI = 1.23-2.21). Therefore, the quadriceps weakness that was observed at 
six months post-ACLr in the patients of our study may place them at risk for 
developing knee OA if these strength deficits continue to persist. This is 
especially true for those patients who plan to return to sport activity, because 
their knee will be exposed to higher ground reaction forces during sports 
compared to activities of daily living. Furthermore, these patients may develop 
knee OA at a very young age, with the average age of patients in the control 
group being 19.4 (± 4.5) years. Since one third of patients are predicted to 
develop knee OA within the first decade after ACLr, at least eight of the 25 
patients can be expected to develop knee OA. However if patients also 
demonstrate persistent quadriceps weakness after ACLr, it may expedite the 
onset of knee OA and/or exacerbate the severity of cartilage degradation. The 
potential for this unfortunate sequence of events supports the significance of 
restoring quadriceps strength in patients during post-ACLr rehabilitation as a 
strategy better protect the knee-joint cartilage from further damage. 
Uninvolved Limb  
Perhaps the most significant findings from our study were the 
neuromuscular quadriceps changes that occurred in the uninvolved limb of 
patients after unilateral ACLr. We hypothesized that the quadriceps strength in 
the uninvolved limb would gradually decrease up until six months after ACLr. Our 
results confirmed this hypothesis, revealing that quadriceps strength was 
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significantly decreased in the uninvolved limb of patients at six month post-ACLr 
when compared to their baseline values. As observed in Figure 4.1, quadriceps 
strength in the uninvolved limb does not follow the same V-shaped temporal 
pattern as the involved limb. The temporal pattern of quadriceps strength in the 
uninvolved limbs tended to have a more gradual decline than that of the involved 
limb. However, instead of improving between three and six months post-ACLr 
like what was observed in the involved limb, quadriceps strength continued to 
decrease. This decrease in quadriceps strength from baseline to six months 
post-ACLr (-0.30 Nm/kg) can be described as true change beyond measurement 
error;592 thus, we are 95% confident that a clinical decrease in quadriceps 
strength occurred in the uninvolved limb of patients at six months post-ACLr.  
Although the quadriceps strength deficits observed in the uninvolved limb 
of patients were not as large as those observed in the involved limb, this finding 
still holds significant clinical value. Based on our knowledge of current literature, 
this would be the first study to report time-based quadriceps strength deficits in 
the uninvolved limb of patients after unilateral ACLr. However, there have been 
several studies that have reported cross-sectional strength deficits in the 
uninvolved limb of patients before and after ACLr when compared to healthy-
matched controls.32,42,45,51,52 Chung and colleagues45 recently assessed the 
longitudinal changes in bilateral isokinetic (concentric) quadriceps strength of 75 
patients at three, six, 12, and 24 months after unilateral ACLr. In addition to 
comparing strength values between limbs, they also compared the peak KET 
values of the ACLr patients to 75 healthy controls who were of equal age, sex, 
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height, weight, and pre-injury physical activity level. In the ACLr group, the 
uninvolved limb’s peak KET was significantly higher than that of the involved limb 
at three months (266.1 ± 43.7 Nm vs. 178.8 ± 51.2 Nm), six months (276.4 ± 42.7 
Nm vs. 224.2 ± 58.5 Nm), 12 months (276.7 ±44.9 Nm vs. 235.4 ± 56.9 Nm), and 
24 months (276.6 ± 42.8 Nm vs. 242.8 ± 55.5 Nm) after ACLr. Interestingly, when 
these values were compared to that of the healthy control group (290.9 ± 40.1 
Nm), both the involved and uninvolved limbs of ACLr group demonstrated 
significantly lower peak KET at each follow-up time point. Although more 
research is needed to understand the manifestation of contralateral quadriceps 
weakness in patients after unilateral ACLr, the results of our study combined with 
prior evidence is enough to deserve clinical consideration.  
This evidence suggests that using the uninvolved limb as the reference 
when assessing quadriceps strength in patients after unilateral ACLr may 
underestimate the magnitude of quadriceps strength deficits. Therefore, using 
quadriceps strength LSI as an indicator of recovery should not be heavily relied 
upon by physicians when making the decision of returning a patient to sport 
activity after ACLr. Quadriceps strength LSI could mask residual quadriceps 
weakness in the involved limb and deceive clinicians when making the decision 
to return patients to their pre-injury activity after ACLr. For example, a patient 
may demonstrate greater than 90% quadriceps strength LSI, but if the 
quadriceps strength of their uninvolved limb has also declined since the initial 
ACL injury, then the recovery of quadriceps strength on the involved limb may 
have been overestimated by the LSI. Clearing a patient to return to their pre-
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injury activity prior to restoring bilateral quadriceps strength may place both of 
their limbs at risk for subsequent knee-joint injury, and expose the knee to 
increased contact forces due to the decreased force absorption capabilities from 
the quadriceps.  
To unmask the quadriceps strength deficits in the involved limbs of 
patients, we recommend that clinicians should not depend on a LSI when 
assessing the recovery of quadriceps strength in patients after unilateral ACLr. 
Alternatively, it is recommended that clinicians compare the quadriceps strength 
of their ACLr patients to those of healthy individuals who are of similar age and 
stature (preferably normalized to bodyweight). If data from healthy individuals is 
not available to clinicians, the second best alternative is to compare the 
postoperative quadriceps strength of the involved limb to the patient’s 
preoperative quadriceps strength of their uninvolved limb recorded prior to ACLr. 
If we use model estimates in our study (see Table 4.3) as an example, the 6-
month quadriceps strength LSI is 64%. However, if the 6-month peak KET of the 
involved limb is compared to the baseline value of the uninvolved limb, the LSI 
equates to 59%. Although acute ACL injury is known to elicit deficits in ipsilateral 
quadriceps strength, there is no evidence to suggest that acute ACL injury affects 
quadriceps strength in the contralateral limb. However, we encourage clinicians 
to assess the quadriceps strength on the uninvolved limb of patients as soon as 
possible after ACL injury to account for the possibility of a crossover effect from 
developing in the uninvolved limb later on. Using these alternative comparison 
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strategies provides clinicians with a clearer representation of quadriceps strength 
recovery in the involved limbs of patients after ACLr 
We believe that it is also important for clinicians to account for the 
potential quadriceps strength deficits that are present in uninvolved limb of 
patients after unilateral ACLr. We agree that in order to improve a patient’s 
function and prevent them from sustaining a subsequent injury upon return to 
sport activity, improving quadriceps strength in involved limb of patients is one of 
the most important goals during post-ACLr rehabilitation. However, neglecting 
potential quadriceps strength deficits in the uninvolved limb could also put 
patients at risk upon return to sport activity. In a study by Schmitt et al.,67 they 
reported that external biomechanical forces during a drop-jump task were 
distributed differently between the limbs of patients at the time of return to sport 
activity after unilateral ACLr. The authors divided patients into high and low 
quadriceps strength groups, and compared biomechanical data to that of age-
matched, healthy participants. Compared to the patients with high quadriceps 
strength and healthy participants, the patients with low quadriceps strength 
demonstrated greater asymmetry in peak external knee flexion moments, peak 
vertical ground reaction forces, and peak loading rates. Specifically, all three 
biomechanical measures were significantly lower in the involved limbs and higher 
in the uninvolved limbs of patients with low quadriceps strength. Whereas, there 
were no significant differences between those patients with high quadriceps 
strength and the healthy participants in regard to biomechanical limb symmetries. 
The asymmetrical distribution of external forces between limbs of patients who 
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exhibit quadriceps weakness after ACLr has been theorized to place both knee-
joints at risk for subsequent knee-joint injury.67,194 While the quadriceps 
weakness exhibited in the involved limb of patients after unilateral ACLr may 
decrease their ability to absorb shock at the surgical knee-joint, their increased 
reliance on the uninvolved limb combined with a potential quadriceps strength 
deficit may also overload the nonsurgical knee-joint. Therefore, we believe that 
clinicians should begin to incorporate a bilateral approach when treating 
quadriceps strength deficits in patients after unilateral ACLr. 
There is compelling evidence supporting the effectiveness of cross-
exercise on improving neuromuscular quadriceps function.111,138,139,509-512,574 
Cross-exercise is the practice of training unilaterally to achieve bilateral 
improvements based on a neural phenomenon known as cross-education.116,513-
516 Cross-education through cross-exercise has been observed with both 
exercise509-512,574 and NMES interventions.111,138,139  However, only one study to 
date has investigated the effect of cross-exercise on the bilateral quadriceps 
strength of patients after ACLr.509 A total of 42 patients were randomized to the 
standard-of-care (control) or cross-exercise group after ACLr. The patients in the 
cross-exercise group performed eccentric exercises (3-5 days/week) on the 
uninvolved limb for eight weeks. Quadriceps strength (isometric) was assessed 
in patients before surgery and nine weeks post-ACLr. Compared to the control 
group, post-ACLr quadriceps strength was 4-8% higher in the uninvolved 
(trained) limb of patients who performed cross-exercise. Quadriceps strength in 
the involved limb still decreased in all patients post-ACLr, but this decrease was 
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21-31% greater in control group. Clinicians should be encouraged to incorporate 
a cross-exercise rehabilitation protocol such as this when treating patients who 
have recently undergone unilateral ACLr.  During the first couple months after 
surgery, most patients are not permitted to perform high-intensity quadriceps 
exercises on their involved limbs to protect the graft; yet these patients have 
gross atrophy and inhibition of their quadriceps that needs to be addressed to 
preserve and restore quadriceps strength. Therefore, until patients are cleared to 
perform high-intensity quadriceps exercises on their involved limb, cross-exercise 
can be performed on their uninvolved limb to facilitate quadriceps strength in the 
uninvolved limb, and mitigate strength deficits in the involved limb. Even 
afterwards, clinicians should continue to incorporate bilateral quadriceps strength 
training during rehabilitation as a way to maximize neuromuscular outcomes and 
improve the protection of both joints. 
5.1.2 Modifications in Neural Quadriceps Dysfunction 
Voluntary Quadriceps Activation 
 An unexpected outcome of this study was the lack the neural quadriceps 
dysfunction in the involved limb of patients after ACLr. We hypothesized that 
voluntary quadriceps activation in the involved limb of patients would follow the 
same V-shaped temporal pattern as what was observed with quadriceps 
strength. However, voluntary quadriceps activation in the involved limb remained 
unchanged in patients after ACLr. Secondly, the degree of quadriceps inhibition 
present in the involved limb before and after ACLr was quite unremarkable. 
Although the quadriceps CAR in the involved limb of patients ranged from 60% to 
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100%, the model estimates at baseline, three and six months, were 93.4%, 
94.1% and 92.7%, respectively. Unfortunately, we are unable to discuss whether 
these estimates are lower than the patients’ quadriceps CAR values of when they 
were healthy, prior to ACL injury. Therefore, we can only compare our results on 
voluntary quadriceps activation to what has been established in the literature. 
Park and Hopkins88 assessed voluntary quadriceps activation levels of 91 healthy 
individuals without a history of knee injury or surgery, and reported an average 
quadriceps CAR value of 95%. Therefore, a quadriceps CAR value of greater 
than or equal to 95% has been generally accepted as the threshold for 
determining whether or not a patient has neural inhibition of their quadriceps after 
ACLr.89,90 In our study, each of the quadriceps CAR estimates fell below this 
threshold (< 95%), but the only time point where the quadriceps could be defined 
as being inhibited beyond measurement error (SEM = 2%),404 was at six months 
post-ACLr (CAR = 92.7%). However, the 95% confidence interval of this 6-month 
estimate (88.1, 96.2) crosses the voluntary quadriceps activation threshold of 
95%, and true change beyond measurement error was not reached (MDC = 
2.8%); thus, we cannot be confident that true quadriceps inhibition was present 
at this time point.  
Based upon the last 20 years of research in this area, the average 
voluntary quadriceps activation in the involved limb of patients, both before and 
after ACLr, has been reported to be as low as 75% to 77%,32,145,289 and as high 
as 99%.24 However, these studies assessed voluntary quadriceps activation in 
patients using different measurement techniques (ITT and %ACT) compared to 
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our study (SIB and CAR), which have been known to provide different 
results.385,395,595-597 Therefore, we felt that it was necessary to only compare our 
results to studies that assessed voluntary quadriceps activation in patients using 
the same measurement techniques. The majority of studies have reported 
average quadriceps CAR values that were at 95% in the involved limb of patients 
before ACLr (90 – 95%).27,89,172,232,290 Lepley et al.51 is the only study that has 
reported a quadriceps CAR value in the involved limb that was below 90% (83.1 
± 8.1%) before ACLr. Conversely, the average quadriceps CAR values that have 
been reported in the involved limb of patients after ACLr vary anywhere between 
75-92%.27,34,48,51,55,91,97,290-293 Interestingly, the lowest quadriceps CAR value 
(75.2 ± 13.4%) was reported in a study whose patients were four years removed 
from ACLr,292 and the highest quadriceps CAR values (91.7 ± 6.4% and 91.8 ± 
4.6%) were reported in a study whose patients were three and seven months 
post-ACLr (respectively).292 The results from the later study are similar to those 
of our study, with high quadriceps CAR estimates (>92%) being observed in 
patients at both three and six months post-ACLr. It can be expected that a high 
degree of quadriceps inhibition is present in patients immediately after ACLr 
based on the principles of AMI. During this acute stage after ACLr, the effusion, 
pain, and inflammation present within the knee-joint is sufficient to inhibit the 
involved limb’s quadriceps. However, force-based measures of voluntary 
quadriceps activation are typically contraindicated in the involved limb of patients 
within the first two months after ACLr due to increased pain, inadequate range-
of-motion, and/or postoperative guidelines that are enforced to protect the graft 
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from being stressed prematurely. After this acute stage, AMI may begin to 
resolve in the quadriceps of patients during the first few months after ACLr, with 
voluntary quadriceps activation approaching normal levels up until one year post-
ACLr. However, a decline in voluntary quadriceps activation may be apparent in 
patients who are years removed from ACLr. Quadriceps inhibition that persists in 
patients years after ACLr may be defined as QAF. Alternatively, a relapse of 
quadriceps inhibition years later may be a reoccurrence of quadriceps AMI that is 
due to the insidious onset of a subsequent knee-joint pathology, such as knee 
OA. Similar patients after ACL injury or reconstruction, patient with knee OA have 
been reported to exhibit deficits in voluntary quadriceps activation.295 However, 
further research is need to explore this theory, and to determine whether deficits 
in voluntary quadriceps activation after ACLr are truly time-dependent. 
The most significant finding observed with the voluntary quadriceps 
activation of patients after ACLr was not in that of the involved limb, but in that of 
the uninvolved limb. We originally hypothesized that voluntary quadriceps 
activation would be lower in the involved limb compared to the uninvolved limb at 
each time point; however, the exact opposite was observed in our results. There 
was a significant main effect for limb observed with quadriceps CAR in patients. 
Regardless of when it was assessed, quadriceps CAR estimate was 
approximately 2.4% lower (on average) in the uninvolved limbs of patients 
compared to their involved limbs. A bilateral voluntary quadriceps activation 
deficits after ACL injury and subsequent ACLr has been consistently reported in 
the literature, and is now considered to be a regular phenomenon in 
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patients.34,51,84,85,91 Furthermore, the amount of neural inhibition present within 
the quadriceps of the contralateral limb is equivalent to that of the ipsilateral 
(involved) limb following unilateral ACLr. In a recent study by Thomas et al.,91 
voluntary quadriceps activation was assessed bilaterally in the limbs of patients 
who were seven months removed from ACLr. The mean quadriceps CAR value 
of the patients’ involved limbs was 87%, while the uninvolved limbs demonstrated 
a quadriceps CAR value of 85% (see Table 4.3). However, our findings were 
unique because the voluntary quadriceps activation in the uninvolved limb of 
patients was actually lower than that of their involved limb. Although we can 
conclude that this difference was beyond measurement error (SEM = 2%), but 
we cannot confidently say that this difference was true due to the confidence 
intervals of our estimates and the MDC (2.8 – 5.5%) for quadriceps CAR.404  
Compared to baseline, no temporal changes were observed with voluntary 
quadriceps activation in the uninvolved limb of patients after ACLr. This finding 
was similar to what was observed in the involved limb of patients after ACLr. 
However, true quadriceps inhibition was more apparent in the uninvolved limb of 
patients before and after ACLr compared to the involved limb. The quadriceps 
CAR estimates at baseline (91%), three months (91.8%), and six months (90.1%) 
post-ACLr were all below the 95% threshold value for determining whether a 
patient has quadriceps inhibition.89,90 These estimates were not only below the 
measurement error for quadriceps CAR (SEM = 2%),404 but their 95% confidence 
intervals did not cross the 95% threshold. Furthermore, true quadriceps inhibition 
can be assumed with more confidence at the 6-month post-ACLr time point 
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(MDC90 = 4.65%) compared to baseline and the 3-month post-ACLr time point 
(MDC = 2.83%).404 However, we are unable to determine whether the pre-injury 
voluntary quadriceps activation levels of our patients would have met the 95% 
threshold that has been previously reported in healthy individuals;88 we can only 
assume that the quadriceps CAR estimates reported in the uninvolved limb of our 
patients reflected quadriceps inhibition, based on the 95% threshold criterion. 
The joint trauma present within the surgically reconstructed knee-joint of 
patients after ACL injury and/or reconstruction seems to be modulating the 
voluntary quadriceps activation of their uninvolved limb. Scientists have yet to 
fully understand the reason for the bilateral quadriceps inhibition that is observed 
in patients after unilateral ACLr. The most popular explanation is that of a neural 
crossover effect that occurs in the central nervous system due to altered afferent 
information being transmitted from the involved knee-joint.42,145,272 Due to this 
bilateral deficit, clinicians are cautioned when using a patient’s uninvolved limb 
as a comparison when assessing the recovery of neuromuscular quadriceps 
function in the involved limb and making return-to-activity decisions after ACLr. 
Consequently, clinicians should be advised to consider a healthy-matched 
control as a comparison, and clinicians should place further attention on the 
uninvolved limb during the rehabilitation of patients following ACLr. 
Corticomotor Excitability 
Like voluntary quadriceps activation, temporal changes in corticomotor 
excitability at the quadriceps were not observed in the involved limb of patients 
after ACLr. As a reminder, a lower quadriceps AMT value (%TMS output) 
199 
 
corresponds to higher corticomotor excitability at the quadriceps. The only study 
that has assessed quadriceps AMT in the involved limb of patients prior to ACLr 
was that of Lepley et al.51 They assessed quadriceps AMT in their patients at an 
average of 35 days after ACL injury, and reported an average AMT of 39.9%. 
This value is very similar to the quadriceps AMT estimate that we reported in our 
patients (39.7%) who were assessed an average of 25 days after ACL injury. 
However, the postoperative quadriceps AMT estimates in our study were 
relatively low compared to what has been previously reported in patients after 
ACLr.34,51,61,84,97 The quadriceps AMT estimates of our patients were 39.1% and 
39.2% at three and six months post-ACLr, respectively (see Table 4.3). The 
majority of studies have reported average quadriceps AMT values that fall 
between 44% and 62% in patients after ACLr.34,51,84,97 It must be noted that most 
of these studies assessed quadriceps AMT in patients who were more than two 
years removed from ACLr.34,84,97 However, Lepley et al.51 assessed quadriceps 
AMT in patients at a time point similar to our study (6 months post-ACLr), but 
their AMT value was higher (46.1% vs. 39.2%). There has been one study that 
has reported low quadriceps AMT values (33.2%) in patients after ACLr,61 but 
their assessment was performed at a time point (33.2 months post-ACLr) much 
later than our study.  
It is not clear why the quadriceps AMT estimates of our patients were 
different than when they were healthy (prior to ACL injury). Therefore, we can 
only compare our results to what has been reported for healthy individuals. Of 
the aforementioned studies that assessed corticomotor excitability in patients 
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before and/or after ACLr, most of them assessed quadriceps AMT in a group of 
healthy individuals as comparison. The majority of these studies reported 
quadriceps AMT values between 36% and 38% in healthy controls.34,51,97 
However, Kuenze et al. reported quadriceps AMT values in healthy controls that 
were greater than 60%. Although the inconsistent results between studies may 
be due to methodological variances, more studies are needed to determine the 
normative values of quadriceps AMT that can be expected in healthy individuals. 
Secondly, due to the limited evidence of corticomotor excitability changes in 
patients before and after ACLr, more longitudinal studies are needed to confirm 
whether corticomotor excitability at the quadriceps is altered in patients after ACL 
injury and reconstruction, and to what extent these alterations exist. Furthermore, 
other supraspinal areas (i.e., sensory cortex, cerebellum, brainstem, etc.) should 
be explored to determine the systemic effect that ACL injury and reconstruction 
have on the neural function of CNS. 
 
5.2 SPECIFIC AIM 2 
5.2.1 Early Neuromuscular Effects on Lower Extremity Function 
Outcomes 
 Lower Extremity Postural Control 
 We originally hypothesized that the patients’ quadriceps strength 
assessed at baseline and three months post-ACLr would be associated with their 
lower extremity postural control at six months post-ACLr. The YBT-A was used to 
assess lower extremity postural control in patients at six months post-ACLr. We 
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chose the anterior reach direction of the YBT, because quadriceps EMG activity 
has been reported to be the highest in that direction.587 The normalized peak 
KET of patients at three months post-ACLr was the only variable that 
demonstrated a significant positive association with 6-month YBT-A reach 
distance (see Table 4.5). For every 1 Nm/kg increase in normalized peak KET at 
three months post-ACLr, an estimated 5.1% increase in normalized YBT-A reach 
distance could have been expected at six months post-ACLr. If we use the 
results from Specific Aim 1 as an example (Table 4.3), the model estimate for 
normalized peak KET of patients at three months post-ACLr was 1.67 Nm/kg. 
Therefore, if the patients increased their normalized peak KET to 2.67 Nm/kg 
between three and six months post-ACLr, they would see a 5.1% increase in 
their normalized YBT-A reach distance at six months post-ACLr, which would 
signify an improvement in their postural control. However, we are only able to 
conclude that this 5.1% increase is statistically significant, and not beyond 
measurement error or a true increase in lower extremity postural control, 
because no study has determined the MDC of the normalized YBT-A reach 
distance. 
 Our results were similar to those reported by Kline and colleagues.72 They 
found that the 3-month postoperative isometric quadriceps strength of ACLr 
patients was significantly correlated their knee flexion excursion and internal 
knee extension moment observed with running at six months post-ACLr. Knee 
flexion excursion and internal knee extension moments are biomechanical 
measures that are believed to be controlled by the activity of quadriceps,68 and 
202 
 
they have previously been found to be correlated with quadriceps strength in 
patients at the time of return-to-sport after ACLr.63 However, the problem is that 
most studies choose to assess these correlations in patients cross-sectionally 
after they have returned to sport activity, and are unable to determine whether 
earlier quadriceps strength deficits can explain the reduced function and/or poor 
biomechanics that are observed in patients around the time that they have 
returned to sport activity. The results of our study combined with those of Kline et 
al.,72 have begun to fill this void by demonstrating that quadriceps strength of 
patients at three months post-ACLr have a direct influence on their lower 
extremity function and biomechanics at six months post-ACLr. Therefore, these 
results demonstrate the importance for clinicians to focus on quadriceps 
strengthening during the early stages of ACLr rehabilitation in order to provide 
patients the opportunity for better outcomes around the time that they are cleared 
to return to sport activity. 
Other studies have also reported significant associations between 
quadriceps strength and lower extremity functional performance in patients after 
ACLr.3,4,7-9,28,39,53-59 Keays and colleagues28 sought to determine whether 
quadriceps strength was correlated with SLH performance before and after ACLr. 
They assessed the isokinetic (concentric) peak KET, single hop for distance, and 
triple hop for distance of 31 patients before unilateral ACLr and at their 6-month 
postoperative follow-up. Prior to surgery, significant correlations were observed 
between isokinetic quadriceps strength and performance on the SLH tests (r = 
0.53 – 0.59). However, stronger correlations were observed at six months post-
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ACLr between quadriceps strength and the SLH (r = 0.62 – 0.74). The results of 
our study not only demonstrated a significant association between postoperative 
quadriceps strength and lower extremity postural control, but that the amount of 
quadriceps strength a patient has earlier after ACLr has a direct effect on the 
degree of postural control they will have months later.  
The anterior reach component of the YBT has been shown to predict 
lower extremity injuries in athletes.585 A recent study by Smith et al.585 assessed 
the bilateral YBT-A reach distance of 184 Division-1 collegiate athletes during 
their pre-participation physical examinations. These athletes were then followed 
throughout their respective sport seasons, and the number of lower extremity 
non-contact injuries were recorded. A total of 81 athletes sustained a lower 
extremity non-contact injury during their sport season. The authors found that 
greater limb asymmetry with the pre-participation YBT-A significantly increased 
the odds of athletes sustaining a lower extremity non-contact injury during their 
sport season (OR = 2.33; 95% CI = 1.15 – 4.76). Therefore, the results of our 
study carry great clinical significance from an injury prevention standpoint. More 
focus should be made to enhancing quadriceps strength in patients during the 
early months after ACLr as a proactive attempt to improve their lower extremity 
postural control and reduce the odds of them sustaining a subsequent lower 
extremity injury upon return to sport activity. However, more research is needed 
to explore the effect that early postoperative quadriceps strength has on other 
measures of lower extremity functional performance, and whether these 
measures can predict subsequent knee-joint injuries. 
204 
 
 Self-Reported Knee Function 
We also hypothesized that the patients’ quadriceps strength assessed at 
baseline and three months post-ACLr would be associated with self-reported 
knee function at six months post-ACLr. The Sport/Rec and QOL domains of the 
KOOS were used to assess self-reported knee function in patients at six months 
post-ACLr. The normalized peak KET of patients at three months post-ACLr was 
not found to be associated to their 6-month postoperative KOOS-Sport/Rec 
score. Similar to what was reported with 6-month YBT-A outcomes, the 
normalized peak KET of patients at three months post-ACLr was the only 
variable that demonstrated a significant positive association with any of the 6-
month KOOS domains (see Table 4.5). The 6-month postoperative KOOS-QOL 
score of patients was the only domain that was influenced by their 3-month 
postoperative quadriceps strength. For every 1 Nm/kg increase in normalized 
peak KET at three months post-ACLr, an estimated 8.9 point increase in KOOS-
QOL score could have been expected at 6-months post-ACLr. This 8.9 point 
increase in KOOS-QOL score would be defined as true change beyond 
measurement error because it surpasses the MDC associated with that KOOS 
domain (MDC95 = 7.2 pts).192 
The fact that 3-month postoperative quadriceps strength effected 6-month 
postoperative KOOS-QOL scores, but not KOOS-Sport/Rec scores may be 
explained by the different aspects of knee function that are addressed by the two 
domains. For the KOOS-Sport/Rec domain, there are five questions that pertain 
to five different activities/movements (squatting, running, jumping, 
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twisting/pivoting, and kneeling). Patients are asked to think of the degree of 
difficulty that they experience (within the past week) with their knee for each 
question. Difficulty is graded on a 5-point Likert scale, ranging from no difficulty to 
extreme difficulty. Conversely, for the KOOS-QOL domain, there are four 
questions that pertain knee function from a broader level of QOL instead of 
activities/movements. Rather than asking patients the degree of difficulty that 
they have with their knee, patients are asked to think of the frequency and 
degree of difficulty that they experience with their knee. Again, the answers are 
graded on a 5-point Likert scale, ranging from either never-to-constantly, or from 
none/not at all-to-extreme/totally. As stated earlier, only one of the 25 patients in 
our study was cleared by a physician to return to unrestricted sport activity at the 
6-month assessment time point. Therefore, the KOOS-Sport/Rec score that was 
observed in patients at six months post-ACLr may not have been accurate, 
because the majority of them were not exposed to sport activities at that time 
point; thus, they did not have a valid reference to relate to when answering 
questions form that domain. Unlike our study, Ithburn et al.63 reported that the 
KOOS Sport/Rec scores observed in patients after ACLr (~ 8 months post-ACLr) 
were different depending on their levels of isometric quadriceps strength. 
Compared to patients with high quadriceps strength (LSI ≥ 90%), patients with 
low quadriceps strength (LSI < 85%) also demonstrated lower KOOS-Sport/Rec 
scores (89.5 ± 11.7 pts vs. 79.6 ± 15.5 pts). The primary difference between our 
study and theirs, is that their patients completed the KOOS-Sport/Rec after they 
were cleared to return to sport activity (~ 7 months post-ACLr), whereas the 
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majority of our patients had not returned to sport activity prior to completing the 
6-month KOOS-Sport/Rec. Although hypothetical, if our patients were exposed to 
sport activity prior to completing the KOOS-Sport/Rec domain at six months post-
ACLr, more accurate scores may have been evidenced, and significant 
associations may have resulted with 3-month postoperative quadriceps strength. 
Since the KOOS-QOL domain does not pertain to sport activities, but rather a 
broader construct of knee function, it may explain why a significant association 
was observed with that self-reported functional outcome measure. 
In addition to the KOOS, several studies have demonstrated significant 
associations between IKDC scores and the quadriceps strength of patients 
following ACLr.8,55,60-62 Perhaps the most impressive study that demonstrated this 
association was that of Pietrosimone and colleagues.61 They assessed isometric 
peak KET and IKDC scores in 15 patients who were an average of 54 months 
removed from ACLr, and performed a linear regression analysis to determine the 
amount of variability in self-reported knee function that could be explained by 
their quadriceps strength. Remarkably, they discovered that isometric quadriceps 
strength predicted over 60% (r2 = 0.61) of the variance in the IKDC scores of 
patients who have a history of ACLr; thus, demonstrating that the majority of 
IKDC scores can be explained by a patient’s quadriceps strength after ACLr, and 
that quadriceps weakness can severely limit their self-perceived function. We 
may have observed more and/or greater associations between early 
postoperative quadriceps and 6-month self-reported knee function if we used the 
IKDC, however, the KOOS-Sport/Rec and KOOS-QOL were intentionally chosen 
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to represent the self-reported knee function in our sample of patients. Compared 
to other self-reported outcome measures, the KOOS is meant for younger, and 
more physically active patients who have sustained a knee injury or have 
undergone knee surgery.588 Furthermore, of the five domains in the KOOS, the 
QOL and Sports/Rec domains have demonstrated the most unidimensionality,589 
and are the most sensitive to changes over time in patients after ACLr,193 thus, 
justifying our rationale for choosing to preferentially assess those two domains in 
our study. That being said, further investigations should performed to determine 
whether early postoperative quadriceps strength has an effect on other self-
reported outcome measures (i.e., IKDC, Cincinnati Knee Score, Knee Outcome 
Survey, etc.) at the time of return to sport activity. 
Lack of Associations with Neural Measures 
Neither quadriceps CAR or AMT (at baseline or 3-months post-ACLr) had 
a significant effect on any of the 6-month lower extremity function outcome 
measures. Based on our original hypotheses, we expected that corticomotor 
excitability would not have a significant influence on the patients’ lower extremity 
function, because quadriceps AMT has been previously shown to be minimally 
correlated with the quadriceps strength of patients after ACLr,61,97 and as 
evidenced in our study, quadriceps strength has been consistently reported to 
influence lower extremity function in patients after ACLr. Therefore, since 
voluntary quadriceps activation has been reported to explain nearly 40% of 
quadriceps strength in patients after ACLr (r2 = 0.37),97 we hypothesized that it 
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would influence the lower extremity function of our patients at six months post-
ACLr, yet this not supported in our results. 
Although we hoped to observe an association between voluntary 
quadriceps activation and lower extremity function in patients after ACLr, the 
absence of this finding is not surprising. To date, only one study has reported on 
the association between voluntary quadriceps activation and lower extremity 
function in patients following ACLr.48 Kuenze and colleagues48 used receiver-
operator-characteristic (ROC) curves as a method to establish clinical thresholds 
for voluntary quadriceps activation (CAR) associated with self-reported knee 
function (KOOS) in patients who were at least six months removed from 
unilateral ACLr. They found that quadriceps CAR LSI greater than 99.2% (area 
under curve = 0.67) was the most effective in identifying a patient with a total 
KOOS score similar to that of healthy individuals (96 pts). However, there are 
several limitations associated with this study, which questions the clinical 
significance of its findings. To begin, quadriceps CAR LSI is not commonly 
assessed, and as was mentioned earlier, LSI may underestimate the amount 
quadriceps dysfunction present in patients after ACLr. Secondly, reporting the 
total KOOS score, which is the sum of the scores for each domain is not advised. 
This is because the intention of the KOOS is to allow clinicians to analyze and 
interpret each domain separately. This is one advantage the KOOS has over 
other self-reported knee outcome measures. 
The correlation between voluntary quadriceps activation and lower 
extremity function may be too low to reach statistical significance. However, 
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voluntary quadriceps activation may serve to moderate the relationship between 
quadriceps strength and lower extremity function in patients with knee OA.134 
Fitzgerald et al.134 assessed quadriceps activation and strength, and lower 
extremity function (Western Ontario and McMaster Universities Osteoarthritis 
Index combined with Get Up and Go test) in 105 patients with radiographic knee 
OA. After performing regression analysis, the authors found that adding the 
quadriceps activation by strength interaction to the regression model resulted in 
the highest explanation of variance for lower extremity function (r2 = 0.22); thus, 
quadriceps inhibition was believed to serve as a moderator between quadriceps 
strength and function. For example, patients who exhibited higher levels of 
quadriceps weakness and quadriceps inhibition, had lower levels of function than 
those with comparable strength and less inhibition. Conversely, patients who 
exhibited lower levels of quadriceps weakness and higher levels of quadriceps 
inhibition, had higher levels of function compared to those of comparable 
strength and less inhibition. Although the authors could not explain why stronger 
patients with more quadriceps inhibition had higher levels of function, they 
hypothesized that if a patient has good quadriceps strength, the presence or 
absence of quadriceps inhibition may not play an important role in affecting their 
function.134 If a patient has enough strength to function well, they may not need 
to fully activate their quadriceps. In contrast, if a patient has significant 
quadriceps weakness and quadriceps inhibition, the combination of the two may 
be sufficient enough to affect their function. Regardless, the effect that voluntary 
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quadriceps activation has on quadriceps strength alone, makes it an important 
outcome for clinicians to consider when treating patients after ACLr. 
 
5.3 SPECIFIC AIM 3 
  5.3.1 Group Patterns  
 Isometric Quadriceps Strength 
 We hypothesized that those patients who were randomly allocated to the 
Home-NMES group would demonstrate greater bilateral improvements in 
quadriceps strength, voluntary activation, and corticomotor excitability at both 
three and six months post-ACLr compared to patients in the control group. 
However, the only significant group difference that was observed in our 
randomized clinical trial was with the isometric quadriceps strength outcome 
measure (see Table 4.6). A main effect for group was reported with isometric 
quadriceps strength, with the control group having an average of 0.36 Nm/kg 
higher normalized peak KET than that of the Home-NMES group (irrespective of 
limb and time). However, this group difference was not because the Home-
NMES group had a negative treatment effect from the home-based NMES 
program, but because group differences in normalized peak KET were present at 
baseline. Although the only statistically significant group difference that was 
present at baseline was with normalized peak KET on the uninvolved limb being 
higher in the control group (see Table 4.2), a trend was also observed in the 
involved limb, with the control group again being higher than the Home-NMES 
group. The mixed model analyses may have accounted for this trend, causing 
211 
 
the model estimates for normalized peak KET to be significantly higher in the 
control group at baseline, regardless of limb. Even if normalized peak KET was 
the same bilaterally between groups at baseline, we do not foresee that the 
Home-NMES group would have demonstrated a greater bilateral improvement in 
isometric quadriceps strength than the control group at either three or six months 
post-ACLr, due to the differences in model estimates for limb and time being 
identical between both groups. Therefore, the isometric quadriceps strength 
deficits observed in Home-NMES group followed the same pattern as the control 
group after ACLr, but they happened to begin with weaker quadriceps at 
baseline. 
Regardless of group allocation, significant limb by time interaction that 
was demonstrated in the results of Specific Aim 3. Similar to the results of 
Specific Aim 1, there was a side-to-side difference in isometric quadriceps 
strength between limbs at each time-point. For both groups, the normalized peak 
KET of the involved limb was significantly lower than that of the uninvolved limb 
at baseline, three months, and six months post-ACLr. Again, the largest 
difference between limbs was observed at three months post-ACLr (-1.35 
Nm/kg), with the next largest difference occurring at six months post-ACLr (-0.95 
Nm/kg), and the smallest difference between limbs was observed at baseline (-
0.32 Nm/kg). Furthermore, if we convert the 6-month model estimates for 
normalized peak KET (see Table 4.6) into quadriceps strength LSIs, they fall 
below the 90% LSI return-to-sport criterion in both groups (Home-NMES = 
65.5%; control = 69.5%) post-ACLr. Thankfully, only one patient in both the 
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Home-NMES group (high-school athlete) and control group (recreational athlete) 
was cleared by a physician to return to sports activity before the 6-month post-
ACLr time point; thus, the majority of the patients in this clinical trial were not 
exposing their surgical knees to the increased external forces associated with 
sport activities, prior to achieving an acceptable limb symmetry in quadriceps 
strength. However, as stated earlier in this chapter, when interpreting a patient’s 
quadriceps strength LSI after unilateral ACLr, it is important to consider the 
possibility of bilateral deficits in quadriceps strength. When available, we 
recommended that clinicians compare the quadriceps strength of their ACLr 
patients to those of healthy individuals, and if healthy data is not available, the 
second best alternative is to compare the postoperative quadriceps strength of 
the involved limb to the patient’s preoperative quadriceps strength of their 
uninvolved limb recorded as soon as possible after ACL injury. These alternative 
comparison strategies to LSI will provide clinicians with a more accurate 
representation of the recovery of quadriceps strength in patients after ACLr. 
Like the results of Specific Aim 1, a V-shaped curve was observed with 
quadriceps strength changes for both groups. Compared to baseline, quadriceps 
strength decreased in patients at three months post-ACLr (-1.07 Nm/kg), and 
then increased at six months post-ACLr (+0.32 Nm/kg), but this increase did not 
reach baseline value (-0.75 Nm/kg); thus, rejecting one component of our 
hypothesis. These changes can all be described as true change that occurred 
beyond measurement error (MDC95 = 0.30 Nm/kg),592 making us 95% confident 
that true clinical changes in quadriceps strength occurred in the involved limb of 
213 
 
both groups after ACLr. Unlike the results of Specific Aim 1, there were no 
statistically significant changes with quadriceps strength in the uninvolved limb 
for either group. However, this was most likely due to larger mixed model 
analysis used for Specific Aim 2. Before post-hoc adjustments, normalized peak 
KET was significantly decreased from baseline to six months post-ACLr an 
average of 0.19 Nm/kg in the uninvolved limbs of both groups (unadjusted p = 
0.02), but after adjusting for multiple comparison, this decrease in peak KET on 
the uninvolved limb did not achieve statistical significance (adjusted p = 0.13). In 
addition, the 95% confidence intervals of the 6-month peak KET estimates 
crossed the baseline estimates in both groups, and only 65% confidence can be 
had that true change occurred in quadriceps strength from baseline to six months 
post-ACLr (MDC = 0.16 Nm/kg).592 The inclusion of the group variable adjusted 
the model estimates for normalized peak KET observed in the uninvolved limb of 
the control group (see Tables 4.3 and 4.6). Since the normalized peak KET 
estimate of the uninvolved limb was lower in the Home-NMES group than the 
control group at baseline, it may have decreased the likelihood of observing a 
statistically significant postoperative decrease in the uninvolved limb. Greater 
responsiveness to change after ACLr can be expected with higher normalized 
peak KET estimates, but since the Home-NMES started with lower normalized 
peak KET, the likelihood of a statistically significant decrease after ACLr is 
reduced; thus, explaining why no temporal changes were observed in the 
uninvolved limb of the control group. Regardless, we still believe that clinicians 
should account for potential bilateral deficits in the quadriceps strength of 
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patients after unilateral ACLr, by incorporating bilateral quadriceps strengthening 
interventions during rehabilitation. 
Voluntary Quadriceps Activation 
As observed with Specific Aim 1, there was a significant difference in 
voluntary activation observed between limbs at baseline. Regardless of group 
membership, the baseline quadriceps CAR estimate in the uninvolved limb of 
patients was on average 4.2% lower than that of the involved limb. However, a 
limb difference in quadriceps CAR was not significant in either group at three or 
six months post-ACLr. The lack of statistically significant limb differences in 
quadriceps CAR of the control group at three and six months post-ACLr are likely 
do to the larger mixed model analysis used for Specific Aim 3 compared to 
Specific Aim 1. The estimated 4.2% difference in quadriceps CAR between limbs 
(involved limb > uninvolved limb) at baseline was greater than what was reported 
in Specific Aim 1 (2.4%). Furthermore, this difference was beyond measurement 
error (SEM = 2%), and can be considered as true change with 68% confidence 
(MDC = 2.8%). As discussed earlier, a bilateral deficit in voluntary quadriceps 
activation of patients after unilateral ACLr has been previously demonstrated in 
the literature,34,51,84,85,91 which is likely the result of a neural crossover 
effect.42,145,272 This bilateral deficit further rejects the practice of relying on LSI 
measurements when assessing the recovery of neuromuscular quadriceps 
function in the involved limb and making return-to-activity decisions for patients 
after ACLr, and supports the inclusion of bilateral interventions during the 
rehabilitation of patients following unilateral ACLr. 
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Although there were no other statistically significant findings observed in 
this clinical trial concerning voluntary quadriceps activation, a case can be made 
that quadriceps inhibition was present in both groups of patients (see Table 4.6). 
Since quadriceps CAR was not assessed in the groups prior to ACL injury, we 
are unable to determine whether the injury and/or ACLr elicited decreases in 
voluntary quadriceps activation. By using the 95% voluntary quadriceps 
activation threshold established in the literature to determine the presence of 
quadriceps inhibition,88-90 we can see that several quadriceps CAR estimates in 
both groups fall below this 95% threshold. In the involved limb, quadriceps 
inhibition was present beyond measurement error at three and six months post-
ACLr in the control group, and at six months post-ACLr in the Home-NMES 
group (SEM = 2%).404 However a true difference (with 90% confidence) to the 
95% threshold was only observed with quadriceps CAR estimate at six months 
post-ACLr (89.8%) in the control group (MDC90 = 4.6%).404 In the uninvolved 
limb, quadriceps inhibition was present beyond measurement error at each time 
point in both groups, but unlike the control group, true difference to the 95% 
threshold could only be seen at baseline (91.7%) and six months (92.2%) post-
ACLr in the Home-NMES group. Furthermore, only 68% confidence can be given 
to the quadriceps inhibition (quadriceps CAR < 95%) that was present in the 
Home-NMES group at baseline and six months post-ACLr (MDC = 2.8%); 
whereas, 90% confidence (MDC90 = 4.6%) can be given to the quadriceps 
inhibition that was present in the control group at three months (quadriceps CAR 
= 89.8%) post-ACLr, and 95% confidence (MDC95 = 5.5%) to the quadriceps 
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inhibition present at baseline (quadriceps CAR = 88.9%) and six months 
(quadriceps CAR = 89.4%) post-ACLr.  
Perhaps this point can be made clearer by observing the 95% confidence 
intervals (error bars) associated with the quadriceps CAR estimate (columns) for 
each group. Figure 4.4. The dashed red line in Figure 4.4 corresponds to the 
healthy normative quadriceps CAR (95%) reported by Park and Hopkins,404 
which is also used as the threshold for determining the presence of quadriceps 
inhibition. In the Home-NMES group, the only confidence interval that did not 
cross the 95% CAR threshold was seen with uninvolved limb at baseline (95% CI 
= 88.5%, 94.4%). Conversely, in the control group, the confidence intervals for all 
time points in the uninvolved limb were below the 95% CAR threshold, and even 
the confidence intervals for the 6-month quadriceps CAR estimate in the involved 
limb fell below this threshold (95% CI = 85.5%, 93.4%). Regardless of the 
observation that less inhibition was observed in the Home-NMES group than the 
control group, we cannot conclude that the home-based NMES treatment was 
effective at improving voluntary quadriceps activation in patients after ACLr. This 
observed difference between groups can be explained by the greater quadriceps 
inhibition observed in the control group at baseline, since no significant changes 
in quadriceps CAR were observed in either group over time. However, the main 
observation of this clinical trial was the presence of quadriceps inhibition in the 
uninvolved limb of patients before and after ACLr. This finding suggests that 
disinhibitory interventions may need to be applied bilaterally in patients after 
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unilateral ACLr as an attempt to maintain quadriceps activation and foster 
quadriceps strength gains during rehabilitation. 
Corticomotor Excitability 
In agreement with Specific Aim 1, no temporal changes in corticomotor 
excitability were observed in either group after ACLr, and no differences were 
found between groups at either time point. Since the quadriceps AMT estimates 
of both groups did not change postoperatively, and are similar to the quadriceps 
AMT values that have been reported in healthy individuals,34,51,97 we believe that 
ACLr may not effect corticomotor excitability as much as what has been reported 
in earlier studies. Due to the limited evidence of corticomotor excitability changes 
in patients after ACLr, more studies are needed to determine the extent that 
these alterations exist. In addition, other supraspinal areas should be explored to 
determine the systemic effect that ACLr has on the CNS. 
5.3.2 Explaining the Lack of Treatment Effect in the Home-NMES 
Group 
Quadriceps Strength 
The most disappointing finding of this randomized clinical trial was the lack 
of a treatment effect observed with the home-based NMES for any of the 
outcome measures pertaining to neuromuscular quadriceps function. Based on 
the time points in which quadriceps strength was assessed in our study, we 
expected that both groups would demonstrate a V-shaped pattern with temporal 
quadriceps strength changes. However, we hypothesized that the decreases in 
quadriceps strength at three and six months post-ACLr would be less extreme in 
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the Home-NMES group compared to the control, due to the superior treatment 
effects that have been reported with NMES. NMES has been well established in 
the literature as an effective modality for restoring quadriceps strength in patients 
after ACLr.70,104-110,598 In a systematic review conducted in 2010, Kim et al.105 
assessed the effect sizes of six randomized clinical trials that compared the 
effect of NMES interventions on improving quadriceps strength in patients after 
ACLr, to that of other strengthening interventions (i.e., exercise, EMGBF, etc.). 
Of the seven clinical trials, six of them had effect sizes which favored the NMES 
interventions, and half of those demonstrated significant effect sizes (95% 
confidence intervals did not cross 0). From a physiological standpoint, NMES is 
effective at improving quadriceps strength in patients ACLr because it 
preferentially recruits type II (fast-twitch) muscle fibers,115,503,504 which are 
thought be more effected in the quadriceps of patients after ACLr.56,65,86,241-243   
Therefore, since type II muscle fibers are responsible for high muscle force 
production, it is logical that NMES would be an effective modality for improving 
quadriceps strength. 
Furthermore, NMES has demonstrated cross-education capabilities after 
unilateral application.111,138,139,508 Although cross-education has been typically 
reported with exercise,509-512 there is evidence to suggest that NMES may induce 
an even greater cross-education effect.138,139 Hortobagyi et al.138 randomized 32 
healthy women to a NMES and control groups, and asked them to perform 840 
eccentric contractions (control = voluntary, NMES = stimulated) over six weeks. 
Each group was tested before and after six weeks to assess for changes in 
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eccentric quadriceps strength. Improvements in quadriceps strength of the 
trained limb were observed in both groups, but the untrained limb of the NMES 
group demonstrated a 60% increase in quadriceps strength, which was greater 
than that of the control group. Since the untrained limb did not received the 
NMES and was unexercised, the bilateral improvement in quadriceps strength 
after a unilateral NMES intervention could only be explained by a neural 
crossover effect within the central nervous system.116,513-516 
Lastly, there have been a handful of recent studies that have also 
demonstrated significant outcomes in patients with the use of home-based 
NMES devices.129-131 The main benefit of home-based NMES is that a larger 
dosage of NMES can be provided to patients after ACLr. Although the control 
group in this study received NMES treatments on their quadriceps at physical 
therapy during the 12-week intervention period (average of 2-3 visits/week), the 
Home-NMES group was allowed more exposure to NMES within the same time 
window. Because of the convenience and higher NMES dosage that is 
associated with home-based NMES devices, we hypothesized that the Home-
NMES group would demonstrate better quadriceps strength outcomes.  
The reason why we did not observe a treatment effect in the Home-NMES 
group with quadriceps strength may have been due to the different treatment 
procedures used in our study, compared to those studies that have reported 
significant quadriceps strength improvements with NMES.70,104,107,110 In our study, 
we had the Home-NMES group perform their NMES treatments with their knees 
in full/maximal extension. However, the most effective NMES protocols used for 
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improving quadriceps strength require patients to position their knees at 60° to 
90° of flexion when applying NMES to achieve a quadriceps contraction that is at 
least 50% of their MVIC.70,98,104,107,110 Although, there have also been studies 
have demonstrated positive quadriceps strength outcomes in patients when 
applying NMES in full knee extension.108,130 Secondly, even though a greater 
training intensity can be provided by applying NMES in knee flexion, it tends to 
be more uncomfortable for patients, and difficult to attain during home-based 
NMES treatments.  
Another reason as to why we did not observe superior quadriceps strength 
outcomes in the Home-NMES group may have been due to the length of our 
intervention. Our study consisted of a 12-week intervention period, which is 
longer compared to most studies that have shown positive quadriceps strength 
outcomes with NMES.105 In the aforementioned systematic review, 105 the three 
randomized clinical trials that demonstrated significant effects sizes in favor of 
NMES for improving quadriceps strength, also had the shortest intervention 
periods (mean = 4.3 weeks).70,110,598 Thus, the authors concluded that longer 
NMES interventions after ACLr may not be as effective in patients. However, 
their conclusion is interesting since quadriceps strength increases observed 
within the first few weeks of an NMES intervention have been attributed to neural 
adaptations, while those observed in the later weeks have been attributed to 
muscle hypertrophy. 111-114 Therefore, NMES interventions may be more effective 
at increasing quadriceps strength via neural adaptations instead of muscle 
hypertrophy. In our study, the soonest our physicians allowed us to assess 
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postoperative quadriceps strength in patients was at 12 weeks post-ACLr; 
therefore, even if a shorter NMES intervention period was used in the Home-
NMES group, we would have been unable to determine whether neural 
adaptations moderated quadriceps strength deficits in patients within the first few 
weeks after ACLr. 
To date, there have been a total of two studies which have assessed the 
effectiveness of home-based NMES for improving quadriceps strength in patients 
following ACLr.104,130 Most recently, Feil et al.130 assessed the effectiveness of 
three home-based interventions at restoring quadriceps strength in patients after 
ACLr by conducting a randomized clinical trial. A total of 131 patients were 
randomly allocated into one of three groups after ACLr: control group, Polystim 
group, or Kneehab group. The Polystim and Kneehab interventions were both 
home-based NMES interventions with identical stimulation parameters (50 Hz, 0 
– 70 mA), but the Polystim intervention was a traditional two-channel NMES 
device with a single current pathway that is applied between an electrode pair, 
whereas the Kneehab intervention is a multipath NMES device that distributes its 
current to multiple pairs of electrodes within single channels. Both NMES groups 
began their interventions three days post-ACLr, and continued them for a total of 
12 weeks (20 min/day, 5 days/week). The control group received the standard-of-
care, but similar to our study, they performed isometric quadriceps contractions 
of the same duration and frequency as the home-based NMES groups, as a 
method to equalize the exercise volume. Isokinetic (concentric) quadriceps 
strength was assessed prior to ACLr, and every six weeks after ACLr, up to 24 
222 
 
weeks. The authors reported that the Kneehab group demonstrated significant 
increases from baseline to 24 weeks post-ACLr that were greater than both the 
Polystim and control groups. However, there were no significant differences 
observed between the Polystim and control groups in regard to quadriceps 
strength outcomes. The authors concluded the Kneehab group demonstrated 
better improvements in quadriceps strength because multipath NMES allowed for 
more spatial recruitment than the traditional NMES that was used in the Polystim 
group.130 
Multipath NMES has been shown to elicit greater evoked KET from the 
quadriceps when compared to traditional NMES.522 Maffiuletti et al.522 attributed 
these effects to both the higher stimulation intensity that is tolerated with 
multipath NMES, and the wider current distribution between multiple pairs of 
electrodes. Compared to the study by Feil et al.,130 the home-based NMES 
device used in our randomized clinical trial was more similar to the Polystim 
group than it was to the Kneehab group. Like the Polystim group, our traditional, 
home-based NMES device consisted of a two channel, single current pathway 
that was applied between a pair of electrodes. Therefore, the lack of quadriceps 
strength improvements observed in the Home-NMES group of our study may 
have been due to the limitation of traditional NMES.  
However, traditional, home-based NMES has also been shown to be less 
effective at restoring quadriceps strength in patients after ACLr than traditional, 
clinic-based NMES.104 In an earlier randomized clinical trial, Synder-Mackler and 
colleagues104 randomly allocated 52 patients to either a clinic-based NMES 
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group or a home-based NMES group following ACLr. The patients in the clinic-
based NMES group received traditional NMES treatments to their quadriceps 
during their physical therapy visits (3 days/week); whereas the patients in the 
home-based NMES group administered traditional NMES treatments to their 
quadriceps using a portable device (15 mins/treatment, 4 treatments/day, 5 
days/week). Both groups began their respective interventions two weeks post-
ACLr, and continued them for the following four weeks. The stimulation 
parameters were the same for clinic-based and home-based NMES (75 Hz, 300 
μs, 50 – 100 mA), and each group was encouraged to increase the NMES 
intensity to maximal toleration. The contraction intensity was monitored weekly 
by assessing the evoked KET (%MVIC) on the uninvolved limb with each 
patients’ maximally tolerated NMES intensity. After four weeks, isometric 
quadriceps strength was assessed in both groups. The clinic-based NMES group 
was reported to train with higher contraction intensities, and had greater 
quadriceps strength recovery than the home-based NMES group. Furthermore, 
there was a significant correlation observed between contraction intensity and 
quadriceps strength recovery in the clinic-based NMES group, but not in the 
home-based NMES group. Interestingly, the home-based NMES group in their 
study trained at a higher average NMES intensity (83 mA) than the clinic-based 
NMES group (55 mA). However, the traditional, clinic-based NMES was able to 
elicit greater contraction intensities in patients after ACLr. This observation is 
odd, because the evoked KET from NMES is known to be linearly related with 
spatial recruitment of the quadriceps, and NMES intensity is believed to directly 
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affect the evoked force of the quadriceps.518,520,521 Therefore, the higher NMES 
intensity used by the home-based NMES group in this study should have 
produced a high contraction intensity, resulting in greater quadriceps strength 
recovery than what was reported.  
The absence of this observation suggests that traditional NMES my only 
be effective with clinic-based devices, due to a limitation associated with portable 
NMES devices. With portable NMES devices, the electrodes are usually housed 
in a garment that is wrapped around the thigh, like the one used in our Home-
NMES group. However, the distances between electrodes are confined to the 
surface area of the garment, which may restrict the degree of spatial recruitment 
NMES has within the quadriceps. Although spatial recruitment can be improved 
by increasing NMES intensity,521 deeper motor units can also be targeted by 
increasing the inter-electrode distance.520 Conversely, clinic-based NMES 
devices are not restricted to a specific inter-electrode distance. Therefore, the 
lower evoked KET observed in the home-based NMES group of the above 
study,104 may be due to the limited inter-electrode distance of portable NMES 
devices. 
However, this potential limitation of portable NMES devices may be 
corrected if multipath NMES is used instead of traditional NMES. As stated 
above, multipath NMES is believed to allow for more spatial recruitment with the 
quadriceps compared to traditional NMES.130 Furthermore, patients have also 
reported experiencing less discomfort with multipath NMES compared to 
traditional NMES. Since three randomized clinical trials have now failed to 
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demonstrate significant quadriceps strength recovery with traditional, home-
based NMES, multipath NMES seems to be the more attractive home-based 
modality for restoring quadriceps strength in patients after ACLr. Regardless, 
more studies are needed to determine whether multipath, home-based NMES is 
as effective as clinic-based NMES for restoring quadriceps strength in patients 
after ACLr. 
Irrespective of the potential limitations associated with the home-based 
NMES device used in our study, we believe that the main reason why quadriceps 
strength improvements were not observed in the Home-NMES group, was 
because of their poor treatment compliance. Compliance has previously been 
shown to be strongly associated with improved functional outcomes and an 
increased likelihood of returning to sport in athletes after ACLr.599 We 
recommended the Home-NMES group to administer the portable NMES device 
to their quadriceps three times a day, five days a week, for 12 weeks following 
ACLr, with each treatment session lasting 15 minutes. Therefore, the targeted 
treatment duration for the Home-NMES group totaled to 45 hours over the 12-
week intervention. However, after extracting the logged minutes from the 
portable NMES devices, only one of the 25 patients randomized to the Home-
NMES group meet the targeted treatment duration (48 hours, 10 minutes), and 
the average treatment duration of the entire group was just below 11 hours. 
Based on this average, the treatment compliance of the Home-NMES group was 
24%. This observation was discouraging, based upon the treatment compliance 
that has been reported with other home-based NMES studies.104,130 Of the two 
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previous studies that assessed the effectiveness of home-based NMES on 
restoring quadriceps strength in patients after ACLr,104,130 both demonstrated far 
better treatment compliance than the Home-NMES group of our study. In the 
study by Feil et al.,130 the targeted treatment duration for the Polystim and 
Kneehab groups was a total of 60 hours over 12 weeks. Although the Polystim 
group registered less total hours (mean = 39 hours, 18 minutes) than the Knee 
group (mean = 45 hours, 20 minutes), they had nearly three times the treatment 
compliance of our Home-NMES group (65% and 75%, respectively). Likewise, 
the targeted treatment duration for the home-based NMES group in the study by 
Synder-Mackler et al.,104 was a total of 20 hours over four weeks. They 
registered an average treatment duration of 18 hours and 41 minutes, which 
equates to over 93% treatment compliance.  
Except for minor differences in the prescribed treatment duration and 
frequency, these studies mentioned no other factors that may have explained the 
higher treatment compliance compared to our study. Like Snyder-Mackler et 
al.,104 patients in the Home-NMES group were contacted on several occasions 
during the intervention period to insure that they were performing the prescribed 
home-based NMES treatments. Although we did not expect the Home-NMES 
group to achieve 100% compliance, we hoped that they would be similar to 
previous home-based NMES studies. We believe that the age of our patients 
may explain why our patients had lower treatment compliance compared to the 
other two home-based NMES studies. The average age of patients in our Home-
NMES group was 19 years, with the majority of them being high school-aged. 
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Conversely, the average age of patients in the two previous studies ranged from 
25 to 35 years.104,130 Due to these age differences, it is likely that immaturity 
contributed to the low treatment compliance observed in our Home-NMES group. 
If this group consisted of patients whose ages were similar to those of the other 
two studies, we may have observed higher treatment compliance, which would 
have allowed us to better determine the effectiveness of our home-based NMES 
intervention on restoring quadriceps strength in patients following ACLr. In 
conclusion, because of the low treatment compliance observed in this 
randomized clinical trial, we were unable to reject or support the effectiveness of 
our home-based NMES intervention. 
Voluntary Quadriceps Activation 
We hypothesized that voluntary quadriceps activation would be more 
improved in the Home-NMES group after ACLr, based on the neural adaptions 
that are associated with NMES. Although improvements in muscle strength are 
easily attributed to the muscle hypertrophy that develops during NMES 
interventions,111-115 neural adaptations elicited by NMES are also responsible for 
these increases in muscle strength.111-113,116,117 Gondin and colleagues113 
reported that after 4-weeks of NMES treatments to the quadriceps of healthy 
individuals, significances increases in quadriceps strength (+11%,, EMG (+42-
44), and voluntary activation (+5%) were observed, but there were no significant 
changes in quadriceps CSA. However, between weeks four and eight, further 
improvements in quadriceps strength (+11%) were accompanied by changes in 
quadriceps CSA (+4%). The neural adaptations demonstrated in this study 
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supports NMES as a potentially effective disinhibitory intervention for the 
quadriceps of patients following ACLr. 
However, there is conflicting evidence concerning the disinhibitory effects 
of NMES on restoring quadriceps function in a patient population. Several studies 
have reported improvements in the voluntary quadriceps activation of patients 
with NMES interventions.116,118-122 In a case series by Stevens et al.,118 patients 
were assigned to one of two interventions, four weeks after receiving bilateral, 
total knee arthroplasty. Three patients participated in a 6-week (3 
sessions/week), bilateral exercise program consisting of range-of-motion 
exercises, lower extremity strengthening exercises, and functional activities. Five 
other patients participated in the same exercise program, while also receiving 
NMES on the weaker quadriceps. Voluntary quadriceps activation was assessed 
in all patients at baseline, mid-intervention (3 weeks), post-intervention (6 
weeks), and at three and six months. Due to the small sample size of patients, 
the authors chose to not report statistics, but a recent systematic review 
calculated the treatment effect sizes for each group to compare the disinhibitory 
effect of NMES to exercise.101 Strong effect sizes were observed at the 3-week 
(1.66, 95% CI = 0.10, 2.90), 6-week (1.65, 95% CI = 0.09, 2.89) 3-month (1.71, 
95% CI = 0.13, 2.96) and 6-months (1.87; 95% CI = 0.24, 3.13) time points in the 
NMES group. Conversely, the effect sizes of the exercise group were weak (-
0.08 – 0.-48) and insignificant (95% CI crossed 0). Thus, it would seem that 
NMES is an effective motor-based modality for improving voluntary quadriceps 
activation in patients. 
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Conversely, there have been an equal number of studies which report less 
favorable effects of NMES for improving voluntary quadriceps activation in 
patients.123-128 Palmieri-Smith et al.125 randomly assigned 30 patients with 
radiographic knee OA to NMES (4 weeks; 3 sessions/week) and a control group. 
The NMES group received NMES to their quadriceps three times per week, for a 
total of four weeks. Whereas, the control group served as the standard-of-care, 
and did not receive any treatment. Voluntary quadriceps activation was assessed 
in all patients at baseline, one week, and 16 weeks post-intervention. Compared 
to the control group, there were no significant differences in quadriceps CAR 
changes at either post-intervention time point. The authors reported treatment 
effect sizes for each group to compare disinhibitory effects between groups. 
Unfortunately, weak and insignificant effect sizes were observed in both the 
NMES and control groups at five (0.2, 95% CI = -0.53, 0.91 vs. 0.0, 95% CI = -
0.78, 0.78) and 15 weeks (0.42, 95% CI = -0.36, 1.18 vs. 0.33, 95% CI = -1.15, 
0.51). Therefore, they concluded that there was no additional benefit from NMES 
for improving voluntary quadriceps activation in patients with knee OA. 
In addition to the mixed evidence pertaining to the effectiveness of NMES 
as a disinhibitory intervention for the quadriceps of patients, the potential 
limitations of the home-based NMES device used in our study, combined with the 
poor treatment compliance of the Home-NMES group (discussed above), may 
have contributed to the lack of voluntary quadriceps activation improvements of 
observed in patients after the 12-week home-based NMES intervention. 
Furthermore, minimal quadriceps inhibition was observed in the limbs of patients 
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in the Home-NMES both before and after ACLr. Therefore, a potential ceiling 
effect with voluntary quadriceps activation may have prevented us from 
observing a disinhibitory effect with home-based NMES. However, this is the first 
known study that has investigated the disinhibitory effectiveness of NMES for the 
quadriceps of patients following ACLr. 
Corticomotor Excitability 
We believed that changes in corticomotor excitability would be 
demonstrated in the patients randomized to the Home-NMES group, because the 
neuromuscular improvements that have been previously reported with NMES are 
believed to involve alterations at the supraspinal level.116,136,137 In a study by 
Blickenstorfer et al.,136 a single session of electrical stimulation was applied to 
wrist extensor and flexor muscles of healthy individuals, while cerebral activation 
patterns were being captured with fMRI. During electrical stimulation, there was 
significant activation noted in the contralateral primary motor cortex, primary 
somatosensory cortex and premotor cortex, the ipsilateral cerebellum, bilateral 
secondary somatosensory cortex, the supplementary motor area, and anterior 
cingulate cortex. Additionally, Hortobagyi and Maffuiletti116 proposed an 
alternative model in which heightened afferent input elicited by NMES may 
explain the neural adaptations observed with NMES. Since NMES cannot bypass 
the afferent fibers located within both the skin and muscle, this barrage of 
afferent impulses may be transmitted to the sensory system. This sensory 
discharge is thought to trigger supraspinal centers to allow for descending control 
of motoneurons, which elicits a facilitation of motor output to the involved muscle. 
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Therefore, the home-based NMES intervention used in our study was thought to 
elicit corticomotor excitability changes in the Home-NMES group through the 
above mechanisms. 
The fact that no changes in corticomotor excitability were observed in the 
Home-NMES group after the home-based NMES intervention was not particularly 
surprising. The quadriceps AMT of the Home-NMES group was similar to that 
which has been reported in healthy individuals, and there were no changes 
observed at any of the postoperative time points. Therefore, a floor-effect with 
quadriceps AMT may have prevented a treatment effect from being observed in 
the Home-NMES group. Furthermore, to our knowledge, this is the first study to 
investigate whether an NMES intervention can elicit changes in the corticomotor 
excitability measured via quadriceps AMT. Since there was no previous evidence 
to compare to, our hypothesis was generated through inductive reasoning. 
 
5.4 LIMITATIONS AND DELIMITATIONS 
  5.4.1 Limitations 
 There were several limitations in this study that were beyond the control of 
the investigators. The a priori power analysis was performed for voluntary 
quadriceps activation. Since there has been no study that has investigated the 
effect of NMES on improving voluntary quadriceps activation in patients after 
ACLr, we had to base our power analysis on observational data from patients 
before and after ACLr.32 This procedure may have incorrectly estimated the 
sample size needed to achieve statistical power. Secondly, the poor treatment 
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compliance of the Home-NMES group was disappointing, and it may have 
prevented us from observing a treatment effect with any of the neuromuscular 
outcome measures. 
  5.4.2 Delimitations 
There were also several delimitations in this study that were within the 
investigators’ control. A healthy-matched control group was not included in this 
study; thus, we were forced to compare the results of Specific Aims 1 and 3 to 
that of previously reported data on healthy individuals. The group differences in 
peak KET at baseline was an observation of this study that could have been 
prevented by using a different randomization protocol. In addition to stratifying 
patients by autograft type and TFI, we could have included baseline peak KET as 
a stratification factor. Alternatively, we could have performed our statistical 
analyses by using the baseline outcome measures of the groups as a covariate. 
However, the similar limb and time patterns that were observed with peak KET 
between groups after ACLr suggests that this limitation did not confound our 
results substantially. Secondly, the lack of a healthy-matched control group 
prevented us from comparing our patient outcome measures to healthy 
individuals who were assessed using the same equipment and procedures. 
Although inter-rater reliability was established with the majority of outcome 
measures used in this study, we cannot not be fully confident that our techniques 
were exactly the same as those of other investigators. Therefore, comparing our 
results to those of data on healthy individuals collected from other investigators 
was not ideal. Thirdly, unlike other neuromuscular outcome measures, we did not 
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assess the corticomotor excitability in the uninvolved limb of patients. We chose 
not to assess quadriceps AMT in both limbs of patients because this measure 
requires the most, and with several other outcome measures being collected, we 
wanted limit the duration of the testing session for our patients. Lastly, we did not 
monitor the contraction intensity used with the home-based NMES device for 
those patients randomized to the Home-NMES group. This delimitation is 
important, because the contraction intensity elicited by NMES is known to be 
linearly related with spatial recruitment and the recovery of quadriceps strength in 
patients after ACLr.104,518 Monitoring the contraction intensity in the Home-NMES 
group would have allowed us to determine the exercise load that was being 
applied to the quadriceps via the home-based NMES device, and whether this 
load was high enough to expect neuromuscular improvements in quadriceps 
function. Contraction intensity could have been determined by assessing the KET 










CHAPTER 6: CONCLUSION 
 
 Our purpose was to determine the temporal neuromuscular quadriceps 
deficits that develop in patients after ACLr, the effect that early deficits have on 
the lower extremity function of patients at six months post-ACLr, and whether a 
home-based NMES intervention could be used to reduce the extent of these 
deficits in patients following ACLr. Our results from Specific Aim 1 indicate that 
although quadriceps weakness is more apparent in the involved limb of patients 
after ACLr, the quadriceps strength of their uninvolved limb is also affected, 
demonstrating reductions at six months post-ACLr. Due to this observation, 
clinicians are encouraged to not rely on quadriceps strength LSI when making 
return-sport-decisions for their patients after recovering from ACLr. In addition, 
the quadriceps inhibition in the involved limb of patients was not as significant as 
what has been previously reported in patients after ACL injury and 
reconstruction. However, the quadriceps in the uninvolved limb of patients 
demonstrated more inhibition, which may explain the quadriceps strength deficits 
observed in the uninvolved limb of patients following ACLr. To reduce the risk of 
subsequent injury upon return-to-sport and protect against the development of 
knee OA, we recommend that clinicians incorporate bilateral interventions aimed 
at restoring quadriceps strength and disinhibiting the quadriceps. 
 Our results from Specific Aim 2 indicate that the early postoperative 
quadriceps strength of patients around three months after ACLr are associated 
with the lower extremity function of these patients at six months post-ACLr. More 
specifically 3-month quadriceps strength was associated with 6-month lower 
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extremity postural control and self-reported quality of life. These findings 
demonstrate the importance of intensive quadriceps strengthening in the early 
stages of ACLr rehabilitation, so that both lower extremity postural control and 
knee-related quality of life of patients can be improved later on. Although the 
neural measures of quadriceps function in patients did not demonstrate 
significant associations with postoperative lower extremity function, the effect that 
NQD has on quadriceps strength is sufficient for it to be considered during the 
rehabilitation of these patients following ACLr. 
 Lastly, we are unable to prove or disprove the effectiveness of home-
based NMES as a modality for restoring quadriceps strength and activation in 
patients after ACLr based on the results from Specific Aim 3. Although the lack of 
treatment effect observed with home-based NMES may be contributed to 
limitations that are associated with portable NMES devices, we believe that poor 
treatment compliance was the main contributor to the lack of treatment effect 
observed in this study. Home-based NMES provides patients with the ability to 
receive higher doses of NMES to the quadriceps. However, before portable 
NMES devices can be prescribed to patients after ACLr, it must be determined 
whether these devices can elicit similar contraction intensities to that of clinic-
based NMES, and if treatment compliance in patients can be enhanced. 
Furthermore, more randomized clinical trials are needed to determine whether 
NMES and other motor-based modalities have disinhibitory effects in the involved 
limb of patients who exhibit quadriceps inhibition after ACLr, and if these 
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modalities possess the capabilities to elicit a crossover effect in the uninvolved 
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APPENDIX: KNEE INJURY AND OSTEOARTHRITIS OUTCOME SCORE 
 
KOOS KNEE SURVEY 
  
Today’s date:   /  /   Date of birth:   /  /    
Name:      
 
INSTRUCTIONS: This survey asks for your view about your knee. This 
information will help us keep track of how you feel about your knee and how 
well you are able to perform your usual activities. 
Answer every question by ticking the appropriate box, only one box for each 
question. If you are unsure about how to answer a question, please give the 
best answer you can. 
 
Symptoms 
These questions should be answered thinking of your knee symptoms during 





The  following  questions  concern  the  amount  of  joint  stiffness  you  have 
experienced during the last week in your knee. Stiffness is a sensation of 















Function, daily living 
The following questions concern your physical function. By this we mean your 
ability to move around and to look after yourself. For each of the following activities 
please indicate the degree of difficulty you have experienced in the last week 












Function, sports and recreational activities 
The following questions concern your physical function when being active on a 
higher level. The questions should be answered thinking of what degree of 





Quality of Life 
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